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Abstract 
 
 
Climate change presents a major threat to global health and will further exacerbate the health 
inequalities that exist internationally. However, the provision of healthcare results in considerable 
greenhouse gas (GHG) emissions and is therefore contributing to climate change itself. 
Meanwhile, the integration of strategies to address climate change into global health efforts will 
realise health co-benefits. Meeting the challenging carbon reduction targets set within the NHS 
will require an improved understanding of the GHG emissions association with different forms of 
healthcare. This thesis explores the environmental impact of the provision of renal medicine 
services within the United Kingdom, placing a particular emphasis upon GHG emissions.  
 
The approach required, and the opportunities that exist, to reduce the environmental impact of 
renal medicine services are first explored through a review of the existing literature and a survey 
of the current practices of renal services in England, Scotland and Wales. A study, adhering to the 
principles of PAS2050, of the GHG emissions attributable to an individual renal service is then 
reported. This is the first assessment of the carbon footprint of an individual specialty service to 
include both direct and indirect GHG emissions. Consideration is given to how the results might 
inform carbon reduction strategies. Indicative carbon burdens for outpatient appointments and 
inpatient admissions are derived in order to facilitate future modelling of the emissions 
attributable to different clinical pathways of care. A second study, in which the GHG emissions 
attributable to different forms of an individual treatment (haemodialysis) are determined, is then 
presented. Finally, four case studies of good environmental practice within renal medicine, 
identified from the earlier literature search and survey, are presented in the context of the results 
of these studies.  
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Chapter 1.  
 
Climate Change, Health and Healthcare. An Introduction to the Thesis.  
 
Introduction 
 
This thesis explores the environmental impact of the provision of renal medicine services within 
the United Kingdom. A particular emphasis is placed upon the emission of greenhouse gases 
(GHG) in recognition of the current consensus amongst the international scientific community 
that GHGs are contributing to climate change [Intergovernmental Panel on Climate Change, 
2007]. 
 
This thesis does not explore the relationship between GHGs and climate change. However, an 
overview of the relationships that may exist between GHG emissions (and, therefore, climate 
change), global health, and the provision of healthcare is provided within this introductory 
chapter in order to contextualise the carbon footprinting studies and other assessments that are 
described in the subsequent chapters.  
 
 
Climate Change 
 
Through global population growth and intensified economic activities, the actions of humans are 
increasingly impacting upon the world’s biophysical and ecological systems and resulting in 
environmental changes such as freshwater shortages, loss of biodiversity, depleted material 
resources and the exhaustion of fisheries. Climate change may represent a further such example.  
 
The earth’s atmosphere contains GHGs, including carbon dioxide (CO2), methane (CH4), nitrous 
oxide (N2O) and water vapour. The ‘greenhouse effect’ describes the process by which the 
selective absorptive properties of these gases attenuate the energy losses from the earth and 
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contribute to ensuring that the earth’s surface is hospitable to life [Serreze, 2010]. The magnitude 
of this greenhouse effect is believed to be changing.  
 
Since the industrial revolution, the combustion of fossil fuels, which were formed hundreds of 
millions of years ago, has released CO2 back into the atmosphere. Atmospheric levels of CO2 had 
risen to a level of 383 parts per million by 2007, more than 100 parts per million greater than at 
the time that James Watt patented the steam engine in 1769 [Rogner et al., 2007]. Furthermore, 
the levels of other GHGs are also increasing, giving a ‘carbon dioxide equivalent’ (CO2eq) level 
of 455 parts per million [Rogner et al., 2007]. Anthropogenic GHG emissions (those originating 
from the activities of human beings) increased by 70% over the last three decades of the 20th 
century, such that by 2004 these emissions had reached 49 billion tonnes CO2eq [Rogner et al., 
2007]. Furthermore, every one of the thirteen years between 1997 and 2009 was amongst the 
fourteen warmest years on record since 1880 [National Oceanic and Atmospheric Administration, 
2010]. The rising global mean annual surface air temperature is accompanied by thawing of the 
permafrosts, glacial and ice sheet mass reductions, a decline in the amount of floating sea ice, and 
rising sea levels [Serreze, 2010]. Indeed, there is now a clear consensus amongst international 
scientists that the rising levels of man-made atmospheric GHGs are potentiating the greenhouse 
effect and represent the predominant driver of global climate change [Intergovernmental Panel on 
Climate Change, 2007].  
 
 
Climate Change and Global Health 
 
The relationship between climate change and global health is complex and not yet fully 
understood [Frumkin et al., 2008; Global Humanitarian Forum, 2009]. Climate change threatens 
the stability, productivity, and resilience of the natural environment upon which human biology 
and ecology depend, and therefore represents a direct threat to population health [McMichael et 
al., 2009]. Further potential indirect threats to global health might result from the impact of 
climate change upon livelihoods, wellbeing, economic productivity, and social stability within 
populations. However, whilst it is therefore apparent that the effects of climate change will 
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impact adversely upon global health, it is also clear that many of the causes of poor health are 
themselves also contributing to climate change. 
 
The Impact of Climate Change upon Global Health   
It is now appreciated that climate change presents a major threat to global health [Costello et al., 
2009; Global Humanitarian Forum, 2009]. Altered patterns of disease and mortality will result 
from food and water insecurity, extreme climatic events (such as flooding, heat waves, wildfires, 
earthquakes and tornados) and changes in the nature and distribution of transmissible diseases 
[Costello et al., 2009; Nichols et al., 2009]. Vulnerable human settlements will suffer directly, 
whilst the resulting population migration will ensure that few regions of the globe are unaffected. 
It has been suggested that these stresses may also result in conflict including war [Costello et al., 
2009; Jarvis et al., 2011].  
 
Furthermore, the effects of anthropogenic climate change upon health will not be distributed 
uniformly around the globe [Campbell-Lendrum & Woodruff, 2006]. The greatest health impacts 
will be felt by those who have contributed the least to the accumulated reservoir of GHG 
emissions, and for whom access to healthcare resources is most limited [McMichael et al., 2004; 
Global Humanitarian Forum, 2009], further exacerbating the health inequalities that exist at a 
global level between the rich and poor [Costello et al., 2009].   
 
The Problems of Global Health and Climate Change share some Common Origins 
Whilst the most devastating health impacts of climate change are yet to be realised [Costello et 
al., 2009], some of the factors contributing to rising anthropogenic GHG emissions are also 
contributing to many of the more immediate public health challenges, including the epidemics of 
obesity, hypertension and diabetes. Worldwide, obesity has more than doubled since 1980; over 
1.5 billion adults are now overweight, of whom around 500 million meet the diagnostic criteria 
for obesity [World Health Organisation, 2011]. At least 2.8 million adults worldwide die each 
year as a result of being overweight or obese. In addition, 44% of the diabetes burden, 23% of the 
ischaemic heart disease burden and between 7% and 41% of certain cancer burdens are 
attributable to overweight and obesity [World Health Organisation, 2011].  
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Obesity most commonly results from an energy imbalance between calorie consumption and 
expenditure. The widespread availability of energy-dense foods which are high in salt, fat and 
sugars, and the increasingly sedentary nature of western lifestyles, are acting synergistically to 
encourage weight gain [Mozaffarian et al, 2011; Prentice & Jebb, 2004]. It has been argued that, 
in the United Kingdom at least, the reduction in physical activity is the more influential of these 
two factors, as the average recorded energy intake has fallen despite escalating levels of obesity 
[Prentice & Jebb, 1997]. The increasing motorisation of human movement, in place of active 
modes of travel such as cycling and walking, has been implicated as a major contributor to the 
reductions in physical activity; in an analysis of the populations of 130 countries, lower levels of 
motor vehicle gasoline consumption per capita were found to correlate with lower average body 
mass indices [Roberts & Edwards, 2010]. As motorised transport is almost entirely dependent on 
fossil fuels and accounts for almost half of all oil use worldwide it is not only driving the obesity 
epidemic but also contributing to climate change. Increasing the uptake of active travel methods 
must therefore be considered integral to strategies to tackle both the immediate public health 
challenges and the more distant health impacts of climate change [Woodcock et al., 2009].  
 
Similarly, the increasingly sedentary nature of many forms of work has also reduced physical 
activity levels. Whilst the proportion of the workforce of the United Kingdom working within 
financial and business services (and undertaking, it might be assumed, relatively sedentary work) 
has been steadily rising, the proportion working within the agricultural sector (and undertaking 
physically demanding work) has been falling. Although around 77% of the total land area of the 
United Kingdom is now farmed [Ashton, 2002], the agricultural workforce now comprises only 
0.5% of the total workforce in England [DEFRA, 2010]. This represents a fall of 12% since 2001. 
By contrast, in 1850 around 22% of the British workforce was in agriculture. The 
industrialisation of the agricultural sector (a process which, of course, has contributed to the 
widespread availability of energy-dense foods and is a major contributor to anthropogenic 
climate change [McMichael et al., 2007]) has not only resulted in a proportional reduction in the 
sector’s workforce but also explains why those remaining in agriculture now undertake 
comparatively less physically demanding work. Similarly, the mechanisation of the construction 
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and building industries, the replacement of labour-intensive steam power with diesel and petrol 
engines, and the use of labour saving devices in the home (for example, vacuum cleaners, 
washing machines, dishwashers, gas and oil fired heating systems in place of coal and wood 
fires) have all contributed to increasingly sedentary lifestyles. The recognition of the health 
benefits of increasing physical activity in the workplace [National Institute for Health and 
Clinical Excellence, 2008] offers an opportunity to reduce the associated GHG emissions, for 
example through active travel plans.  
 
Livestock production is another major contributor to emissions of GHGs [McMichael et al., 
2007; Steinfield et al., 2006] and a further example of the overlap with health. The annual GHG 
emissions arising from the consumption of a mixed meat and vegetable diet, with the mean 
American caloric content and composition, are almost 1.5 tonnes CO2eq greater per person than 
the consumption of the same number of calories from plant sources [Eshel & Martin, 2006]. 
Meanwhile, diets lower in red meats are associated with health benefits including reduced risks of 
diabetes, cancer and ischaemic heart disease [Aune et al., 2009; World Cancer Fund, 2007; 
Larsson & Wolk, 2006; Sinha et al., 2009]. 
 
The magnitude, timeframe and geographical distribution of the obesity epidemic have, for some 
time now, been indicative that its primary vectors (the imbalance in calorie consumption and 
expenditure) have resulted from societal changes at a population level. Indeed, it has been 
suggested that a more enlightened health sector might have engaged at an early stage with those 
other sectors, such as those responsible for transport and food, with the capacity to influence 
these vectors [Egger et al., 2003]. The recognition of the significance of climate change, and its 
connections to global health, must now trigger effective collaboration amongst such sectors, such 
that population health is re-affirmed as an organising principle of sustainable development.  
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Climate Change and the Provision of Healthcare 
 
Whilst it is therefore clear that, left unchecked, the impact of climate change upon global health 
may be considerable, it is also evident that the integration of strategies to address climate change 
into global health efforts will realise valuable health co-benefits. Additional reasons why the 
healthcare sector, and the specialty of renal medicine, should implement strategies to reduce its 
GHG emissions include: the legally binding targets introduced by the Government through the 
Climate Change Act of 2008 [National Archives, 2008(a)]; the possibilities for financial savings, 
initially primarily through increased energy efficiency, at a time of unprecedented reductions in 
the resources available to the National Health Service (NHS) [Audit Commission, 2010]; and the 
need, and opportunity, for NHS organisations and professionals to set an example [Royal College 
of Physicians, 2010; Roberts, 2009].  
 
However, the integration of strategies to address climate change within global health activities 
must begin with the consideration of the delivery of healthcare itself - as this results in the release 
of GHG, thereby directly contributing to climate change and its attendant threat to global health 
[Sustainable Development Commission, 2008; Chung & Meltzer, 2009; Lyle et al, 2009]. Indeed, 
the magnitude of this contribution is considerable. The NHS England Carbon Emissions Carbon 
Footprinting Report concluded that the GHG emissions attributable to the NHS in England alone 
represent 25% of the carbon footprint of the public sector of the United Kingdom [Sustainable 
Development Commission, 2008]. 
 
 
The Challenge Facing the NHS 
 
Informed by the NHS England Carbon Emissions Carbon Footprinting Report, the NHS Carbon 
Reduction Strategy has set targets for the reduction of GHG emissions within the NHS [NHS 
Sustainable Development Unit, 2009]. Taking 2007 levels as the baseline, the strategy requires an 
80% reduction before 2050 and a 34% reduction as early as 2020. These are challenging targets 
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which will only be achieved by fully understanding the GHG emissions associated with the 
delivery of healthcare. 
 
 
An Outline of this Thesis 
 
Human activity, including the provision of healthcare, has many consequences for the Earth’s 
physical and biological systems. This thesis explores the environmental impact of the specialty of 
renal medicine and begins to identify strategies to reduce it. In recognition of the particularly 
urgent nature of the threat to global health posed by climate change, the thesis focuses upon the 
GHG emissions arising from the provision of renal services, although examples of the wider 
environmental consequences (such as the consumption of water and of non-renewable resources, 
environmental pollution and impacts on biodiversity) of these services are also identified. For the 
benefit of non-physicians, Appendix 1 describes the nature of renal services within the United 
Kingdom, focusing upon those aspects of service provision which are of particular relevance to 
this thesis.   
 
Chapter 2 considers the approach required to reduce the GHG emissions of renal services in the 
United Kingdom. It concludes that improvements in energy efficiency alone will not be 
sufficient, and that a transformation of the way in which renal services are provided will be 
required. The principles that might underpin such a clinical transformation are illustrated using 
examples of good environmental practice identified through a search of the medical literature.   
 
Chapter 3 considers the extent to which these strategies are already incorporated into the delivery 
of the renal services of England, Scotland and Wales. Further examples of good environmental 
practice are identified, as well as opportunities for improvements. This chapter draws upon the 
responses of 58 renal services to a wide-ranging and in-depth survey of sustainability, designed to 
identify strategies for improvement across the different areas of renal services, including building 
energy use, patient and staff travel, the procurement of resources and consumable goods, and 
waste management strategies.  
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Having identified, in the preceding two chapters, opportunities to reduce the GHG emissions 
associated with renal services from both the medical literature and existing practice, Chapter 4 
seeks to contextualise these opportunities through the description of a study of the GHG 
emissions attributable to an individual renal service within the United Kingdom. This study 
represents the first assessment of the carbon footprint of an individual specialty service to include 
both direct and indirect emissions. The chapter considers the overall emissions attributable to the 
service, and also how knowledge of the contributions made by the different sectors (including 
building energy use, travel, procurement and waste management) can inform carbon reduction 
strategies. Indicative carbon burdens for two individual healthcare activities, the provision of 
outpatient appointments and inpatient admissions, are derived in order to facilitate future 
modelling of the emissions attributable to different clinical pathways of care.  
 
This description of the carbon footprint of a healthcare service is followed by the calculation of 
the GHG emissions attributable to an individual treatment. In Chapter 5 the emissions arising 
from the differing modalities and treatment regimes, including both in-centre haemodialysis 
(ICHD) and home haemodialysis (HHD), which are used to deliver maintenance haemodialysis 
are modelled, in order to inform carbon reduction strategies at the level of both individual 
treatments and haemodialysis programmes.  
 
Chapter 6 presents four case studies of good environmental practice. These were identified from 
the literature search and survey reported in Chapters 2 and 3. The case studies were developed in 
collaboration with individual renal services within the United Kingdom, and illustrate how the 
environmental agenda may be aligned with those of care quality and financial cost. The case 
studies include the salvage of reject water during haemodialysis, the use of telephone 
consultations in place of traditional outpatient appointments in the follow up of renal transplant 
recipients, the retro-fitting of heat exchangers to haemodialysis machines, and the role of waste 
management strategies within a renal service. 
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Finally, Chapter 7 concludes the thesis by reviewing its key findings and discussing 
recommendations for future research.  
 
 
The Green Nephrology Programme 
 
The contents of this thesis draw on work undertaken by the author as part of the Green 
Nephrology Programme [Connor, Tomson et al., 2010]. The programme seeks to develop and 
implement measures to reduce the environmental impact of the provision of renal healthcare, 
whilst also improving the quality of this care and reducing the financial costs associated with 
delivering it. The Green Nephrology Programme is delivered through The Centre for Sustainable 
Healthcare (formerly The Campaign for Greener Healthcare), a United Kingdom charity, in 
partnership with many of the organisations responsible for shaping the way in which renal 
healthcare is provided (including NHS Kidney Care, the British Renal Society, the Renal 
Association, the Association of Renal Industries and the National Kidney Federation). The author 
was seconded from his clinical duties to work as the Green Nephrology Fellow between 
September 2009 and August 2010. The Green Nephrology Programme is now established as a 
respected programme for quality improvement in renal medicine and was featured in Sir Michael 
Marmot’s 2010 report on health inequalities, ‘Fair Society, Healthy Lives’ [Marmot, 2010]. 
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Chapter 2.  
 
Opportunities to Reduce the Environmental Impact of the Provision of 
Renal Healthcare.  
 
Introduction 
 
The reasons why the healthcare sector, including the specialty of renal medicine, should seek to 
reduce its GHG emissions were discussed in the previous chapter. The infrastructure required to 
provide renal healthcare includes medical inpatient wards, outpatient clinics, administration 
services, and a relatively high use of electrical medical equipment (for example, dialysis 
machines).  It might therefore be anticipated that measures to reduce building energy use could 
make an important contribution towards achieving such a reduction [O’Leary, 2010]. However, 
the NHS Carbon Reduction Strategy has identified nine key areas in which emissions must be 
reduced within the delivery of healthcare [NHS Sustainable Development Unit, 2009]. This more 
wide-ranging approach has been informed by the NHS Carbon Emissions Carbon Footprinting 
Report [Sustainable Development Commission, 2008], which suggests that building energy use 
contributes only 22% of the overall emissions of NHS England - an indication that, whilst 
initiatives to improve energy efficiency may be both visible and important, they can form only a 
part of the solution. Instead, a clinical transformation of the current systems and practices used to 
deliver healthcare is required to reduce emissions across the different areas.  
 
Four principles have previously been proposed to support this clinical transformation: [Connor, 
Mortimer et al., 2010; Mortimer, 2010]. 
 
• the prevention of disease 
• the education and empowerment of patients in their own care 
• leaner service delivery 
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• the preferential use of those treatment options and medical technologies with lower 
environmental impacts 
 
This chapter will consider how these principles might be applied to the provision of renal 
services, illustrating the approach using examples identified from the published medical 
literature. The chapter then focuses upon further opportunities to improve the environmental 
impact of three aspects of renal services that are anticipated to offer particular scope for change; 
the provision of dialysis, the management of waste, and the procurement of medical equipment 
and pharmaceuticals. 
 
 
Methodology 
 
Attempts to develop a search term that would succinctly identify those publications relating to 
environmental issues across all fields of healthcare proved unsuccessful, resulting in 
unmanageable numbers of irrelevant articles as a result of the need to include a wide variety of 
terms. For example, a literature search through Pubmed 
(http://www.ncbi.nlm.nih.gov/sites/entrez) for articles published in English since 1st January 2000 
using the search term (“sustainable” OR “sustainability” OR “environment” OR “environmental 
impact” OR “carbon footprint” OR “greenhouse gas” OR “climate change”) returned 317,719 
articles despite restricting the search to the titles and abstracts. For reasons of practicality, 
therefore, the literature search was limited to those articles relating to environmental issues 
within the field of renal medicine.  
 
A final literature search was therefore undertaken on 8th January 2011, through Pubmed, for 
articles published in English since 1st January 2000. The search term, ((“dialysis” OR “renal unit” 
OR “renal units” OR “renal service” OR “renal services” OR “nephrology service” OR 
“nephrology services”) AND (“sustainable” OR “sustainability” OR “environment” OR 
“environmental impact” OR “carbon footprint” OR “greenhouse gas” OR “climate change” OR 
“waste”)), was restricted to titles and abstracts. The abstracts of the 377 articles identified were 
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reviewed. Four publications were excluded on the basis of having arisen from work undertaken as 
part of this thesis (Table 1). Only a further 10 articles were of relevance, of which nine were 
published since January 1st 2005 (Table 2). These were retrieved and further articles of potential 
interest were identified from the reference lists. 
 
Table 1: Literature search results: publications excluded on the basis of having arisen from 
work undertaken for this thesis.    
Author(s) Title Reference 
Connor A, Lillywhite 
R, Cooke MW. 
The carbon footprints of home and 
in-center maintenance 
hemodialysis in the United 
Kingdom. 
Hemodialysis International, 
15:39-51, 2011.    
Connor A, Lillywhite 
R, Cooke MW. 
The carbon footprint of a renal 
service in the United Kingdom. 
Quarterly Journal of Medicine, 
103(12):965-975, 2010. 
Connor A, Mortimer F. 
The green nephrology survey of 
sustainability in renal units in 
England, Scotland and Wales. 
Journal of Renal Care, 
36(3):153-160, 2010. 
Connor A, Milne S, 
Owen A, Boyle G, 
Mortimer F, Stevens P. 
Toward greener dialysis: a case 
study to illustrate and encourage 
the salvage of reject water. 
Journal of Renal Care, 36(2):68-
72, 2010.  
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Table 2: Literature search results: publications considered to be of relevance to Chapter 2.  
Author(s) Title Reference 
None listed Low carbon dialysis for James Paget. 
Health Estate, 64(8):76-77, 
2010.  
James R. 
Incineration: why this may be the 
most environmentally sound method 
of renal healthcare waste disposal. 
Journal of Renal Care, 
36(3):161-169, 2010.  
Cheng YW, Li KC, 
Sung FC. 
Medical waste generation in selected 
clinical facilities in Taiwan. 
Waste Management, 30(8-
9):1690-1695, 2010. 
Agar JW. 
Conserving water in and applying 
solar power to haemodialysis: 'green 
dialysis' through wiser resource 
utilization. 
Nephrology (Carlton), 
15(4):448-453; 2010.  
Hoenich NA, Levin 
R, Ronco C. 
Water for haemodialysis and related 
therapies: recent standards and 
emerging issues. 
Blood Purification, 29(2):81-85, 
2010. 
Upadhyay A, Sosa 
MA, Jaber BL. 
Single-use versus reusable dialyzers: 
the known unknowns. 
Clinical Journal of the 
American Society of 
Nephrology, 2(5):1079-1086, 
2007.  
James R. 
Dialysis and the environment: 
comparing home and unit based 
haemodialysis. 
Journal of Renal Care, 
33(3):119-123, 2007. 
Twardowski ZJ. 
Dialyzer reuse--part II: advantages 
and disadvantages. 
Seminars in Dialysis, 19(3):217-
226, 2006. 
Hoenich NA, Levin 
R, Pearce C. 
Clinical waste generation from renal 
units: implications and solutions. 
Seminars in Dialysis, 18(5):396-
400, 2005. 
Park LK. 
 
Guidelines on disposing of medical 
waste in the dialysis clinic. 
 
Nephrology News Issues, 
16(3):16-17, 2002. 
 
Note: it was not possible to 
obtain the full text of this article.  
 
The use of standard literature search techniques to identify good environmental practice within 
healthcare is problematic. The Institute of Medicine recognises six domains of quality within 
healthcare, suggesting that high quality healthcare should be safe, timely, effective, efficient, 
equitable and patient-centred [Institute of Medicine, 2001]. Within the medical literature, it is 
upon these domains that the majority of the reports of treatments, technologies and patient 
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pathways focus, although the importance of placing sustainability at heart of health service 
decision-making has been acknowledged [Royal College of Physicians, 2010(a)]. In many cases, 
therefore, the potential of a treatment, technology or patient pathway to reduce the environmental 
impact of the delivery of healthcare may pass unrecognised or unreported. Furthermore, where 
environmental benefits have been identified in articles, the terminology used to report them may 
be highly variable. It is therefore likely that the search has uncovered only a small proportion of 
the examples of good environmental practice in current practice.  
 
This chapter is not, therefore, intended to represent a definitive report of good environmental 
practice occurring within renal services, but will, instead, provide an insight into the 
opportunities available to effect a clinical transformation of the delivery of kidney care in the 
United Kingdom. With this in mind, the examples described deliberately extend beyond 
improvements in energy efficiency to include strategies encompassing many of the different 
aspects of the delivery of renal healthcare. 
 
 
Applying the principles of clinical transformation to renal medicine 
 
The four principles considered to underpin a transformation to more sustainable clinical practice 
have previously been listed [Connor, Mortimer et al., 2010; Mortimer, 2010]. The application of 
these principles to the provision of renal services is now considered, and the approach is 
illustrated using examples identified from the published medical literature. 
 
 
Disease Prevention and Health Promotion 
 
The increasing demand for healthcare is, in part, driven by improvements in our ability to 
diagnose and treat disease and is contributing to the rising financial costs [Organisation for 
Economic Co-operation and Development, 2010] and GHG emissions [Sustainable Development 
Commission, 2008] associated with the provision of healthcare in the United Kingdom. Strategies 
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designed to prevent the development or progression of diseases might be expected to reduce the 
rate at which the demand for healthcare rises within a population. This, in turn, might be 
anticipated to reduce the GHG emissions associated with the management of these diseases if, as 
seems likely, the emissions attributable to the preventative strategies are consistently lower than 
those arising from the management of the conditions in their absence. Both in individual patient 
care, and through broader advocacy, renal services should be encouraged to tackle the underlying 
causes of disease – modifying the social, economic and environmental determinants of health. 
The identification of effective strategies to achieve this must become a research priority.  
 
For example, although the recent implementation of routine reporting of estimated glomerular 
filtration rate (eGFR) blood tests across most healthcare services in the United Kingdom was 
initially followed by a rise in the number of referrals to nephrology services (with a resultant 
increase in the workloads and, presumably, GHG emissions of these services), these referrals are 
now being reduced to more manageable levels whilst nephrologists are seeing fewer patients 
‘crash landing’ with end-stage renal disease (ESRD) than was the case prior to eGFR reporting 
[O’Donoghue, 2009; Phillips et al, 2009; Byrne, Ford et al. 2010]. Taking admission to hospital 
to be a surrogate for the consumption of resources and therefore the emission of GHGs, it is to be 
anticipated that the unplanned commencement of dialysis will, in the longer term, generate more 
GHG emissions that a planned start, as the former results in more frequent and prolonged 
hospitalisations [Dogan et al., 2005; Lamiere & Van Biesen, 1999; Mendelssohn et al., 2011]. An 
improved understanding of the extent to which the reduction in patients requiring unplanned 
starts on dialysis lowers the environmental impact of the service as a whole will, in turn, inform 
the overall value of the eGFR reporting initiative to the healthcare system.  
 
The electronic recording of patients' blood results offers further opportunities for the early 
detection of renal disease, thereby allowing treatment to prevent disease progression. The 
implementation of a computerised screening system, identifying patients with both diabetes 
mellitus and falling eGFR results (suggestive of progressive kidney damage) is being used to 
bring patients at high risk of end stage renal disease to the attention of a local renal service in a 
timely manner [Rayner et al., 2006]. Recent data suggest a resultant reduction in the incidence of 
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diabetic patients requiring transplantation or dialysis, (personal communication with the author, 
24th September 2010), with anticipated financial and environmental benefits. 
 
 
Patient empowerment and self-care 
 
Patient empowerment is an established component of the successful management of chronic 
disease, [Bodenheimer et al., 200] but its potential benefit in facilitating lower-carbon care also 
merits consideration. Empowered patients are both proactive and reactive in the management of 
their conditions, preventing and responding to the challenges their illnesses present. Such 
patients, for example those undertaking home-based renal replacement therapies, often require 
less input from healthcare professionals, potentially reducing the financial and carbon costs of the 
care they receive. Chapter 5 reports a comparative study of the GHG emissions attributable the 
provision of haemodialysis at home and in-centre. 
 
Strategies to empower patients, and to teach them when and how to access healthcare 
appropriately, may play an important role in the transformation to lower carbon healthcare. 
Established patient empowerment tools are already in use amongst renal services. Renal Patient 
View is a computer system that allows patients to access the results of their blood tests and 
investigations, and that provides reliable information on their condition [Turner, 2006]. The 
service is free to, and popular with, patients [Bartlett et al., 2007]. 
 
Further opportunities are evident within other specialties. For example, the Birmingham Own 
Health project is a regional, evidenced-based, tele-health system that was developed to increase 
the level of self care for people with a range of long term conditions, including diabetes mellitus 
and heart disease. A strategic aim of the project is to induce a paradigm shift from predominantly 
face-to-face care to remote care, with the particular intention of making the service available to 
‘hard to reach’ groups who were known not to access healthcare when provided in the traditional 
way. Results from both routine service monitoring and user evaluations have shown 
improvements in both behavioural and biochemical markers in relation to diabetes and heart 
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disease and high levels of patient satisfaction [National Archives, 2008(b)]. Diabetic nephropathy 
was the most common primary renal disease in patients commencing renal replacement therapy* 
(RRT) in the United Kingdom in 2008 [Byrne, Ford at al., 2010]. Although difficult to quantify, 
it is likely, therefore, that the GHG emissions attributable to the running of a service such as the 
Birmingham Own Health project (which is delivered remotely using telephones) will be heavily 
outweighed by reductions in the emissions resulting from the reduced use of traditional models of 
healthcare, including dialysis, due to improvements in patient health.  
 
 
Leaner service delivery 
 
Developed within the car manufacturing industry, ‘lean’ is a tool to improve flow and eliminate 
lower value activities (and waste). Duplication is common within healthcare systems. The 
application of lean methodologies and the reduction of waste in particular, might therefore be 
anticipated to reduce the associated GHG emissions and financial costs. Indeed, lean 
methodology has formed the backbone of diverse initiatives to meet many challenges within the 
healthcare setting. Examples include improving patient safety [Varkey et al., 2007], enhancing 
the timeliness and quality of the reporting of radiological [Cavagna et al., 2003] and histological 
[Serrano et al., 2010] investigations, and reducing patient waiting times in Emergency 
Departments [Ng et al., 2010], elective [Kullar et al., 2009] and semi-elective services [Ahmed-
Jushruf & Griffiths, 2007].  
 
Lean methodologies might be used to drive reductions in the GHG emissions of renal services 
through the elimination of ‘low value’ healthcare treatments, technologies and models of care. 
Although challenging to define, these might include: those treatments that have been proven to be 
ineffective or, worse still, to do more harm than good; those for which there is no supporting 
evidence and which are not being delivered in such a way that this evidence can be developed; 
those for which evidence of efficacy does exist, but which are being provided outside of the 
                                                 
*
 The term ‘renal replacement therapy’ refers to the two forms of dialysis (haemodialysis and peritoneal dialysis), and also 
to renal transplantation. 
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context in which such evidence was gathered; and those that use resources which would produce 
a better balance of benefit to harm if invested in a different service for the same patients [Gray, 
2007]. Healthcare research has an important role to play in ensuring that only safe and effective 
healthcare is provided; the carbon footprint of the clinical trials required to determine reliable 
information is significant [Lyle et al., 2009; Burnett et al., 2007], but is likely to be far less than 
that of the ineffective treatments, technologies and models of care that may persist in the absence 
of such trials. Indeed, the leading funding body of healthcare research within the NHS has 
recently developed guidelines to reduce the GHG emissions arising from the research trials it 
supports [Lyle et al., 2009; National Institute for Health Research, 2010].  
 
Examples of ‘low value’ practices exist within renal medicine. The provision of haemodialysis is 
both financially expensive and resource intensive. Yet our understanding of when to initiate (and 
discontinue) this treatment, in the settings of both acute and chronic kidney diseases, remains far 
from complete [Cruz et al., 2010; Macedo & Mehta, 2010; Wright et al., 2010]. It is likely, 
therefore, that many patients are receiving unnecessary dialysis treatments, perhaps for prolonged 
periods of time, and possibly to the detriment of their health [Wright et al., 2010; Clark et al., 
2011; Cooper et al., 2010]. An improved understanding of issues such as these may result in 
valuable financial and carbon savings, as well as a better patient experience.  
 
The principle of removing waste can be extended beyond the treatments themselves to include 
the manner of their delivery. Chapter 4 describes how patient travel contributes to the overall 
GHG emissions of a renal service. Initiatives to reduce patient travel, through services such as the 
outreach clinics that are increasingly common in Australia [National Health and Hospitals 
Reform Commission], might not only improve the patients’ experience but also reduce the 
associated emissions. Similarly, patients often attend multiple clinics for different, but related, 
health concerns without co-ordination of appointment dates. For example patients with diabetic 
nephrology may be seen in both the diabetes and nephrology clinics. Opportunities exist to 
reduce patient travel emissions, and once again improve the patients’ experience and care, by 
running joint clinics for these patients.  
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Alternatively, perhaps patients may not even need to attend the clinic in person to receive their 
care. Indeed, many clinicians, faced with the challenge of providing increasingly high standards 
of care to growing numbers of patients with rising expectations, are exploring models of remote 
care. These offer patients and clinicians a number of benefits including enhanced access to 
healthcare, heightened continuity of care, patient empowerment and time savings. Clear benefits 
to the patients and the environment also arise from the reduction in patient travel. Remote care is 
not appropriate when formal physical examination is a likely necessity, but is well suited to the 
provision of follow up for chronic disease, which forms much of the workload of a renal service. 
Yet, whilst remote care has become an established method of reducing the burden on primary 
care and Emergency Departments, relatively little information exists on its use within renal 
medicine. Videoconferencing can facilitate routine consultations between nephrologists and 
dialysing patients [Whitten & Buis, 2008]. Studies have also demonstrated that telemedicine can 
improve access to healthcare, reduce costs, and lessen patient travel, in both haemodialysis and 
peritoneal dialysis [Jennett et al., 2003].  
 
Remote healthcare spans a number of the principles of clinical transformation. Not only does the 
elimination of patient and staff travel represent the removal of waste from the system, but such 
strategies can contribute to patient empowerment and the promotion of self care; this is illustrated 
in Chapter 6 through the report of the use of telephone consultations to provide routine follow up 
to renal transplant recipients. However, further research should focus on the safety of remote care 
and upon measuring its benefits (including those of an environmental nature), in order that the 
fourth principle of clinical transformation – that more sustainable pathways of care are preferred 
wherever possible – may be realised by ensuring that local funding models support remote 
healthcare services within renal medicine.  
 
 
The preferential use of lower carbon technologies, treatments and patient pathways 
 
Clinicians and, where appropriate, patients should be encouraged to choose clinically effective 
treatments with the optimal environmental profiles. However, this will require that measures of 
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environmental impact are included in the evaluation of medical technologies, treatments and 
pathways of care. The results of the literature search outlined earlier in this chapter illustrate that 
such measures are rarely, if ever, assessed, although such an undertaking is now advocated by the 
National Institute of Healthcare Research [National Institute of Healthcare Research, 2010].  
 
Assuming that the spectrum of future research is broadened to support this strategy, it should not 
be expected of clinicians that they make such decisions on an individual patient basis. Instead, 
these considerations must be incorporated into not only the policies and guidance defining the 
nature of high quality kidney care (such as the National Service Framework for renal services in 
the United Kingdom) but also the systems designed to drive this care (such as the payment and 
commissioning systems).  
 
Technological advances present opportunities for lower carbon models of care. The introduction 
of an e-consultation service, facilitating the timely provision of advice by nephrologists to 
clinicians in primary care, has been shown to reduce the number of referrals of patients with mild 
to moderate chronic kidney disease [Stoves et al., 2010]. The confidence of primary care 
clinicians to manage these patients locally was improved and the specialist recommendations 
were well followed.  
 
This chapter has considered firstly, the need for a clinical transformation and, secondly, the 
principles with which such a transformation might be effected within renal medicine, illustrating 
each principle with examples of good environmental practice identified from the medical 
literature. It is important to note that the sustainability agenda has not been responsible for any of 
the developments in the provision of renal medicine provided as examples of improved 
sustainable practice. Indeed, in almost all cases, the primary driver for change has been an 
improvement in one or more of the six domains of quality in the healthcare as described by the 
Institute of Medicine [Institute of Medicine, 2001]. It is clear, therefore, that the transformation to 
more sustainable renal medicine can be achieved alongside improvements in patient care.  
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Consideration will now be given to further opportunities to improve the environmental impact of 
three aspects of renal services that offer particular scope for change; the provision of dialysis, 
waste management, and the procurement of medical equipment and pharmaceuticals. 
 
 
Opportunities to lessen the impact of dialysis upon the environment 
 
The provision of RRT to patients with ESRD forms a major component of the workload of most 
renal services in the United Kingdom. Whilst transplantation represents the optimal form of RRT 
for the majority of patients, the scarcity of donor organs means that the prevalence of patients 
receiving dialysis (411 per million population) is greater than that of patients with a functioning 
renal transplant (363 per million population) [Byrne, Steenkamp et al., 2010]. Although, as these 
figures indicate, the absolute number of patients receiving maintenance dialysis in the United 
Kingdom remains small, a number of factors combine to suggest that the provision of dialysis is 
likely to make a major contribution to the GHG emissions of a renal service: the therapy is 
required life-long; the treatments are required frequently; and each treatment consumes 
substantial resources (energy and water) and produces considerable plastic and packaging waste. 
Furthermore, in the United Kingdom, 43% of all patients receiving RRT undertake ICHD [Byrne, 
Steenkamp et al., 2010], for which the thrice-weekly return travel to the dialysis facility is most 
commonly undertaken by car [The Health and Social Care Information Centre, 2010], a 
particularly carbon intensive form of transport [DEFRA, 2009]. 
 
HHD is arguably more cost-effective [Baboolal et al., 2008] and offers an improved quality of 
life [Finkelstein, 2007]. Whilst robust evidence of improved patient outcomes by way of 
randomised controlled trials is lacking (primarily as a result of the difficulties presented by the 
inherent selection bias), many clinicians are increasingly convinced of the superiority of HHD 
and very few would argue it to be genuinely inferior. However, the uptake of HHD varies 
dramatically between and within countries, and has declined considerably in many regions 
[MacGregor et al., 2006]. Significant expansion of HHD is likely to be possible in many 
countries, in part through embracing evolving technologies.  
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The importance of understanding the environmental impacts of both ICHD and HHD is therefore 
clear. There has been one study on this subject to date [James, 2007], in which methodological 
difficulties in analysing the absolute carbon footprints of these two modalities prompted the 
adoption of a comparative approach in which quantification of the differences in their 
environmental impacts was attempted. Chapter 5 reports the first analysis of the absolute carbon 
footprints of these treatment modalities, including both direct and indirect emissions. Chapter 6 
presents case studies of individual measures to reduce the water use, energy consumption and 
waste production associated with haemodialysis. Meanwhile, further opportunities to reduce the 
environmental impact of the provision of haemodialysis also exist, of which a few are discussed 
here. 
 
 
Water Consumption during Haemodialysis 
 
Water is a finite natural resource. The proportion of the world’s population living in water 
stressed areas is projected to rise from one third to almost half by 2030 [Food and Agriculture 
Organization of the United Nations, 2007; Organisation for Economic Co-operation and 
Development, 2008]. The quantity of water consumed is a particularly striking feature of the use 
of a standard haemodialysis machine. A patient receiving a four hour haemodialysis treatment, 
with a standard target dialysate flow rate of 500 millilitres per minute, will require 120 litres of 
dialysate. In most facilities, this is drawn from the mains water supply and the purification 
process commonly employs reverse osmosis to remove residual salts. Reverse osmosis systems 
reject around two thirds of the water presented to them. Accounting for the water necessary to 
prime and cleanse the dialysis machine, a total volume approaching 500 litres of mains water is 
required per patient per treatment. 
 
The ‘reject water’ from the reverse osmosis system is high-grade water that commonly meets the 
biochemical criteria for potable water and, although it remains legally unacceptable for drinking 
its use for alternative purposes poses no infection risk as reject water does not come into contact 
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with either the patient or the dialyser [Agar et al., 2009]. However, in the overwhelming majority 
of haemodialysis services worldwide, large volumes of reject water are simply lost to drain. A 
case study in Chapter 6 presents the simple methodology required to recycle reject water for other 
uses (such as laundry, sanitation and low pressure boiler feed), illustrating the financial savings 
that have been realised by a United Kingdom renal service.  The extent to which reject water is 
salvaged within the renal services of England, Scotland and Wales is explored in Chapter 3. In 
Chapters 4 and 5, consideration is given to the contributions made by water use to the carbon 
footprints of a renal service and different haemodialysis regimes (including those of the new 
technologies with far smaller water consumptions) respectively.  
 
 
Energy use in Haemodialysis 
 
Although water is a precious resource, Chapter 4 will demonstrate that its use within renal 
services is unlikely to contribute substantially to their overall carbon footprint (as opposed to 
their ecological footprint). Accordingly, therefore, the salvage of reject water results in relatively 
small reductions in GHG emissions. In this regard, the use of solar or other alternative energy 
sources to power dialysis and water purification machinery appears more promising and is now 
being piloted by one renal service in Australia [Agar et al., 2010]. Reductions in actual energy 
used may be achievable through the use of heat exchangers (described in Chapter 6) and variable 
pump speed reverse osmosis plants [Health Estate Journal, 2010].  
 
 
Dialysate Delivery, Production and Use 
 
The use of central delivery systems to provide concentrated dialysate acid reduces both dialysate 
wastage and the plastic waste derived from dialysate containers (which may prove difficult to 
recycle as the possibility of residual acid often discourages local recycling facilities). Further 
environmental savings are possible if this concentrate is delivered in 1:44 concentration (the 
maximum that most machines can proportion), thereby reducing the emissions related to the 
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transportation of large volumes of liquids that are predominantly produced in mainland Europe. 
This benefit would be greater still if the dialysate components were to be delivered in powder 
form and reconstituted on site, however availability and concerns around composition errors and 
contamination presently discourage many units from this option.  
 
Clinicians should also be made aware of the considerable increases in reject water production 
(around 72 litres per treatment) that arise from increasing the dialysate flow rate from 500 to 800 
millilitres per minute, and the lack of firm evidence that this strategy actually increases delivered 
dialysis dose at all [Golper & Ward, 2009]. Furthermore, increasing the dialysate flow rate 
requires a greater volume of dialysate concentrate. In the absence of central delivery systems, this 
frequently results in the opening of a second container of dialysate (with any remainder being 
discarded), thereby doubling both the financial cost and the amount of plastic waste attributable 
to the dialysate usage.  
 
 
Dialyser Reuse 
 
GHG emissions arise from the manufacture and distribution of dialysers. In the United States, 
although many dialysis facilities dispose of dialysers after a single use, 40% of facilities re-use 
them (usually for between 10 and 20 dialysis treatments). It has been estimated that, in the United 
States, dialyser usage contributes over 4,000 tonnes of polymer waste annually, and that this 
figure would fall to approximately 1,000 tonnes if all dialysis facilities were to re-use dialysers 
for ten dialysis treatments [Upadhyay et al., 2007]. Dialyser reuse reduces not only those 
emissions attributable to their manufacture and distribution, but also those arising from the 
incineration of this polymer waste. Dialyser reuse also reduces the amount of dialyser-related 
packaging waste. 
 
Dialyser reuse has been primarily driven by financial considerations [Twardowski, 2006] and is 
most commonplace in the United States. A further advantage, the prevention of first-use 
syndromes through the improvement in blood-membrane biocompatibility, has become less 
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significant as more biocompatible membranes have become available. The health concerns 
around infection risk and exposure to residual germicide from the decontamination process are 
sufficiently small that dialyser reuse is undertaken in 40% of dialysis facilities in the United, 
although rates are falling. 
 
Yet the sustainability of dialyser reuse is unclear. The use of germicides, such as formaldehyde 
and peracetic acid, in the decontamination process raises environmental concerns as it produces 
increased liquid waste (heated water, chemicals and disinfectants) and chemical vapours (such as 
hypochloric acid). The disinfection process also increases the use of disposable waste (such as 
masks, gloves, aprons and test strips). As both single-use practice and more frequent dialysis 
regimes are becoming increasingly common worldwide, there is a pressing need for further 
advances in dialysis waste management. Chapter 5 reports the first quantification of the GHG 
emissions saved through dialyser reuse. 
 
 
The Management of Clinical Waste in Renal Medicine 
 
Haemodialysis is dependent upon the use of sterile, single-use items such as dialysers and blood 
lines, as well as non-sterile items such as dialysate, and therefore produces considerable amounts 
of waste. Previous studies suggest that a single haemodialysis session produces approximately 
2.5 kilograms (kg) of solid clinical waste, of which 38% is plastic [Hoenich et al., 2005]. 
Estimates of the amount of solid clinical waste produced annually by a patient undertaking thrice 
weekly haemodialysis vary between 241 and 390 kg per year [Hoenich et al., 2005; James, 2010]. 
The discrepancies may be attributable, in part, to the use of dialysers and blood lines of differing 
weights [James, 2010], and neither estimate accounts for the substantial cardboard and polythene 
waste that is often associated with packaging. Whilst these figures compare favourably with the 
estimated 617 kg of clinical waste produced per year by a patient undertaking a standard 
continuous ambulatory peritoneal dialysis regime (an alternative treatment to haemodialysis) 
[Hoenich et al., 2005], the proportion of patients undertaking the latter therapy nationally is far 
smaller than those receiving haemodialysis [Byrne, Steenkamp et al., 2010] and the 
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haemodialysis programmes of United Kingdom renal services must therefore be expected to 
aggregate substantially more waste than the peritoneal dialysis programmes.  
 
The vast majority of healthcare waste undergoes disposal through incineration or landfill, with 
only small proportion being sent for recycling or reuse. Much of the waste generated from 
dialysis products and their packaging falls into the category of clinical waste (that which is 
infectious or hazardous). Clinical waste is subject to the Environmental Protection Act of 1990 in 
the United Kingdom and is almost invariably incinerated, although newer technologies for the 
disposal of particular types of clinical waste are emerging.  
 
Uncertainty exists regarding the respective environmental profiles of incineration and landfill for 
healthcare waste. Although the incineration of healthcare waste, using modern incinerators, has 
recently been argued to confer a number of environmental advantages over disposal to landfill 
(not only does incineration allow for the possibility of energy recovery, but it has also been 
suggested that the overall GHG burden associated with landfill may also be greater than 
previously believed) [James, 2010], disposal to landfill remains the cheaper option and is 
therefore presently widely favoured for the non-clinical waste produced by dialysis. Further 
research is required to better understand the possible environmental dividends from preferentially 
diverting waste to incineration. 
 
Although there is little published literature on this topic, renal services should be strongly 
encouraged to develop sustainable waste management strategies. The segregation of waste at 
source is vital to ensure that non-clinical waste (e.g packaging) is, where possible, recycled. For 
example, although commonly incinerated or sent to landfill, plastic dialysate concentrate 
containers should not enter the clinical waste stream unless contaminated by blood or bodily 
fluids, but should instead be recycled or simply reused [James, 2010]. However, waste 
segregation is often poorly achieved in the hospital setting, where clinical waste bags have been 
reported to contain between and 10.2% and 53.2% non-clinical waste by weight [Tudor et al., 
2008]. The case study described in Chapter 6 provides an insight into how improvements might 
be made within a dialysis unit. Although the effective segregation of waste requires staff 
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education and the availability of extra physical space, the benefits appear worth the investment - 
in the case of haemodialysis it has been estimated to yield up to a 29% reduction in the waste 
produced per treatment [James, 2010].  
 
 
The Interface with the Renal and Pharmaceutical Industries 
 
Procurement contributes 60% of the total NHS emissions, with pharmaceuticals and medical 
equipment being primarily responsible [Sustainable Development Commission, 2009]. This 
figure unmasks the indirect emissions related to the manufacturing process. The interface 
between the suppliers of consumable medical goods and those delivering healthcare therefore 
represents an important opportunity for improving sustainability within renal services. The 
process of procurement is a case in point. The incorporation of sustainability criteria by renal 
services into all procurement contracts for dialysis consumables might be expected to incentivise 
improvements amongst industry competitors. However, the extent to which sustainability criteria 
are applied by renal services, and the nature of any criteria in use, is presently unclear, and will 
be explored in greater detail in Chapter 3. Developments in the use of sustainability criteria 
within renal services are also discussed in the concluding chapter.  
 
Dialogue between the industry and healthcare providers is also vital at each stage of the product 
life cycle; for example, are all the components of a product routinely utilised? Will suppliers 
remove packaging for recycling at delivery? Can recyclable plastics be used to make the 
packaging? 
 
Sustainable procurement, on a global scale, might also be employed to drive down those GHG 
emissions arising in the supply chains of pharmaceuticals, but the process will be a slow one. 
Influencing the consumption of medications may appear more immediately feasible. Up to forty 
percent of medications prescribed to those with chronic conditions are never taken [World Health 
Organisation, 2003]. This figure may be even higher amongst the renal population, in whom 
polypharmacy and complicated medication regimes are commonplace. These medications are 
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rarely returned to the pharmacy and, in any case, the Royal Pharmaceutical Society of Great 
Britain dictates that all returned medications must be destroyed (as the quality can no longer be 
guaranteed), entailing considerable financial and environmental costs.  
 
Attention must therefore focus on reducing drug wastage, in which clinicians can play a major 
role through three simple measures. Firstly, they should identify and modify poor compliance. 
Secondly, prescribers should strive to reduce ‘inequivalence’, whereby different items on the 
same prescription are allotted differing durations. This requires patients to manage their repeat 
prescriptions. Some patients will struggle to order only the items they require and instead will 
choose to re-order all the items regardless of their existing stock, leading to drug hoarding. 
Finally, the prescription of excessive quantities should be avoided, as this leads to greater 
wastage when changes are made. This is particularly important when medications are first 
commenced and changes are most likely. Reducing the need for medications through the 
adoption of healthier, lower carbon, lifestyles will also help to reduce the need for medications 
and, in turn, their associated emissions.  
 
 
The Impact of Environmental Pollution 
 
This chapter has focused primarily upon the environmental gains that may be achievable through 
service redesign within renal medicine. However, the converse – that renal services and patients 
might benefit from reductions in environmental pollution made outside of the healthcare setting – 
might also be true. Solvents, such as hydrofluorocarbons, are man-made chemicals with high 
global warming potentials that are used to manufacture products such as paints, adhesives, 
automotive electronics, computers and medical equipment. Occupational solvent exposure 
hastens the progression of existing chronic kidney disease and may also contribute to its initiation 
[Jacob et al., 2007]. Similarly, heavy metals such as cadmium, mercury and lead, are non-
biodegradable, have long half-lives, and represent a major environmental hazard. They are also 
nephrotoxic at very low doses, through both acute and chronic exposures, and cause varying 
degrees of nephropathy from tubular dysfunction to ESRD [Barregard et al., 2010]. These 
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examples illustrate how public health strategies to limit environmental pollution, for example 
through reductions in the use of these metals in dental amalgams (mercury) or smoking cessation 
strategies (cadmium), might reduce the burden of kidney disease.  
 
Even within renal services, direct exposure to man-made chemicals in clinical products may be 
harming both patients and the environment. Dialysis products made from polyvinylchloride 
typically contain the softener di-(2-ethylhexyl)-phthalate, which is toxic to reproduction 
according to the European Union Directive 67/548/EEC on Classification and Labelling of 
Dangerous Substances. The 2008 European Union Risk Assessment on di-(2-ethylhexyl)-
phthalate highlighted the need to limit risks to consumers from medical equipment used in long 
term haemodialysis [European Chemicals Bureau, 2008]. Plastic dialysis products that are free of 
polyvinyl chloride and di-(2-ethylhexyl)-phthalate are now available and the wholesale 
elimination of di-(2-ethylhexyl)-phthalate could be achieved through alterations to renal services’ 
procurement policies. 
 
 
Are Measures to Reduce the Environmental Impact of Renal Services 
Affordable?  
 
The cost of limiting emissions to below 550 parts per million CO2eq has been estimated at 1% of 
the global per capita consumption per year, whilst allowing unchecked emissions may cost the 
world up to 20% of global consumption per year, albeit not realised for up to 200 years [Stern, 
2007]. Thus the argument that measures to reduce emissions will cripple the world’s economy, 
and that further economic growth should precede their introduction, is weak, and such measures 
should be implemented now. But, given that the current economic climate will ensure that 
healthcare systems, including the NHS, will face unprecedented reductions in resources (or, at the 
very least, diminished expansion in the face of ongoing increases in demand), should they too 
invest in green technologies now? 
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It might be argued that they should, as the aforementioned economic arguments apply less well to 
the NHS, in which increased activity is dependent upon economic growth, rather than being a 
driver for it. Indeed, the spiralling costs of the healthcare system in the United States are 
considered to be a major threat to the nation’s economy. Instead, with lean principles and the 
removal of waste at the heart of many of the green initiatives appropriate to renal services, the 
potential for a profitable return on an investment is real, as is illustrated through the case studies 
detailed in the Chapter 6.  
 
 
Conclusion 
 
It has been suggested in this chapter that improvements in energy efficiency alone will be 
insufficient to allow renal services to meet the challenging targets of the NHS Carbon Reduction 
Strategy [NHS Sustainable Development Unit, 2009]. Instead, it is proposed that a clinical 
transformation of the way in which renal services are delivered is required, and that service 
redesign should be focused on those aspects adding real value to patient care. The principles that 
might underpin such a transformation have been illustrated with examples of good environmental 
practice identified predominantly from the medical literature. However, it is clear that many 
opportunities to improve the sustainability of renal services will not previously have been 
reported. Chapter 3 therefore examines the current practices of renal services throughout 
England, Scotland and Wales, seeking primarily to identify further examples of good practice and 
assess the extent to which improvements in sustainability might be made.   
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Chapter 3.  
 
A Survey of Sustainability in Renal Services in England, Scotland and 
Wales. 
 
 
Introduction 
 
Chapter 2 considered how the principles of a clinical transformation to lower carbon healthcare 
might be applied within the specialty of renal medicine. The chapter discussed examples of good 
environmental practice that are either already occurring within the provision of renal healthcare 
or that might be translated across from current practice within other specialties. Whilst these 
examples were predominantly identified from the medical literature, it was acknowledged that 
standard literature search techniques might be expected to identify only a proportion of the 
examples of good environmental practice that have been reported and that, furthermore, many 
examples will not have been reported in the literature. For these reasons, a survey of the renal 
services of England, Scotland and Wales was undertaken, in order to better understand both the 
current and best practices of resource use. This chapter reports the findings of The Green 
Nephrology Survey of Sustainability in Renal Units in England, Scotland and Wales [Connor & 
Mortimer, 2010]. The survey was undertaken as part of the Green Nephrology Programme, 
within which context the objectives of the survey were: to establish a baseline for the sustainable 
use of resources within renal services; to identify examples of good environmental practice; to 
ascertain opportunities for reducing the environmental impact of renal services; and to act as an 
engagement and educational tool for the respondents of the survey and the units that they 
represented.  
 
The meanings of the term ‘sustainability’ are wide-ranging. Within this thesis it is used to 
describe a reconciliation of the environmental, social and economic demands affecting resource 
use in order to facilitate ‘sustainable development’ (the pattern of resource use that allows us to 
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meet our current needs, whilst preserving the environment in order that the needs of future 
generations might also be met) [United Nations General Assembly, 1987].  
 
 
Methodology  
 
The survey focussed upon the environmental threat posed by climate change and was designed to 
address opportunities for the reduction of GHG emissions (mitigation strategies) and the 
preparedness for climate change (adaptation strategies). Short sections on governance and 
attitudes to sustainability within renal services were also included. The questions were informed 
by the way in which renal services are provided in the United Kingdom, and by the NHS Carbon 
Emissions: Carbon Footprinting Report, which revealed that, across the NHS in England, 22% 
emissions arise from energy use on site, 16% are attributable to travel, and 62% result from 
consumption of procured goods and services [Sustainable Development Commission, 2008]. The 
questionnaire comprised 41 stems, each with a varying number of closed-response questions. A 
free-text box was also provided with the majority of these stems and respondents were invited to 
add information they considered to be of relevance. The full questionnaire is available online at 
www.greenerhealthcare.org/webfm_send/76 (last accessed 28th February, 2011).  
 
Seventy eight adult and paediatric renal units were identified across England, Scotland and Wales 
from the Renal Registry website (www.renalreg.com). Sixty-three of these units provided a 
contact to complete the survey, of which 58 (92.0%) submitted responses between October 27th 
2009 and March 9th 2010. Respondents were predominantly Green Nephrology Local 
Representatives (individual staff members with widely differing roles within their local units, 
who were actively identified as part of the Green Nephrology Programme between September 
2009 and January 2010). Each contact was offered the opportunity to complete the survey online 
or in hard copy, and up to three ‘reminder’ emails were sent to maximise the response rate.  
 
Feedback was provided to participating units by way of individualised annotated slide sets. These 
slide sets included the aggregated national results and, to facilitate comparison, the data 
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submitted by the individual unit. Green Nephrology Local Representatives were encouraged to 
present these slide sets at local departmental meetings in order to provoke discussion and bring 
about change. Although a potentially effective tool to stimulate change in healthcare service 
delivery, the use of league tables (at either a regional or national level) to display the results was 
not considered appropriate as it had not been suggested to respondents as a possibility prior to 
their participation on behalf of their units. Alternatives to providing simply the aggregated 
national results as the comparator for each unit’s performance were considered: it was rarely 
considered necessary to state the gold standard (for example, it is clear that the gold standard for 
the use of low energy light bulbs is for them to be present in 100% of fittings); the extent of 
variation existing around the national averages may have been of interest, but it was considered 
important to keep the results, and their interpretation, simple.   
 
 
Results and Interpretation 
 
As not every respondent submitted data for every question, percentages are also quoted in this 
report to allow a more accurate appreciation of the results. Almost all responses (55, 95%) related 
to hub units, whilst just three (5%) detailed a satellite unit. 
 
Building Energy Use  
Building energy use (heating and cooling, hot water and electricity consumption) contributes 
22% of the overall NHS carbon footprint [Sustainable Development Commission, 2008] and 
offers a number of ‘quick wins’ for renal units seeking to reduce their carbon footprint.  
 
Lighting 
The level of lighting was reported to be appropriate in most (42, 75%) units, with only five (9%) 
considering their units to be too bright. Although low-energy light bulbs are used in ‘all or almost 
all’ lights in over a quarter (17, 30%) of surveyed units, they are used ‘in none or very few’ of the 
lights in 23 (40%) surveyed units, suggesting an opportunity for improvement. When not 
required, lights are ‘usually or always’ switched off in over half (35, 61%) of surveyed units and 
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are ‘occasionally’ switched off in a further 16 (28%) surveyed units. The results suggest that this 
could be improved through the more widespread use of motion sensors, which are not used at all 
in the majority (36, 63%) of surveyed units.  
 
Heating 
Inaccessible thermostat and heating controls render it impossible for staff to control the heating in 
35 (61%) of the surveyed units. Furthermore, air chilling facilities are not automatically switched 
off when the heating is switched on in 29 (51%) surveyed units. Shading is provided for south 
facing windows in only 36 (63%) surveyed units. Overall, it was felt by staff that appropriate 
temperatures were maintained in only 35 (63%) units. Renal units could therefore be encouraged 
to ensure that their staff can control room temperatures, whilst appreciating the needs of the 
patients when doing so (as, for example, patients undergoing dialysis often feel cold).  
 
Energy Use within Information Technology 
Although the benefits of switching off information technology equipment overnight (financial 
and environmental savings, improved computer updating and running speeds) are being 
recognised, with 34 (60%) surveyed units actively encouraging their staff to switch computers 
off, only six (11%) units have automatic mechanisms in place to ensure that this occurs. This is a 
‘quick win’ that could be more widely adopted.  
 
Equipment 
The recapture of heat from hospital equipment represents an opportunity to reduce electricity use. 
Only 14 (25%) of surveyed units reported recapturing heat from dialysis effluent. Although this 
value is almost certainly an under-representation of the true number (the presence of heat 
exchangers, which are increasingly incorporated into modern haemodialysis machines as 
standard, may not be immediately apparent to respondents unfamiliar with the machines utilised 
in their unit), it does suggest that the simple process of retro-fitting heat exchangers to dialysis 
machines without them might allow some of the remaining units to recapture heat and reduce 
electricity use. This is explored as a case study in Chapter 6. Improving on the seven (13%) 
Central Sterile Services Departments reporting to recapture heat from the process of sterilizing 
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medical equipment may be less feasible however. Meanwhile, only 13 (23%) surveyed units 
reported having policies to preferentially purchase energy efficient equipment, and these policies 
are often inconsistent (for example, in one unit the energy rating of fridges is considered 
important, whilst that of dialysis machines is not).  
 
Energy Sources 
The use of lower-carbon, renewable energy sources reduces fossil fuel consumption and could 
undoubtedly be undertaken more widely by renal units, and their parent hospitals, both through 
local energy generation and through the procurement of energy from a provider with a genuine 
commitment to renewable energy sources. Two surveyed units (4%) currently generate energy 
from solar panels, with plans are in place to fit panels in two further units, although no units 
currently generate energy from wind turbines.  
 
Patient and Staff Travel 
Travel contributed 16% to the overall NHS carbon emissions [Sustainable Development 
Commission, 2008], but might be expected to contribute more significantly to the footprint of 
renal services given that the predominant form of RRT, ICHD [Byrne, Steenkamp et al., 2010], 
necessitates thrice weekly return journeys to hospital. Geographical factors will influence the 
potential for individual units to reduce the carbon footprint of associated travel. The majority of 
respondents felt that their units covered an equal mix of urban and rural areas (32, 55%), with 20 
(35%) covering predominantly urban areas.  
 
Staff Travel 
The trusts of 46 (81%) units have signed up to the Cycle to Work scheme 
(www.cyclescheme.co.uk) whilst 47 (83%) units provide secure cycle parking and 39 (68%) have 
adequate shower and changing facilities. Walking and cycling were considered to be unsafe in 12 
(21%) units, suggesting that it may be difficult to improve on these figures. 
 
Changes to staff shift patterns might enable greater use of public transport. Although 54 (95%) 
respondents considered their units to be reasonably or highly accessible by public transport, staff 
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shift patterns do not correspond to the public transport timetables in 28 (49%) of cases, with a 
further 10 (18%) units unclear about this. It was noted that those staff on early or late shifts are 
often poorly served by public transport. Car share schemes operate in 29 (51%) of units (or 
trusts), although respondents commented that trusts rarely offer incentives for their uptake.  
 
Patient Travel 
As over half of surveyed units (37, 65%) do not actively provide information about public 
transport or encourage its use, public transport is probably also underused by patients as well as 
staff. Although anecdotally a source of much frustration to dialysis patients, 39 (68%) units 
reported that treatment schedules are designed to correspond to patient travel timetables and 
thereby allow efficient journey planning. Only 11 (19%) surveyed units predominantly use low 
emission vehicles for patient travel and it was noted that renal units may have no direct control 
over such services.  
 
Given the potential health co-benefits [Woodcock et al., 2009], renal units should ensure that 
active transport (cycling and walking) is a genuine option for those patients and staff wishing to 
pursue it. For example, some units reported offering more flexible patient transport planning, 
providing transport home for those patients who preferred to walk to their dialysis sessions (as 
the treatment may leave patients feeling tired). Twenty-four (42%) of surveyed units currently 
provide information on the health benefits of active transport to patients. Telemedicine offers the 
opportunity to reduce unnecessary travel [Yellowlees et al., 2010]. The provision of remote 
healthcare, in different guises, was reported in seven (12%) surveyed units.  
 
Procured Goods & Services (Consumption and Procurement Practice) 
Procurement is responsible for 62% of the GHG emissions attributable to NHS England, with 
pharmaceuticals and medical equipment contributing 30% of total emissions [Sustainable 
Development Commission, 2008]. With many patients with renal disease experiencing 
polypharmacy, and the widespread availability of renal replacement therapies being highly 
dependent upon the use of consumable items of medical equipment, the reduction of this aspect 
of the carbon footprint of renal services must be an important longer term goal.  
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Sustainable Procurement Strategies  
The widespread incorporation of sustainability criteria into the procurement contracts put out to 
tender by renal services represents an opportunity to reduce the environmental impact of the renal 
industry. These criteria might initially be used to encourage the measurement of different aspects 
of the environmental impact of the supplying organisations and their products, with future 
iterations focusing upon improvements in these measures.  
 
The benefits of sustainable procurement extend beyond its benefit to the environment. An NHS 
organisation is many things, including: an employer; a purchaser of goods and services; a 
manager of transport, energy, waste and water; a landowner; a commissioner of building work; 
and an educator. How such an organisation behaves may therefore impact at a local level upon 
the health and well being of the people and society, the economy and the environment. As 
significant components of the healthcare organisations of which they are part, renal services can 
therefore make an important contribution towards sustainable development within their day to 
day running. The Good Corporate Citizenship model, within which procurement forms one of the 
six strands of development, allows renal services (and their parent organisations) to showcase this 
contribution and to set an example [Sustainable Development Commission, 2006]. 
 
Renal services may also make considerable financial savings through sustainable procurement, 
reducing utility bills and operating costs through the purchase of energy, water and resource 
efficient products, services and buildings. The significant waste management costs incurred by 
NHS organisations might be reduced by the purchase of environmentally preferable products 
[Tudor et al., 2008]. Furthermore, the implementation of sustainable procurement strategies 
might help renal services to meet the challenges of the impending regulatory and fiscal policies 
for carbon reduction, such as the NHS Carbon Reduction Strategy [NHS Sustainable 
Development Unit, 2009] and the Carbon Reduction Commitment Energy Efficiency Scheme 
[Department of Energy and Climate Change, 2010]. 
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However, despite the benefits to renal services, the survey results indicate that sustainability 
criteria are currently incorporated into only 7% of contracts for peritoneal dialysis supplies, 9% 
of contracts for haemodialysis supplies and 4% of contracts for office supplies. Respondents also 
highlighted the exclusion of sustainability criteria from the recent Scotland-wide consumable 
procurement contract, despite calls for their inclusion from clinicians. Potential barriers to 
sustainable procurement must therefore be considered, and informal feedback from respondents 
indicates that implementation is hindered by a number of factors, including: difficulties 
determining effective sustainability criteria; competing considerations within the procurement 
process, including financial cost; a lack of guidance at the level of individual renal services; and 
the different patterns of procurement currently existing amongst, and within, different renal 
services.  
 
The determination of effective sustainability criteria represents a particular challenge. The criteria 
must assess genuinely measurable standards of sustainability, and should lie within the reach of 
the majority of supplying organisations, yet also result in improvements in current practice. They 
should relate, ideally, to both the product and the organisation, including the relevant supply 
chains. They should be afforded appropriate weighting within the contract and, finally, they 
should not contravene European Union directives regarding fair trade.  
 
Printers and Paper Use  
Further ‘quick wins’ are possible by addressing printer and paper use. Printers in renal units are 
rarely (12, 21%) set to draft quality and almost never set to print double-sided (7, 12%). Less 
than a third of units purchase recycled paper (17, 30%) despite twice as many recognising the 
importance of recycling by providing recycling bins in their administrative areas (38, 67%). 
Email is preferred to paper copy for letters to primary care in only 4 (7%) units.  
 
Clinical Supplies 
Haemodialysis fluids are delivered to units in individual cartridges (rather than by central 
delivery) in 24 (44%) surveyed units, increasing plastic and packaging waste. Similarly, 24 
(44%) surveyed units reported not purchasing their dialysates in the highest available 
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concentration, increasing the volumes that must be transported. Furthermore, no effort is made to 
recycle the extensive plastic and paper packaging associated with single-use dialysis equipment 
in 38 (69%) units whilst, of those that do, the majority (57%) estimate that they recycle less than 
40% of it.   
 
Healthcare Waste Management 
Healthcare produces two main forms of waste; non-clinical (domestic) waste and clinical waste. 
Whilst the former may be sent to landfill or, preferably, recycled, the latter must be incinerated. 
As was discussed in Chapter 2, further research is required to better understand the respective 
environmental impacts of the different disposal strategies for healthcare waste. Meanwhile, 
however, renal services should still be encouraged to develop sustainable waste management 
strategies, to which the effective segregation of waste at source is vital. Only that waste which 
genuinely requires incineration should enter the clinical waste stream, and recyclable domestic 
waste should not be sent to landfill. Waste segregation requires staff education and facilities, 
which occupy extra space, to stream clinical and non-clinical waste.  
 
Although 34 (60%) respondents felt that efforts to stream waste were moderately satisfactory in 
their units (with ‘domestic waste sometimes ending up in clinical waste bags and sharps bins’), 
this subjective response is at odds with that of more objective studies [Hutchins, 2009]. Regular 
waste auditing within renal services may challenge staff beliefs around, and improve upon, the 
current standards of waste segregation. 
 
Recycling bins for non-clinical packaging and plastic wastes are not present in the clinical areas 
of 41 (73%) and 45 (79%) surveyed units respectively, indicating potential for ‘quick wins’. 
Similarly, many suppliers are able to collect and directly re-use the pallets and cardboard boxes 
used in the delivery of dialysis supplies, but this is presently only occurring in 27% (for 
haemodialysis related delivery waste) and 15% (for peritoneal dialysis related delivery waste) of 
surveyed units. Only 40% of those units from whom pallets and cardboard are not collected by 
the supplier are sending these items for recycling themselves.  
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Food Packaging and Recycling 
The extent to which the packaging associated with inpatient food is recycled is also poor. 
Recycling rates below 25% were reported by most units for plastic (30, 58% of units), aluminium 
(31, 60%), paper (20, 40%) and glass (25, 48%) forms of catering waste. However, as some units 
reported recycling greater than 80% of each of these items, improvements in this area should be 
feasible. Respondents commented that the outsourcing of catering to national organisations 
reduces the opportunity to influence recycling and the sourcing of local produce.  
 
Water Conservation 
Water is a precious and finite natural resource - but one that is under threat [Intergovernmental 
Panel on Climate Change, 2007]. The same water stores that were available to the 300 million 
inhabitants of the earth in Roman times are now shared amongst a global population of 6.7 billion 
people, more than one third of whom now live in water-stressed countries [Food and Agriculture 
Organization of the United Nations]. We therefore have a responsibility to use water carefully. 
As was discussed in Chapter 2, the needless ‘loss-to-drain’ of reject water during the production 
of the dialysate for haemodialysis remains by far the most profligate use of water within 
healthcare. Presently only two surveyed units (4%) have installed the simple methodology 
required to conserve this high grade water. This not only allows it to be put to alternative 
purposes (such as laundry, sanitation systems and low pressure boiler feed) but has also been 
shown to make sound financial business sense [Agar et al., 2009; Connor, Milne et al., 2010]. A 
detailed report of the conservation of reject water from haemodialysis is included as a Case Study 
in Chapter 6.  
 
Water-saving taps are not present in any sinks in the majority (36, 64%) of surveyed units, and 
are present in only a few sinks in nine (16%) of the remaining surveyed units, indicating that their 
widespread adoption should be encouraged. Despite renal units often having large roof areas, 
only one (2%) unit reported harvesting rain water.   
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The Built Environment 
Buildings should be designed to encourage sustainable development and support lower carbon 
activity in every aspect of their fabric and function [NHS Sustainable Development Unit, 2009]. 
However, more than half of respondents (32, 56%) felt that the impact of staff and patient travel 
had borne little influence on where new facilities were built, whilst almost one third (18, 32%) 
believed that opportunities to incorporate natural light, heating and ventilation were passed over. 
Most surveyed units offer both patients (39, 70%) and staff (40, 73%) little access to green 
spaces. The majority of respondents (36, 64%) were unable to ascertain whether either new 
buildings or refurbishments were required to meet specific Building Research Establishment 
Environmental Assessment Method (BREEAM) ratings. More positively, reported examples of 
good practice included the use of ground heat source pumps and heat recapture from activity 
within buildings, whilst one unit is investigating the possibility of a wood chip boiler.  
 
How important is climate change perceived to be by renal units? 
Given that respondents to the survey were predominantly Green Nephrology Local 
Representatives, it is perhaps not surprising that 33 (65%) believed that reducing the carbon 
footprint of the provision of renal services is ‘very important and must be prioritised’ (with the 
remaining 35% of respondents to this question believing that it is ‘important but that other 
improvements to the service should take priority’). However, many respondents also commented 
that there was considerable ambivalence to the topic within their units, and the results indicate 
that renal services do not presently perceive climate change to be of direct relevance to their 
practice. Most surveyed units (52, 91%) have not undertaken a sustainability audit (which would 
typically include assessments of energy, transport and waste management). The majority of 
surveyed units (50, 88%) do not have Green Action Plans and do not include sustainability as a 
regular topic in the departmental management meetings (49, 86%). Although 16 (29%) surveyed 
units have a published policy on carbon reduction and/or sustainability, this is likely to be 
undertaken at Trust level.  
 
No information on environmental issues is included in staff induction programmes at 49 (86%) 
surveyed units. No training in the relevance of environmental issues to their daily work is 
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provided in 48 (84%) of surveyed units. Most surveyed units (47, 83%) have no system in place 
to allow staff to contribute suggestions for carbon reduction within the unit, a source of 
frustration for many respondents.  
 
Preparedness for the Effects of Climate Change 
Heat waves, flooding, storms and other extreme weather events are likely to increase in 
frequency as a result of climate change [Costello et al., 2009]. The Climate Change Act 2008 
requires that all statutory sectors, including the health sector, have robust adaptation plans in 
place [National Archives, 2008(a)]. It is therefore heartening to find that most surveyed units 
have emergency strategies to cover interruptions to the power (56, 98%) and water (48, 84%) 
supplies. However, most surveyed units (30, 54%) do not have provisional arrangements should 
weather disrupt the travel plans for the haemodialysis patients, whose lives would be endangered 
were they to be unable to attend their thrice-weekly in-centre treatments.  
  
Only seven (12%) surveyed units have incorporated the National Heat Wave Plan into their 
policies [Department of Health, 2010(a)]. Increases in the rate of emergency admissions to 
hospital during heat waves have been reported for patients with kidney disease in both the United 
Kingdom and elsewhere [Kovats et al., 2004; Hansen et al., 2008], suggesting that such patients 
may be at greater risk than most from extreme temperatures. This may be particularly true for 
those patients with chronic kidney disease who are not yet requiring dialysis, and in whom, it 
might be postulated, a smaller degree of intravascular hypovolaemia (resulting from the increased 
insensible losses that occur during periods of hot weather) may have a more detrimental impact 
upon kidney function. Furthermore, it has been suggested that medications, including some of 
those commonly prescribed to patients with kidney disease, may increase susceptibility to 
dehydration during heat waves [Hajat et al., 2010]. However, only 18 (32%) surveyed units 
provide formal information to patients regarding how to care for themselves during heat waves, 
whilst only half (31, 54%) of surveyed units are able to keep temperatures in their clinical areas 
below 26 °C during heat waves. 
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Limitations 
 
The design of this survey suffered from the conflict between the need to gather sufficiently 
quantitative data in order that the future iterations of the survey might permit the monitoring of 
sustainability, and the desire to ensure that respondents (newly appointed to their roles and 
without data collection systems in place for this information) could complete the survey without 
undue difficulty. As such, not all of the desired data were requested and surrogate metrics were 
employed in many instances instead. It might be hoped that future iterations of the survey may 
collect more quantitative data. For example, the interest in lightbulbs results primarily from the 
carbon emissions related to the energy that they use. The optimal metric to represent this might 
perhaps therefore be the lightbulb-associated CO2eq produced per metre of indoor space over a 
given time period. However, requesting such information from each unit is clearly not practical, 
and this iteration of the survey simply asked respondents to estimate (within specified percentage 
groupings) the extent to which low-energy bulbs are used in their unit. This example also 
illustrates the role that sub-metering within hospitals (in this case, sub-metering of the lighbulb-
associated energy use with a renal unit) could play in identifying and reducing energy usage and 
financial costs.  
 
The respondents to this survey were predominantly Green Nephrology Local Representatives. 
These individuals had committed to working with the Green Nephrology Programme to achieve 
its wider goals on behalf of their units. It might be anticipated, therefore, that these individuals 
would have a keener interest than most in the issues around climate change, and that this might in 
turn enable them to provide more accurate and insightful answers to the survey questionnaire. 
However, it should be noted that these individuals have widely differing roles within their local 
units, and this diversity might also have influenced their responses. 
 
Respondents were not found for 15 of the 78 originally identified renal units. It is possible that 
those units that did not respond were those practising least sustainably (particularly as 
respondents were predominantly Green Nephrology Local Representatives), introducing a degree 
of bias within the results. However, there were no apparent demographical differences between 
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those units providing responses and those not doing so, and, overall, the results were considered 
to adequately reflect practice across the United Kingdom.  
 
 
Discussion 
 
The primary objective of this survey was to establish a baseline for environmental practice within 
the delivery of renal services across England, Scotland and Wales. In essence, the Green 
Nephrology Programme is a series of individual Clinical Systems Improvement projects 
interwoven amongst the widespread development of a sustainability culture within kidney care. 
Future iterations of this survey will allow the magnitude and direction of any change resulting 
from these interventions to be monitored. The role of the Renal Registry reflects an appreciation 
of the importance of monitoring outcomes within renal medicine. However, the discipline of 
patient safety – another relatively recent and rapidly evolving dimension of clinical care from 
which the Green Nephrology Programme can learn – has been cited as an area in which the 
inappropriately late adoption of such monitoring has hindered further progress in the field 
[Vincent et al., 2008].  
 
The survey was also intended to support a transformation to lower carbon care by identifying the 
most fruitful areas for attention. It was designed to identify examples of good environmental 
practice already being achieved in individual renal units, with a view to facilitating their 
widespread adoption through the development of case studies such as those reported in Chapter 6. 
The survey was also designed to identify those aspects of the provision of renal care in which 
current practice is commonly particularly damaging to the environment, but in which simple 
interventions might lead to significant improvements. The Green Nephrology Programme was 
aligned with the objectives of the national 10:10 Campaign and these ‘quick wins’ were 
presented in poster format as the 10:10 Renal Checklist [The Centre for Sustainable Healthcare, 
2010].  
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Finally, the use of slide sets to convey the results of the survey to the participating units has 
ensured that the work has an educational component, raising awareness of the Green Nephrology 
Programme, providing receptive members of the renal community with ideas to improve the 
environmental profiles of their units, and highlighting the extent and importance of the change 
required.  
 
 
Implications for Renal Units 
The results of this survey indicate the extent to which the sustainability of resource use within 
renal services might be improved. In response to these results, the Green Nephrology Programme 
is encouraging renal services to develop a sustainability culture within their units, with every unit 
in England, Scotland and Wales appointing a Green Nephrology Local Representative and 
sustainability becoming a regular feature at their departmental meetings. Units are encouraged to 
implement a system to allow staff members to contribute improvement ideas. The development 
of strong relationships between renal services and their respective Estates and Procurement 
departments will enable the introduction of more wide-reaching sustainability initiatives. Where 
possible, patients should be offered the opportunity of involvement in their unit’s green 
initiatives.   
 
The results of this survey support the premise that sustainable healthcare requires not only 
sustainable estates management but also sustainable clinical practice. Sustainability should 
become a key consideration in the development of care pathways and existing practices should be 
reviewed. For example, can patient travel be safely reduced by telephone consultations or through 
the administration of iron infusions in the community? 
 
 
Implications for the Green Nephrology Programme 
The results of this survey have informed the choices of case studies developed to date (the 
conservation of reject water, the retro-fitting of heat-exchangers to dialysis machines, the 
provision of follow up to transplant recipients by telephone consultation and recycling within 
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renal units are all reported in Chapter 6). The results also highlight areas in which further work 
should be focused, including patient and staff travel, information technology, and implementing 
sustainable procurement strategies. 
 
Variation exists between the demographics of the populations served by different renal units, the 
services that are provided, and the pathways and infrastructure used to deliver these services. 
Although our survey facilitates crude comparisons of the environmental impact of individual 
aspects of the services provided by different renal units, it was not possible to attribute an 
accurate weighting to impacts of these parameters, and a comparative analysis of the overall 
sustainability of the different renal units was not possible. At a more simplistic level, however, no 
individual units, or models of service, were readily discernible as more sustainable. In particular, 
there were no obvious differences in the sustainability of those units providing acute 
transplantation services or paediatric care. 
   
 
Areas for Further Research 
 
Although vital for the longer term success of the Green Nephrology Programme, no attempt was 
made to measure the existence of a ‘sustainability culture’ within the renal community with this 
survey. Similarly, no attempt was made to ascertain any measures taken by individual units to 
encourage more sustainable lifestyles amongst their patients. Finally, as has been mentioned 
previously, this survey was unable to accurately assess the overall sustainability of an individual 
renal service. A better understanding of both the overall impact of a renal service upon the 
environment, and the contribution of the different aspects of this service to its overall impact, is 
therefore required. This is explored in detail in Chapter 4.  
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Chapter 4. 
 
The Carbon Footprint of a Renal Service in the United Kingdom. 
 
 
Introduction  
 
Although many opportunities to reduce the environmental impact of renal healthcare (and, in 
particular, the GHG associated with its delivery) have been described in the preceding chapters, it 
is clear that a clinical transformation of the provision of renal services will be required if the 
challenging targets set out by the NHS Carbon Reduction Strategy are to be met [NHS 
Sustainable Development Unit, 2009]. Meanwhile, the recent NHS Next Stage review 
[Department of Health, 2008] has outlined a similar need for service change and innovation 
within the NHS in order to improve the more widely recognised domains of quality within patient 
care. Such service reconfigurations present an opportunity to integrate the principles of a clinical 
transformation towards lower carbon care into renal services.  
 
However, there has been little evaluation of this opportunity to date, with the current economic 
climate focusing consideration upon the financial, rather than environmental, impacts that any 
reconfigurations might have. Indeed, the evidence base to support the implementation of 
individual strategies to provide lower carbon renal healthcare is currently slender. The literature 
review described in Chapter 2 retrieved only a handful of publications relating to sustainability 
within renal medicine, and the examples of good environmental practice identified through the 
survey reported in Chapter 3 were occurring predominantly in isolation and without evidence of 
shared learning. Similarly, a recent systematic review concluded that there has been very little 
original research into the implementation or evaluation of actions to reduce the contribution made 
by the NHS to climate change [Nichols et al., 2009]. Further research, including carbon 
footprinting studies, is therefore required to better understand the environmental impacts of 
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healthcare technologies, treatments and pathways, such that these impacts can be considered 
during service reconfigurations.  
 
Chapters 4 and 5 begin to address this deficit in our understanding by reporting carbon 
footprinting studies of standard renal services and treatments respectively. Chapter 4 begins by 
considering what is meant by a carbon footprinting study and the different approaches that may 
be taken, before exploring, by way of a literature review, the extent to which such techniques 
have been applied within the healthcare sector as a whole (appreciating that very little work of 
this nature has previously been undertaken within the specialty of renal medicine itself). From 
this platform, the remainder of the chapter reports a study of the carbon footprint of a single renal 
service, the Dorset Renal Service, and estimates the GHG emissions arising from the provision of 
renal healthcare across England. These results might act as an evidence base for future decision 
making in the transformation to lower carbon kidney care, highlighting the areas of the service 
with the greatest carbon footprint and facilitating the evaluation of alternative service 
configurations. The methodology also presents a template for renal services wishing to assess 
their own carbon footprint.  
 
 
What is a Carbon Footprint? 
 
Although there is only one scientific journal devoted to life cycle assessment [Finkbeiner, 2008], 
many such assessments have been undertaken in the last decade. The methodology has evolved, 
and its use has become more widespread, as concern regarding the threats posed by global 
climate change has risen. Within this context, the term ‘carbon footprint’ has been used 
ubiquitously in both public debate and the scientific literature. Broadly speaking, it has been used 
to refer to an assessment of the gaseous emissions resulting from a product or process, with 
particular attention given to those emissions considered to be of relevance to climate change. 
However, the need to settle upon a concise and unambiguous definition appears to have been 
recognised only relatively recently.  
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The Carbon Trust (2007) considers carbon footprinting to be “a technique for identifying and 
measuring the individual GHG emissions from each activity within a supply chain process step 
and the framework for attributing these to each output product (we [The Carbon Trust] will refer 
to this as the product’s ‘carbon footprint’).” However, many possible configurations to the 
measurement and quantification of a carbon footprint exist within this terminology. Important 
aspects that must therefore be described in the methodology of a carbon footprint analysis should 
include, but are by no means limited to, the following: 
 
• the scope of the emissions. For example, the calculation of a carbon footprint might 
include every GHG specified by the Intergovernmental Panel on Climate Change 
(IPCC) 2007 report [Intergovernmental Panel on Climate Change, 2007]. Alternatively, 
it might only include the six GHGs described in the Kyoto Protocol Reference Manual 
[United Nations Framework Convention on Climate Change, 2008], or even simply CO2 
itself. Limited data availability makes it more difficult to quantify particular GHGs and, 
although it may be possible to present a partially aggregated indicator, it may be 
considered more appropriate to include only CO2 in order that the study is more 
interpretable (and therefore comparable).  
 
• the source of the emissions. A decision may be made not to include those emissions 
that do not stem from fossil fuels, for example, such as CO2 emissions from soils. 
 
• the impact of the life cycles of the goods and services lying within the boundaries of 
the footprint. Consideration must be given to whether the analysis is concerned only 
with the direct emissions attributable to the use of these goods and services, or whether 
it will also include the indirect emissions embodied in their production processes. 
Ultimately, the clear definition and description of boundary issues is arguably of greater 
importance than decision of what to include and exclude, as it is this that facilitates 
comparison and replication.  
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• the inclusion of carbon offsetting, and what this actually encompasses. It might be 
argued, for example, that the use of renewable energy is a form of offsetting.  
 
• the units of measurement.  
  
Some of these questions are addressed in an attempt by Wiedmann and Minx to refine the 
definition further, with their proposal that “the carbon footprint is a measure of the exclusive total 
amount of CO2 emissions that is directly and indirectly caused by an activity or is accumulated 
over the life stages of a product” [Wiedmann & Minx, 2008].  
 
At its most basic, the process of developing a carbon footprint therefore involves the setting of 
boundaries, the identification of the GHGs to be included, the choice of the most appropriate 
methodology, the definition of the accounting rules and timeframe, the collection and assessment 
of the data, and the consideration of the degree of uncertainty within the assessment. 
 
The requirements set out by the earlier definitions can be met through differing methodologies, 
influenced in part by the aims of the study and the availability of the data. An environmental 
input-output analysis offers a top-down approach to developing a carbon footprint, in which 
input-output tables of economic accounting data are used to determine economic activity within a 
sector, which is then combined with data regarding the emissions attributable to the sectors. The 
boundary is therefore defined by the economic system, allowing the inclusion of direct and 
indirect emissions. This was the methodology used in the NHS England Carbon Footprinting 
study [Sustainable Development Commission, 2008].  
 
However, the nature of this approach is such that it lacks detail as it assumes homogeneity of 
financial prices, outputs and their carbon emissions at sector level. Hence it is less appropriate for 
use in the assessment of smaller organisations, processes or individual products. An alternative 
approach is the process analysis or life cycle assessment (LCA), in which specific primary and 
secondary process data are generally collected from the bottom up. This is well suited to the 
assessment of the environmental impact of individual products or services from the cradle to the 
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grave, but, as a system boundary must be set, this approach can lead to truncation errors of 
unknown size. In order to harness the strengths of these two techniques, they may be integrated 
into a hybrid environmental input-output life cycle assessment (EIO-LCA) method. This 
preserves the detail and accuracy of the bottom up approach for the more important processes, 
whilst the coverage of the majority of the less significant processes by the input-output 
assessment avoids truncation error and fills gaps where primary data are lacking, for example 
within the supply chain. A further benefit of this hybrid approach is the enhanced understanding 
of the uncertainty inherent in the result. This is further discussed under the heading ‘Uncertainty 
in the Results’. 
 
Standardisation of carbon footprinting methodology is ongoing. PAS2050 is a Publically 
Available Specification (PAS) for assessing product or service life cycle GHG emissions, and 
was developed under the auspices of the Carbon Trust, the Department for Environment, Food 
and Rural Affairs (DEFRA), and the British Standards Institution [British Standards, DEFRA & 
Carbon Trust, 2008]. It is of relevance to the approach taken in this study that the PAS 2050 
methodology is based upon a LCA method, with input-output analysis playing a negligible role. 
However, given the aforementioned benefits of the hybrid approach, it is anticipated that 
alternative standardisations currently under development will afford a greater prominence to 
input-output analysis. 
 
  
What a Carbon Footprint is not 
 
This thesis focuses primarily upon the contribution made to climate change by the provision of 
renal healthcare, and the calculation of a carbon footprint quantifies the GHG emissions released 
by the service or product being assessed. GHG emissions contribute to anthropogenic climate 
change, but represent only one component of the environmental impact of the service or product. 
A carbon footprint does not assess other potential social, economic or environmental impacts 
such as non-GHG emissions, acidification, eutrophication, toxicity or biodiversity.  
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The Application of Carbon Footprinting within the Healthcare Sector 
 
There have been very few published carbon footprinting studies relating to the healthcare sector. 
A literature search was undertaken on 2nd November 2010, through Pubmed, for articles 
published in English. The search term ("greenhouse gas" OR "greenhouse gases" OR "carbon 
footprint" OR “life-cycle assessment”) was restricted to titles and abstracts. The titles and, where 
considered necessary, abstracts of the 1656 articles identified were reviewed. A total of only 8 
articles were subjectively considered to report carbon footprinting studies relating to the 
healthcare sector.  
 
After the exclusion of an article arising from work undertaken for this thesis [Connor, Lillywhite 
et al, 2010], only two of the carbon footprinting studies retrieved in this search attempted to 
include both the direct and indirect emissions attributable to the organisation or process under 
consideration [Chung & Meltzer, 2009; Somner et al., 2008], although the magnitude of the 
contribution of supply chain emissions to the carbon footprints of healthcare in both England and 
the United States is now appreciated [Sustainable Development Commission, 2008; Chung & 
Meltzer, 2009]. The challenge of including these emissions is illustrated by the rather simplistic 
use, in a study comparing the carbon footprints of medical and surgical treatments for gastro-
oesophageal reflux [Gatenby, 2011], of a measure of the overall carbon intensity of the healthcare 
delivered by the NHS. In the absence of available specific emissions factors, the author of this 
study applied a figure for the overall carbon intensity of healthcare that had been derived from a 
previous study [Sustainable Development Commission, 2008] to all aspects of the treatments 
being studied except the procurement of medical equipment and pharmaceuticals. 
 
Three of the retrieved studies included travel emissions alone, [Zander et al., 2010; Davie et al., 
2010; Wootton et al., 2010] as did two further articles identified from the references of retrieved 
publications [Callister & Griffiths, 2007; Crane, 2006]. Meanwhile, a proof-of-concept study, 
centred around the collection of energy consumption data from two anonymous North American 
emergency medical services, has shown that it is feasible for individual healthcare specialty 
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services to provide data regarding both building energy use and travel [Blanchard & Brown, 
2009]. The emissions attributable to the water used during the process of surgical scrubbing, and 
the energy require to heat it, have also been reported [Somner et al., 2008].  
 
In keeping with the findings of Chapter 2, this literature search again highlighted the problem of 
identifying the relevant literature within the field of sustainability within healthcare. For example, 
despite the choice of terms, the search did not retrieve an article reporting an LCA of reusable 
and disposable plastic anaesthetic trays [McGain et al., 2010], for which the key-words were 
“anaesthesia”, “drug trays”, “disposable”, “reusable”, “single-use” and “costs”, although the 
article in question is cited by the Pubmed database. Similarly, the search did not retrieve a report 
of the carbon footprints of HHD and ICHD, which is discussed in Chapter 5 [James, 2007]. 
 
The study of most relevance to this chapter was not, in fact, cited on Pubmed. The carbon 
footprint of NHS England was calculated using an input-output table comprising 178 industrial 
sectors, with expenditure data derived from national level supply-and-use tables [Sustainable 
Development Commission, 2008]. Industrial sector emissions factors were derived from 
emissions data provided by National Statistics Environmental Accounts. As travel emissions 
were estimated from National Travel Survey data and added to the resultant footprint, this was a 
top-down approach complemented by bottom-up data where available. A similar environmental 
input-output lifecycle assessment using expenditure data was performed to estimate the carbon 
footprint of the United States Health Care Sector [Chung & Meltzer, 2009].  
 
As was mentioned in Chapter 2, the GHG emissions released by clinical research trials have been 
investigated by way of an assessment of the aggregated carbon footprint of a sample of twelve 
randomised controlled clinical trials [Lyle et al., 2009]. Data were collected for a number of 
activities, including the travel of staff and participants, and the energy used to manufacture the 
information technology equipment required to run the trials. Standard emissions factors were 
applied to these data. The factors used for pharmaceuticals and medical equipment were taken 
from the NHS England study [Sustainable Development Commission, 2008]. The total CO2 
 54 
emissions were calculated to be 941 tonnes and were predominantly due to travel. Once again, 
although cited on Pubmed, this article was not retrieved by the literature search described above. 
 
An early step towards meeting the challenging targets set out by the NHS Carbon Reduction 
Strategy must be the establishment of a sound understanding of the sources, and magnitudes, of 
the GHG emissions associated with the delivery of healthcare. The results of this literature 
search, and others [Nichols et al., 2009], suggest that the evidence base to support carbon 
reduction strategies specific to renal medicine (and, indeed, all specialties) is presently 
insufficient. It is upon this premise that the assessments of the GHG emissions attributable to 
both an individual renal service and the provision of renal healthcare across England are now 
reported. The assessment of the carbon footprint of the Dorset Renal Service includes both direct 
and indirect emissions and is, therefore, the first fully comprehensive report of the carbon 
footprint of an individual healthcare specialty service.  
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The Carbon Footprints of a Single Renal Service in the United Kingdom and 
the Delivery of Renal Healthcare across England. 
 
 
Aims 
 
The primary aim of this study was to calculate the carbon footprint of the Dorset Renal Service. 
The secondary aims were to estimate the carbon footprint of the provision of renal healthcare 
across England and to provide a methodology to allow other renal services to ascertain their own 
carbon footprints more readily. 
 
 
Methodology 
 
 
The Dorset Renal Service Model  
 
In order to understand this report, it is essential to appreciate that the Dorset Renal Service 
consists of a number of component parts provided across a number of geographical sites. The 
Dorset Renal Service is based within a District General Hospital (Dorset County Hospital 
Dorchester, DCH) and provides renal services at three further sites (Yeovil District Hospital, 
YDH; Poole General Hospital, PGH; Royal Bournemouth Hospital, RBH). It serves a 
geographical area of approximately 1300 square miles (see figure 1) and a population of 865,000 
people. It does not provide paediatric nephrology services.  
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Figure 1. The geographical area covered by the Dorset Renal Service. 
 
The components of the Dorset Renal Service are inpatient care, outpatient care, peritoneal 
dialysis, haemodialysis, transplantation and administration. Inpatient care is provided in a 14 bed 
ward (DCH). Outpatient care is provided through the 7 clinics held each week across the 4 sites 
(DCH, RBH, PGH, YDH). A single pre-dialysis nurse runs 2 clinics a month across two sites 
(DCH, RBH) and undertakes occasional home visits. Haemodialysis is provided to a total of 225 
patients, who dialyse across the 4 centres (55 at DCH, 60 at RBH, 63 at PGH, 45 at YDH). A 
further 2 patients undertake HHD. Two dialysis technicians provide services to DCH, RBH and 
YDH. Peritoneal dialysis is provided from 2 centres to 54 patients (15 from DCH, 39 from RBH). 
Patients receiving renal transplants have their investigative work-up undertaken at the hospital 
local to the clinic they attend. There is one Transplantation Specialist Nurse who undertakes 
twice monthly clinics and makes occasional home visits. Transplantation surgery is performed at 
a tertiary centre (Southmead Hospital (SMH), Bristol), 65 miles away by road. After discharge, 
patients are typically followed up as outpatients at the tertiary centre for an average of three 
weeks, prior to referral back to their local clinic.  
 
A medical team of five consultants and three registrars provide care across the components of the 
service. Three junior doctors provide care to inpatients at DCH.  A nurse-led renal anaemia team 
provide care across the different components of the service. Iron infusions are undertaken at 
DCH. Three dieticians provide care across the different components of the service. Social work 
care is provided by two social workers working solely within the Dorset Renal Service.  
Occupational therapy is provided by one occupational therapist, who can refer to local services 
where necessary. A psychologist provides care to patients across the different components of the 
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service. Within the Dorset Renal Service, physiotherapy is only provided to inpatients. Aside 
from transplantation, surgery integral to the care provided by the Dorset Renal Service (dialysis 
access surgery, parathyroidectomy) is primarily undertaken at DCH. Patients requiring inpatient 
stays are managed on the renal ward. A small amount of day-case dialysis access surgery is 
undertaken at RBH. Administrative work is undertaken primarily at DCH. Domestic staff provide 
cleaning services at each of the different components of the service.  
 
 
Emissions Terminology  
 
The Kyoto Protocol recognises six GHGs in its targets [United Nations Framework Convention 
on Climate Change, 2008]. CO2 is released from both natural events (such as volcanism) and the 
burning of fossil fuels by man. As a result of the latter, CO2 is, by some margin, the most 
prevalent anthropogenic GHG within the atmosphere aside from water vapour. Emissions of 
GHGs may be quantified in terms of their global warming potential - the global warming 
potential of 1 kg of the gas in question being equivalent to the amount of a reference gas that 
would produce an effect of similar magnitude over a defined time period. The IPCC recognises 
three time periods, of which the most commonly used is 100 years. CO2 is the gas most 
commonly used as the reference gas. Therefore the emissions of other gases are frequently 
expressed in the units of CO2eq. Within the US Health Care Sector, approximately 80% of the 
total global warming potential has been attributed to CO2 emissions [Chung & Meltzer, 2009]. 
Similarly, over 85% of the NHS England GHG emissions were CO2 emissions [Sustainable 
Development Commission, 2008]. Furthermore, this remained uniform between sectors and 
subsectors, with minor exceptions being food procurement and waste, which have increased 
GHG emissions due to production and degradation of organic material. This figure of 85% is also 
comparable to the CO2 proportion from all United Kingdom emissions. However, the remaining 
five GHGs recognised by the Kyoto Protocol have higher global warming potential than CO2 and 
therefore contribute significantly to climate change, even if emitted in small volumes. This study 
includes the two of these GHGs (CH4 and N2O) anticipated to be of the greatest relevance to 
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healthcare-associated emissions.  The contribution made by refrigerants was considered to be 
negligible and was therefore excluded.  
 
 
Unit of Measurement 
 
Total emissions, including CO2 and non-CO2 (CH4 and N2O) GHGs, have been calculated across 
the components of the Dorset Renal Service and are reported in tonnes of CO2eq per year.  
 
 
Overview of Methodology  
 
As was outlined earlier, the methodology employed in the analysis of a carbon footprint may be 
influenced in part by the availability and nature of the data. This was a component analysis study, 
in which the contributing parts of the Dorset Renal Service were identified and data relating to 
their emissions were collected.  
 
A ‘bottom up’ approach was adopted to collate the data relating to building energy use, travel, 
waste and water use. The data collected were disaggregated in source and physical in nature. As 
such, this part of the study might be considered to be a process analysis, or LCA, in which 
emissions were determined at each stage of the production process.  Established emissions factors 
were applied to reconcile the data to a common unit of measurement (CO2eq).  
 
However, the complexities and innumerable processes involved in healthcare provision render 
the process analysis approach to environmental accounting impractical for the analysis of all 
aspects of the Dorset Renal Service. The procurement data were therefore collected 
predominantly through a ‘top down’ approach (for example, pharmaceutical and medical 
equipment data), complemented by data collected using a ‘bottom up’ approach where possible 
(for example, construction). The procurement data were therefore less well disaggregated across 
the different components of the Dorset Renal Service (haemodialysis, peritoneal dialysis, 
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inpatient care, outpatient care, transplantation and administration) at their respective sites (DCH, 
RBH, PGH, YDH, SMH). For example, the pharmaceutical data for the RBH peritoneal dialysis 
service were inextricably embedded within the pharmaceutical data for the RBH haemodialysis 
service. The procurement data were also predominantly collected as economic data, as physical 
data were not consistently available. Once again, established emissions factors were applied to 
reconcile the data to the common denominator (CO2eq). Whilst the approach to the procurement 
sector therefore shares similarities with that in an environmental input-output analysis, in that the 
boundary defined by the provision of care by the Dorset Renal Service is mimicked by its 
economic system, the mix of economic and physical data did not lend itself to an environmental 
input-output analysis in the true sense of the term.  
 
Overall, this hybrid of approaches has allowed the inclusion of both indirect emissions (such as 
those arising from the manufacture of pharmaceuticals) and direct emissions (such as those 
arising from the burning of fossil fuels to facilitate travel). This report adheres to the principles 
and definitions defined within PAS2050 [British Standards, DEFRA & Carbon Trust, 2008]. Any 
exceptions to this are clearly described and their rationale explained.    
 
 
Consumption versus Production Emissions  
 
In keeping with the NHS England carbon footprint study [Sustainable Development Commission, 
2008], the emissions for the Dorset Renal Service have been calculated on a consumption basis, 
and are the sum of emissions from three sources: direct carbon emissions from building energy 
use; direct carbon emissions from patient, visitor and staff travel; and procurement emissions. 
Procurement emissions can be defined as the embodied emissions associated with production, 
consumption and disposal of all goods and services consumed within the Dorset Renal Service or 
arising in the industrial supply and disposal chains. These goods may originate overseas, and the 
consumption of the Dorset Renal Service (and the delivery of renal healthcare across England) 
therefore has a global reach. 
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The emissions from the three sources outlined above were calculated for each of the components 
(inpatient care, outpatient care, haemodialysis, peritoneal dialysis, transplantation, and 
administration) of the Dorset Renal Service at each of the sites at which they are provided (DCH, 
RBH, PGH, YDH, SMH), and summated to calculate the carbon footprint of the Dorset Renal 
Service.  
 
 
Calculating the Carbon Footprint of the Provision of Renal Services throughout 
England 
 
Although data relating to procurement and building energy use are submitted to national 
databases by Acute Trusts incorporating renal services, it is not possible to isolate the 
contribution of the renal services to this data and it is not therefore possible to directly calculate 
the carbon footprint of the provision of renal services across England through this approach.  
 
Instead, an estimation of the carbon cost of the provision of renal healthcare across England has 
been reached through extrapolation of the results of the carbon footprint of the Dorset Renal 
Service. The methodology of such an extrapolation should ideally account for the considerable 
variation existing between individual renal services. One such source of variation is the extent to 
which resources are allocated to the different components of the service (haemodialysis, 
peritoneal dialysis, inpatient care, outpatient care, transplantation and administration), and the 
numbers and proportions of patients accessing these components. Unfortunately, within the 
sectors, the aggregated nature of much of the data (particularly within the procurement and travel 
sectors) prevents accurate allocation of the carbon footprint of the Dorset Renal Service to its 
component parts, and  an approach in which comparisons of the sizes of the components of the 
different services was incorporated is therefore not feasible.  
 
Instead, the approach has been as follows. Data from the Renal Registry includes calculations of 
the observed and expected sizes of the prevalent RRT populations (those patients receiving 
haemodialysis, peritoneal dialysis or with a functioning transplant) for geographical areas [Byrne, 
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Steenkamp et al., 2010]. The observed and expected sizes of the prevalent RRT populations are 
combined to produce a standardised prevalence ratio for each geographical area. The standardised 
prevalence ratio for the Dorset population is 0.79, whilst that of the Bournemouth and Poole 
population is 0.84. The standardised prevalence ratio for the area covered by the Dorset Renal 
Service has therefore been considered to be 0.81 (splitting the difference between the two areas, 
but weighting the resulting value towards that of the Dorset population as the Dorset Primary 
Care Trust contributes 57.5% of the total population covered). It has then been assumed that the 
‘size’ of the Dorset Renal Service is approximately 81% of that of a ‘typical’ renal service, and 
also that a linear relationship exists between the size of a renal service and its carbon footprint. 
The carbon burden of the delivery of renal healthcare across England has therefore been reached 
by the application of an uplift factor (100/81, or 1.234567) to the carbon footprint of the Dorset 
Renal Service, and multiplying this by the number of renal services serving the population of 
England.  
 
It should be recognised that the need for RRT depends on many factors, including social and 
demographic factors such as age, gender, social deprivation and ethnicity. The comparison of 
crude prevalence rates by geographical area can therefore be misleading, and the results of this 
approach can therefore be considered to be only an estimate of the carbon footprint of the 
delivery of renal healthcare across England.   
 
 
Data Sources 
 
Two types of data are necessary to calculate a carbon footprint: activity data and emissions 
factors. The former relates to the amounts of materials and energy involved in the service or 
product being analysed, whilst the latter allow conversion of these quantities into GHG 
emissions. In keeping with the requirements of PAS2050 [British Standards, DEFRA & Carbon 
Trust, 2008], the activity data are almost exclusively primary data (determined by direct 
measurements made within the service). The two exceptions to this are the data sourced for waste 
(in which activity data were estimated from a combination of primary and secondary data – 
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namely peer-reviewed publications) and building energy use (in which secondary data relating to 
the hospitals rather than the renal departments were collected).  
 
This section also outlines the context of any assumptions that have been made during the 
collection of the data, and the emissions factors that have been applied. These assumptions and 
emissions factors are documented in greater detail in dedicated sections within this description of 
the methodology.  
 
 
Building Energy Use data 
 
Emissions relating to the building energy use by the different components of the Dorset Renal 
Service are calculated from data submitted by the respective Estates Departments to the Estates 
Return Information Collection (ERIC) database. This database provides the electricity, gas, oil, 
coal hot water and steam use of the hospitals in which the components of the Dorset Renal 
Service are situated. The data are provided in gigajoules. For the purposes of this study, the data 
are converted to kilowatt hours (kWh) and multiplied by DEFRA emissions factors (in kg CO2eq 
per kWh).  
 
The proportion of floor space occupied by the Dorset Renal Service within each of the NHS 
facilities was used to calculate the building energy use attributable to it from the data submitted 
by the respective facilities to the ERIC data.  
 
Where floor space is shared between the Dorset Renal Service and other services (for example, 
the outpatients clinics), the building energy use attributable to the Dorset Renal Service has been 
determined on the basis of the proportion of the time for which the area is used by the Dorset 
Renal Service. For example, the Outpatients Department in DCH is used by the Dorset Renal 
Service for two of the ten sessions per week, and 20% of the building energy use relating to the 
Outpatients Department has therefore been assigned to the Dorset Renal Service.  
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The building energy use of the DCH Radiology Department that is attributable to the Dorset 
Renal Service has been estimated from data relating to the proportion of its workload that is 
requested by the Dorset Renal Service, and an estimation of the proportion of the floor space 
required for a single patient episode.  
 
Two components of the Dorset Renal Service (the haemodialysis units in YDH and PGH) do not 
contribute building energy use data to the ERIC data. The building energy use data for these 
components were sourced directly from meter readings.  
 
 
Travel data 
 
‘Travel’ is defined as the movement of people, and ‘transport’ as the movement of goods and 
services. In this analysis, transport emissions from goods and services are contained within their 
sub-sector procurement emissions. Where it was necessary to determine distances for staff, 
patient and visitor travel from postcodes, these were calculated using GoogleMaps 
(http://maps.google.co.uk).  
 
Emissions relating to staff business and commuting travel are calculated from data derived from 
staff travel surveys undertaken within each component, and at each site, of the Dorset Renal 
Service. These surveys collected information for each member of staff regarding the distances 
travelled over given periods of time and the modalities of travel used (car, bus, train, active 
transport, air travel). These data were extrapolated up to represent annual data. DEFRA emissions 
factors, in kg CO2eq per kilometre (km), were applied to these data.  
 
Emissions data relating to visitor travel were calculated from estimations of travel data derived 
from the National Transport Survey 2006 [Department for Transport, National Statistics, 2006]. 
DEFRA emissions factors, in kg CO2eq per km, were applied to these data. 
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Emissions relating to patient travel to outpatient clinics are calculated from data derived from 
patient travel surveys undertaken within each clinic held at each site. These surveys collected 
information from each patient regarding the distance travelled and the modality of travel used 
(car, bus, train, active transport). These data were extrapolated up to represent annual data. 
DEFRA emissions factors, in kg CO2eq per km, were applied to these data.  
 
Emissions relating to patient travel to outpatient clinics with the both the pre-dialysis nurse 
specialist and the transplant nurse specialist are calculated from data derived from the postcodes 
of patients attending these clinics over a three month period and the sites at which they attended. 
Assumptions were made about the modality of transport used. These data were extrapolated up to 
represent annual data. DEFRA emissions factors, in kg CO2eq per km, were applied to these data.  
 
Emissions relating to patient travel to dialysis treatments are calculated from data derived from 
the patients’ postcodes and the postcodes of the sites at which they received dialysis. Data 
regarding the most common modality of travel for each patient were included. These data were 
extrapolated up to represent annual data. DEFRA emissions factors, in kg CO2eq per km, were 
applied to these data.  
 
Emissions relating to patient travel to the inpatient ward (to receive inpatient treatment as an 
inpatient or as a day case) were calculated from a two month sample of patients. Distances 
travelled where obtained from postcodes. Assumptions were made about the modality of this 
travel. These data were extrapolated up to represent annual data. DEFRA emissions factors, in kg 
CO2eq per km, were applied to these data. 
 
Emissions relating to patient travel to the peritoneal dialysis departments were calculated from 
data derived from patients’ postcodes and the postcodes of the sites at which they received 
treatment. Assumptions were made to provide data regarding the most common modality of 
travel and the number of visits. These data were extrapolated up to represent annual data. DEFRA 
emissions factors, in kg CO2eq per km, were applied to these data. 
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Emissions relating to patient travel to attend follow-up appointments at SMH during the weeks 
following transplantation surgery were determined from the postcodes of patients undergoing 
transplantation during the accounting period. The number of journeys was estimated on the basis 
of the time between their surgery and the point in time at which they were referred back to the 
care of the Dorset Renal Service. Assumptions were made about the modality of travel used. 
DEFRA emissions factors, in kg CO2eq per km, were applied to these data. 
 
Emissions relating to patient travel to attend for pathological investigations were estimated from 
assumptions regarding the number of patients undergoing blood tests, their modality of travel, 
and the return distances that they would travel to attend for these blood tests. DEFRA emissions 
factors, in kg CO2eq per km, were applied to these data. 
 
Emissions relating to patient travel to attend for iron infusions were calculated from a six month 
sample of patients. Distances travelled were obtained from postcodes. Assumptions were made 
about the modality of this travel. These data were extrapolated up to represent annual data. 
DEFRA emissions factors, in kg CO2eq per km, were applied to these data. 
 
Emissions relating to patient travel to attend for radiological investigations were calculated from 
a year’s sample of patients. Distances travelled where obtained from postcodes. The modalities of 
travel used were estimated, based on the average one way distance and data regarding modality 
and journey length taken from the National Transport Survey, 2006. These data were extrapolated 
up to represent annual data. DEFRA emissions factors, in kg CO2eq per km, were applied to these 
data. 
 
 
Procurement data  
 
The footprinting technique used in this report calculates carbon emissions relating to procurement 
from expenditure data (from the Procurement Department, DCH) and industrial sector emissions 
factors (from National Statistics of Environmental Accounts data and from DEFRA). Whilst the 
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expenditure data have been collected for the defined accounting period, they have been deflated 
to 2004 values as the emissions factors for supply chain emissions that have been used in this 
study were produced from economic input-output tables of 2004 prices. A deflation factor of 
1.121363 was applied. This was derived from data regarding the annual rates of inflation between 
2004 and 2009 (obtained from the website of the Office for National Statistics [Office for 
National Statistics, 2011]). The exceptions to this approach were the collection of water and 
waste activity data, for which physical data (rather than economic data) were collected.  
 
Emissions data relating to pharmaceuticals are calculated from data on the financial expenditure 
by the Dorset Renal Service on pharmaceuticals (from the Pharmacy Department, DCH) and 
DEFRA emissions factors.  
 
Emissions data relating to medical equipment are calculated from data on the financial 
expenditure by the Dorset Renal Service on medical equipment (provided by Procurement 
Department, DCH, as expenditure through NHS Supply Chain and as non-stock purchases). 
Medical equipment predominantly includes, but is by no means limited to, the items of 
disposable equipment required by medical and nursing staff to provide care on the renal inpatient 
ward, the dialysis units and in the outpatient departments. This represents a diverse range of 
items, from generic items available throughout hospitals (such as urinary catheters, needles, 
syringes, gauzes and dressings) to highly specialised items required to provide care to patients 
with kidney disease (such as dialysis access catheters, peritoneal catheters, biopsy needles, 
dialysers and dialysis concentrates). Examples of the non-disposable items that are also 
occasionally purchased include stethoscopes and surgical-clip removers. DEFRA emissions 
factors have been applied to this activity data. Data for PGH and YDH haemodialysis units were 
not available (as these are privately run organisations) and were therefore estimated on a per 
patient basis from the DCH haemodialysis unit data.  
 
Emissions data relating to the undertaking of radiological investigations are calculated from data 
on the number of radiological investigations undertaken by the Radiology Department at DCH on 
patients referred from the Dorset Renal Service. Activity data regarding the numbers of 
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radiological investigations undertaken at RBH, PGH and YDH at the request of the Dorset Renal 
Service have been estimated. In the absence of data regarding the emissions arising from 
radiological investigations, an estimated figure of 0.1 kg CO2eq per test has been assigned.  
 
Emissions data relating to the collection and analysis of samples sent to the Pathology 
Department are calculated from data on the number of pathology investigations undertaken by the 
Pathology Department at DCH on patients referred from the Dorset Renal Service. Activity data 
regarding the numbers of pathology investigations undertaken at RBH, PGH and YDH at the 
request of the Dorset Renal Service have been estimated. In the absence of data regarding the 
emissions arising from radiological investigations, an estimated figure of 0.05 kg CO2eq per test 
has been assigned. Multiple tests may be run from each sample collected.  
 
Emissions data relating to paper and office supplies are calculated from the financial expenditure 
of the Dorset Renal Service on paper and office supplies (provided by the Procurement 
Department, DCH, with the exception of the data relating to the YDH haemodialysis component, 
which was estimated) and DEFRA emissions factors.   
 
Emissions data relating to water are calculated from the volumes of water utilised for 
haemodialysis and DEFRA emissions factors.   
 
Emissions data relating to food are calculated from the financial expenditure of the Dorset Renal 
Service on the different foodstuffs and beverages (provided by the Catering Department, DCH, 
and by the Procurement Department, DCH) and industrial sector emissions factors (from the 
National Statistics of Environmental Accounts).   
 
Emissions data relating to the laundry services used by the Dorset Renal Service are calculated 
from measurements of the amount of laundry generated by patient activities (for example, one 
day as an inpatient, or one haemodialysis treatment), estimations of the distances travelled by this 
laundry (to and from private laundry companies), assumptions regarding the energy consumption 
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of the washing and drying machines, and DEFRA emissions factors (for freight transport and 
purchased electricity consumption).  
 
Emissions data relating to construction (for maintenance purposes only) are calculated from 
estimations derived from data provided by the DCH Estates Department detailing the expenditure 
per square metre on construction, and DEFRA emissions factors.   
 
Emissions data relating to information technology are derived from data regarding the annual 
financial expenditure on information technology within each component of the Dorset Renal 
Service (derived from data detailing the amount of information technology equipment and 
assumptions regarding its rate of replacement) and the application of DEFRA emissions factors.  
 
The components of the Dorset Renal Service each produce waste. The disposal of this waste 
contributes to the carbon footprint of the Dorset Renal Service. The model used in this study 
assigns the carbon embedded in products to the manufacturing process, and it is therefore 
included within the carbon footprint attributable to their procurement. It is important that this 
carbon is not then ‘double counted’ during the calculation of the emissions arising from the 
disposal of these products. Therefore, the ‘end of life’ carbon footprint has been calculated using 
the DEFRA emissions factors for waste treatment processes [DEFRA, 2009], as opposed to the 
sum of the ‘end of life’ and ‘production’ carbon footprints.  
 
Waste is categorised as being either clinical or domestic waste. The disposal of the waste 
produced by the Dorset Renal Service is undertaken by the following three methods only; 
incineration, recycling, and landfill. Clinical waste is incinerated. The assumptions that have been 
made about energy recovery during incineration are detailed in the Assumptions section under the 
heading Waste Management. Domestic waste is further categorised by its disposal and 
constituents into the subgroups of: domestic waste that is incinerated; domestic waste that is 
recycled; domestic waste that is non-organic and sent to landfill; domestic waste that is organic 
(food) and sent to landfill; and domestic waste that is organic (non-food) and sent to landfill. The 
weights of the waste produced, within these different subgroups, by the different components of 
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the Dorset Renal Service have been estimated from published data [Tudor et al., 2008; Askarian 
et al., 2004; Hoenich et al., 2005; Audit Commission, 1997] DEFRA emissions factors have been 
applied to these weights. A full account of the methodology for the determination of the 
emissions data for waste is provided in Appendix 2.  
 
Emissions data relating to sanitation products are calculated from data on the financial 
expenditure by the Dorset Renal Service on sanitation products (provided by the Procurement 
Department, DCH, as expenditure through NHS Supply Chain and as non-stock purchases) and 
DEFRA emissions factors.  
 
With the exceptions of the subsectors of pharmaceuticals and water, procurement data relating to 
the PGH and YDH haemodialysis services were limited as these are financed privately. Data for 
these services were estimated from the data collected for the DCH and RBH haemodialysis 
services on the basis of the number of treatments provided.  
 
 
Boundary Setting: Inclusions and Exclusions 
  
The boundary of the carbon footprint of the Dorset Renal Service has been set to include its 
component parts; namely the delivery of inpatient care, outpatient care, haemodialysis services, 
peritoneal dialysis services, transplantation services and administration, provided across the 
geographical sites (DCH, RBH, PGH, YDH and SMH).  
 
 
Building Energy Use 
 
The building energy use required to provide the aforementioned services at each site is included. 
The Dorset Renal Service delivers some care in facilities shared with other services. In such 
cases, only the building energy use attributable to the time for which the Dorset Renal Service 
uses these facilities is included.  
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Travel 
 
Within each of these services, the carbon burden of staff, patient and visitor travel are included 
within the boundary.  
 
Staff Travel 
The travel of all staff working within the Dorset Renal Service was included; namely, ward and 
dialysis nursing staff (including auxiliary nursing staff and the clinical education team), doctors, 
dieticians, physiotherapists, occupational therapists, administrative staff, psychologists, 
phlebotomists, transplant nurse specialists, pre-dialysis nurse specialists, anaemia nurse 
specialists, dialysis technicians and social workers.  
 
Although PAS2050 [British Standards, DEFRA, Carbon Trust, 2008] demands that the system 
boundary of the service should exclude GHG emissions associated with the travel of employees 
to and from their normal place of work, this report includes the commuting travel of all staff (as 
well as their business travel) in order to maintain consistency with the NHS England Carbon 
Footprinting Study [Sustainable Development Commission, 2008]. For those staff whose work 
was not exclusively based within the Dorset Renal Service (for example, psychologists), 
inclusion of their commuting travel was limited to those days in which they undertook any work 
on behalf of the Dorset Renal Service.   
 
Patient Travel 
Although PAS2050 [British Standards, DEFRA, Carbon Trust, 2008] demands that the system 
boundary of the service should exclude GHG emissions associated with the travel of consumers 
(in this case, patients) to and from the point of service use, this report includes patient travel in 
order to maintain consistency with the NHS England Carbon Footprinting Study [Sustainable 
Development Commission, 2008]. As such, all travel undertaken by patients to attend treatments 
or diagnostic investigations provided by, or organised by, the Dorset Renal Service has been 
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included. This includes the return travel of inpatients to and from the ward, the return travel of 
patients attending either the ward or the hospital for day-case treatments (including, for example, 
iron infusions, blood transfusions, and temporary dialysis access procedures), the return travel of 
patients attending for the return travel of patients undergoing haemodialysis, the return travel of 
patients on peritoneal dialysis to their unit, the return travel of patients to outpatient appointments 
(including those with doctors, pre-dialysis nurse specialists, and transplant nurse specialists), the 
return travel of recently transplanted patients to outpatient appointments at the tertiary centre 
(SMH), and the return travel of patients attending for pathological or radiological investigations. 
Travel by patients to activities other than treatments or investigations, such as educational 
seminars, has not been included. 
 
Visitor Travel 
All travel undertaken by people visiting inpatients under the care of the Dorset Renal Service was 
included. The travel of people visiting patients who were not inpatients at the time was not 
included and was considered to be insignificant.  
 
Transport 
The transport of certain pathological specimens (including renal biopsy specimens) sent to other 
establishments to be processed was included. 
 
 
Procurement 
 
As the footprint includes both direct and indirect emissions, those emissions relating to the 
procurement of products and services contributing to the Dorset Renal Service are also included; 
namely, the procurement of pharmaceuticals, medical equipment, diagnostic investigations, paper 
and office supplies, the provision of food and drink to patients (inpatients and those receiving 
haemodialysis), construction (for maintenance purposes only), information technologies 
(computers, printers and fax machines only), laundry services, water, sanitation products, and the 
collection and treatment of waste.  
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Inter-departmental Overlap of Resource Use  
 
The provision of clinical care to patients involves considerable overlap between different clinical 
services. For example, the overall care of a patient whose care is primarily delivered by the 
Dorset Renal Service may include diagnostic investigations performed by the Radiology Service. 
In such cases, the aspects of the secondary service which would be required to be in place even if 
patients from the Dorset Renal Service did not access the secondary service, have been excluded 
from the carbon footprint of the Dorset Renal Service, whilst those aspects of the service that are 
directly attributable to the patients from the Dorset Renal Service have been included.  
 
Therefore, in the aforementioned example, the business and commuting travel of the staff 
working within the Radiology Service would be considered to lie outside of the boundary of the 
carbon footprint of the Dorset Renal Service. However, the travel of patients referred by the 
Dorset Renal Service to undergo investigations performed by the Radiology Service, the 
procurement of the materials required to undertake these particular investigations, and the 
building energy use consumed by the particular part of the department during the time taken to 
undertake them, have all been included.  
 
 
Specific Boundaries Set within Procurement 
 
Occupational Therapy & Physiotherapy 
Occupational therapy is provided by one occupational therapist who can refer to local services 
where necessary. Only the occupational therapy provided by the therapist working within the 
Dorset Renal Service was included in the carbon footprint. Only physiotherapy provided by the 
physiotherapist affiliated to the Dorset Renal Service was included in the carbon footprint (this 
was limited to inpatient physiotherapy).   
 
 73 
Waste 
The disposal of all forms of waste produced by the Dorset Renal Service was included. These 
included clinical waste (which is incinerated off site), domestic waste which is recycled, and 
three forms of domestic waste that are sent to landfill; non-organic, organic (food) and organic 
(not food). The domestic waste that is recycled requires further comment as, since the recycling 
process is not undertaken within the Dorset Renal Service, the carbon recovered is realised 
outside of the boundary of this carbon footprint study. However, the DEFRA emissions factors 
for recycling have been applied to this waste (rather than to consider the disposal of this waste to 
have no impact upon the overall carbon footprint of the Dorset Renal Service) in order to 
maintain consistency in the approach to waste management.  
 
Pharmaceuticals 
The financial cost of the provision of pharmaceuticals to patients under the care of the Dorset 
Renal Service, for the treatment of both renal conditions and non-renal conditions, is shared 
between the Dorset Renal Service and the patients’ Primary Care Trusts (PCT). For example, a 
medication may initially be prescribed by the Dorset Renal Service, but repeat prescriptions may 
be provided by the Primary Care Trust. Alternatively, a medication may be continually prescribed 
by the Dorset Renal Service. This is the case for medications to treat both renal and non-renal 
conditions, although medications prescribed by the Dorset Renal Service are more likely to be 
intended for the treatment of renal conditions. This report includes only those emissions 
associated with pharmaceuticals prescribed (and funded) by the Dorset Renal Service.  
 
Surgery 
The most common surgical procedures undertaken in conjunction with the Dorset Renal Service 
are dialysis access procedures and parathyroidectomy operations. These are undertaken at DCH 
and are integral to the care provided by the Dorset Renal Service. Carbon emissions relating 
directly to the surgical procedures (for example, building energy use in the operating theatre, and 
the procurement of surgical and anaesthetic equipment and pharmaceuticals), and to the peri-
operative care of the patients (for example, building energy use on the inpatient ward), are 
considered to lie within the carbon footprint of the Dorset Renal Service. The same is true for 
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renal transplantation which, although a less frequent procedure, is also integral to the care 
provided by the Dorset Renal Service but is undertaken elsewhere (SMH). Surgical procedures 
other than those described here lie outside of the boundary of the carbon footprint. 
 
 
Universal Exclusions 
 
The following sources of emissions were considered to lie outside of the boundary; the capital 
cost of machinery used repeatedly (including haemodialysis machines, see below); buildings; 
human inputs into the processes; food for staff; scientific research into renal medicine; staff 
training; water use other than that used in haemodialysis; business services; immaterial emissions 
sources (those anticipated to be less than 1% of total footprint). 
 
Equipment Sterilisation 
Although the Dorset Renal Service uses a very small amount of medical equipment requiring 
subsequent sterilisation in the hospital Sterilisation Services Department, the emissions relating 
to this process are considered highly unlikely to contribute more than 1% of the overall carbon 
footprint and were excluded from the carbon footprint of the Dorset Renal Service.  
 
Machinery 
The use of medical equipment, in the form of machinery, for the provision of dialysis is 
fundamental to a renal service. The manufacture of this machinery requires energy and results in 
GHG emissions.  The machinery required for particular forms of peritoneal dialysis is used in a 
minority of patients, is loaned from the pharmaceutical company, and is used repeatedly. The 
machinery required for haemodialysis has a considerable lifetime (with guidance suggesting 
replacement at between 7 and 10 years, or between 25,000 and 40,000 hours of use [Renal 
Association, 2009]) and is used repeatedly. To maintain consistency with PAS2050 [British 
Standards, DEFRA, Carbon Trust, 2008], the GHG emissions arising from the production of 
capital goods used in the life cycle of the service have been excluded from the assessment of the 
GHG emissions of the service. However, emissions related to disposable consumables or 
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pharmaceuticals used within this machinery are included. For haemodialysis, examples of these 
consumables include blood lines and synthetic fibre dialysers, which are made entirely from 
plastics. For peritoneal dialysis, examples include plastic tubing (‘connecting kits’) and dialysis 
fluids (six litre bags most commonly made from plastics and containing glucose-based electrolyte 
solutions). 
 
Business Services 
The Dorset Renal Service is responsible for a proportion of the work undertaken by the business 
services central to the running of the hospitals within which it is based. Such services will include 
Human Resources, Finances, Patient Liaison Services, Car Parking Services and 
Communications. The Dorset Renal Service will also be responsible for a proportion of the work 
undertaken by other ‘non-business’ services, such as Chaplaincy, Health and Safety, Portering 
Services, Library Services. However, accurate data regarding the contribution of these services to 
the overall emissions of the Dorset Renal Service are not available, but preliminary calculations 
from secondary data suggest that these sources are not likely contribute significantly. They have 
therefore been excluded from the calculation of the carbon footprint of the Dorset Renal Service. 
These lists are not exhaustive, but their inclusion is intended to provide a representation of 
services lying outside of the boundary of this report. 
 
 
Accounting Period 
 
This study calculates emissions for the Dorset Renal Service for the period April 1st 2008 to 
March 31st 2009, since that is the period for which full datasets are available. However, staff and 
patient travel surveys were undertaken in late 2009.  
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Assumptions  
 
In order that this report is truly meaningful, and to facilitate replication, the assumptions made in 
the methodology, data collection and interpretation are outlined here. 
 
 
Assumptions made regarding Building Energy Use 
 
It has been assumed that the building energy use for a given floor space of each component of the 
Dorset Renal Service is comparable to the building energy use, for the same floor space, of the 
establishments in which each component is housed. It should be acknowledged that it is possible 
that the building energy use of certain components of the Dorset Renal Service (such as the 
haemodialysis units) may be greater than the building energy use averaged for the whole of the 
establishment in which they are housed. However, it is also possible that this may not be the case, 
as there are many other areas within the hospitals that might be anticipated to have high energy 
usage (for example, the cardiac catheterisation laboratory). The exception to this approach was 
the assumption that building energy use within surgical theatres was double that of the average 
building energy use of the hospital within which the theatres are sited. A full assessment was 
beyond the scope of this report. It has been assumed that the number of radiological 
investigations performed at the request of the Dorset Renal Service at sites other than the DCH 
Radiology Department is sufficiently small that the building energy use it entails will not 
contribute significantly to the carbon footprint of the Dorset Renal Service. 
 
 
Assumptions made regarding Travel 
 
Where travel was reported to have been undertaken by car, the DEFRA emissions factor for an 
‘average sized car using petrol or diesel’ was used.  
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Where not otherwise specified, journeys by car and bus were assumed to have taken the shortest 
possible route by road. 
 
In the absence of a means to calculate the distance of journeys reported to have been made by 
train, such distances were assumed to be comparable to the shortest route by road.   
 
Where not otherwise mentioned, business travel by air was considered to have departed from 
Bournemouth Airport.  
 
To maintain consistency with PAS2050 [British Standards, DEFRA, Carbon Trust, 2008], no 
uplift factor was applied for air travel.  
 
Staff Travel (commuting and business) 
Where data relating to phlebotomy staff were not captured by surveys, they were estimated using 
the following assumptions: a phlebotomy service is provided by a single phlebotomist and is 
available 6 days per week for inpatients and at all clinics; a phlebotomist is assumed to live 2 km 
from their place of work and to travel by car. 
 
Where data relating to members of the surgical teams were not captured by surveys, they were 
estimated using the following assumptions: every theatre list requires one anaesthetist, one 
operating department assistant, one surgeon, one assistant surgeon, three theatre nurses and two 
recovery nurses, all of whom were assumed to live 10 km from their place of work and to travel 
by car.  
 
Where data relating to domestic staff were not captured by surveys, they were estimated using the 
following assumptions: a cleaning service of one member of the domestic staff is available 7 days 
per week for inpatients, 6 days a week for haemodialysis services, 5 days a week for 
administration services, and at all clinics; peritoneal dialysis services are included within the 
haemodialysis services for these purposes; a member of the domestic staff is assumed to live 2 
km from their place of work and to travel by car. 
 78 
 
Patient Travel 
With the exception of the data captured by surveys, it was assumed that all patients commenced 
all journeys from, and returned directly to, their own homes.   
 
It was assumed that 75% of patients arriving and leaving the inpatient ward travelled by car and 
that the remaining 25% travelled by ambulance.  
 
It was assumed that 90% of patients attending the ward for day case treatment travelled by car 
and that the remaining 10% travelled by ambulance.  
 
It was assumed that patients receiving peritoneal dialysis would visit their department three times 
per year in addition to their routine outpatient clinic appointments. It was assumed that all travel 
was by car.  
 
It was assumed that all travel by patients to attend outpatient clinics with the pre-dialysis nurse 
specialist, the transplant nurse specialist, or at the SMH clinic in the weeks following 
transplantation, was undertaken by car.   
 
It was assumed that all patient travel to attend for iron infusions was undertaken by car. 
 
It was assumed that two thirds of all patients attending outpatient appointments would be 
required to undergo a blood test prior to this, and that each of these patients would travel 2 km 
each way by car to attend for this. 
 
Visitor Travel 
No data regarding the travel of visitors were available. It was assumed that only inpatients 
received visitors. It was assumed that the 14 beds on the inpatient ward were occupied at all 
times. It was assumed that each inpatient would receive one visitor every other day. It was 
assumed that each visitor undertook a 40km round trip, reflecting the fact that the inpatient unit 
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covers a large geographical region. In keeping with the National Transport Survey 2006 for 
distances of this length, it was assumed that 84.3% of these journeys were made by car, 9.6% of 
these journeys were made by bus, 3.6% of these journeys were made by rail, 0.6% of these 
journeys were made by active transport, and 1.9% of these journeys were made by other means 
[Department for Transport, National Statistics, 2006].   
 
 
Assumptions made regarding Procurement 
 
Pharmaceuticals 
No assumptions have been made regarding pharmaceuticals. 
 
Medical Equipment 
In the absence of specific data, the financial expenditure on medical equipment for the YDH and 
PGH haemodialysis services was assumed to be the same, per patient, as for the DCH 
haemodialysis service.  
 
Pathology Investigations 
In the absence of specific data, an assumption has been made that the emissions associated with a 
pathological investigation of any kind (including the sampling procedure and the analysis of the 
specimen) is 0.05 kg CO2eq.  
 
Radiology Investigations 
In the absence of specific data, an assumption has been made that the emissions associated with 
undertaking any radiological investigation has been assumed to be 0.1 kg CO2eq. This relatively 
small value is intended to reflect the small amount of materials consumed in producing 
radiological images that are viewed electronically.  
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Paper 
It was assumed that paper was purchased in reams of 5OO sheets. In order to allow the use of 
DEFRA emissions factors (which, for paper, relate to financial cost), it was assumed that each 
ream cost £5.  
 
Food  
The food consumed ‘per bed’ per year within DCH has been assumed to be representative of the 
food consumed by the inpatients under the care of the Dorset Renal Service.  
 
Information Technology 
It has been assumed that emissions derived from information technology relate only to the 
equipment, and that this is limited to computers, printers and fax machines. It has been assumed 
that these items are replaced every three years. It has been assumed that the financial costs of 
replacing a computer, a printer and a fax machine, are £500, £75 and £100 respectively.  
 
Water 
Only the water used to provide haemodialysis has been included in the analysis on the 
assumption that all other water use is minimal in comparison. 
 
Laundry Services 
DCH has a very small laundry department onsite but contracts out the majority of the hospital’s 
laundry requirements to a private company. The other sites at which the Dorset Renal Service 
provides patient care have no laundry facilities on site. It has therefore been assumed that all 
linen used by the Dorset Renal Service is laundered off-site, and that this occurs at the nearest 
facility of the company with whom the relevant hospital has a laundry contract. It has been 
assumed that the laundry travels in rigid, diesel, heavy goods vehicles which run at the United 
Kingdom average capacity. As the Dorset Renal Service laundry forms a component of the local 
site’s overall laundry burden, it has been assumed that the number of journeys made is equivalent 
to the total weight of laundry produced per year, divided by the maximum capacity of the 
vehicles used. In the absence of more accurate data, it has been assumed that the washing and 
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drying machines have energy efficiencies, per kg load, equivalent to that of standard domestic 
machines.  
 
Construction 
In the absence of specific data, the financial expenditure on construction, for a given floor space, 
of the components of the Dorset Renal Service has been assumed to be similar to that of the DCH 
site.   
 
Sanitation 
In the absence of specific data, the financial expenditure on sanitation, for a given floor space, of 
the components of the Dorset Renal Service has been assumed to be similar to that of the DCH 
site. 
 
Waste Management 
A number of assumptions were made regarding the production and disposal of waste. Their 
context is explained in detail in Appendix 2.  
 
1. It was assumed that, on the inpatient ward and in the dialysis facilities, 40% of all waste was 
clinical waste and that the remaining 60% was domestic waste. It was assumed that, in the 
outpatients departments, only 20% of all waste was clinical waste and the remaining 80% was 
domestic waste. In the administration areas it was assumed that all waste was domestic waste. 
 
2. It was assumed that all clinical waste was incinerated. It was assumed that the carbon burden 
resulting from the disposal to landfill of any ash formed from incineration would be negligible. It 
was assumed that no energy recovery would be feasible from the incineration of clinical waste (as 
fuel fired incineration would be required to establish the high temperatures needed to ensure safe 
disposal of the waste, and given that the contents of clinical waste would be unlikely to burn 
without fuel fired incineration). In line with these considerations, it was also assumed that the 
DEFRA emissions factors – which do not relate specifically to incineration of clinical waste – 
would underestimate the emissions arising from the process, and therefore the highest quoted 
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emissions factor for incineration was universally applied to the different constituents of the 
clinical waste.   
 
3. On the basis of peer reviewed publications [Askarian et al., 2004; Olko & Winch, 2002] it has 
been assumed that segregation at source within the healthcare setting is imperfect, and that 25% 
of all waste entering the clinical waste stream is in fact domestic waste, which is therefore 
incinerated.  
 
4. It was assumed that 30% of all domestic waste would be recycled. It has been assumed that all 
recycling is ‘closed loop recycling’ whereby the material does not change and is used again for 
the same purpose. 
 
5. It was assumed that the remaining 70% of domestic waste would go to landfill. 
 
6. On the basis of peer reviewed publications [Askarian et al., 2004; Olko & Winch, 2002], it was 
assumed that 60% of the domestic waste going to landfill would be organic waste and that the 
remaining 40% would be non-organic. In the inpatient ward and administration areas, it was 
estimated that 25% of the organic waste would be food waste. In the other areas, it was estimated 
that only 8% of the organic waste would be food waste.  
 
 
Emissions Factors 
 
 
The Choice of Emissions Factors   
 
The gold standard methodology for the assessment of the production of GHGs associated with a 
process or product is the recording of the emissions at source through continuous emissions 
monitoring. However, this is an impractical approach for most carbon footprint assessments. 
Instead, emissions factors (also referred to as carbon conversion factors or GHG conversion 
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factors) may be applied to activity data to calculate emissions data. Emissions factors are 
available from a number of different sources, including the IPCC, DEFRA and the United 
Kingdom Emissions Factor Database. The different emission factor databases include emission 
factors for different products and materials. Furthermore, for a given material, product or process, 
there may be considerable variation in the emission factors quoted by the different databases. 
There are a number of reasons for this variation. Firstly, it may be the result of the differing 
conditions in which the materials or products may be manufactured, used and disposed of (for 
example, practice will vary on a regional basis and variation between emissions factors 
developed in differing countries is common). Secondly, it may relate to the differing scientific 
approaches used in the development of the emissions factors. Thirdly, the variation may originate 
from the use of differing system boundaries; input-output data typically have wider boundaries 
than process data. It is important that those emissions factors most appropriate to the intended 
purpose are selected in order that the assessment of a carbon footprint is as accurate as possible. 
Also, the emissions factors used should be clearly stated in the report in order that the carbon 
footprint can be appropriately interpreted and replicated.  
 
The Emissions Factors for Medical Equipment and Pharmaceuticals 
The preliminary results of this study suggested that the emissions arising within the supply chain 
and attributable to the procurement of medical equipment and pharmaceuticals were likely to 
contribute a substantial proportion of the carbon footprint of the Dorset Renal Service. It was 
therefore considered particularly important that the emissions factors applied to activity data 
within these subsectors were as accurate and appropriate as possible. However, emissions factors 
for the procurement of medical equipment and pharmaceuticals were identified in only two 
databases; emissions factors provided by the National Statistics of Environmental Accounts were 
used in the assessment of the carbon footprint of NHS England and are listed in the report 
[Sustainable Development Commission, 2008], whilst DEFRA also provides supply chain 
emissions factors for these subsectors [DEFRA, 2009]. Of further concern was the fact that, not 
only did considerable variation exist between the emission factors quoted by these two databases 
for the two subsectors (Table 3), but both databases quoted absolute figures without confidence 
intervals. 
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Table 3. The emissions factors available for the procurement of pharmaceuticals and 
medical equipment.   
Emissions Factor Database 
Emissions Factor for 
Pharmaceuticals (kg CO2 
per £) 
Emissions Factor for 
Medical Equipment (kg 
CO2 per £) 
National Statistics of Environmental 
Accounts [Sustainable Development Commission, 
2008]
 
0.20 0.24 
DEFRA [DEFRA, 2009] 0.62 0.45 
 
As it was not clear which emissions factors were the most appropriate for the assessment of the 
carbon footprint of the Dorset Renal Service, consideration was first given to the methodologies 
underpinning their development.  
 
The DEFRA emissions factors for supply chain emissions are provided by the Centre for 
Sustainability Accounting in York. These factors are based on an input-output economic model, 
which describes in monetary terms how the goods and services produced by different sectors of 
the economy are used by other sectors to produce their own output. These monetary accounts are 
linked to information about the GHG emissions of different sectors of the economy. By using the 
input-output model, these emissions are then attributed to the monetary transactions taking place 
in the economy. The result is an estimate of the total upstream emissions associated with the 
supply of a particular product group. As the input-output tables used for this exercise were in 
2004 basic prices (i.e. net of taxes on products and distributors' margins), DEFRA advises that it 
may be appropriate to take subsequent price changes into account when using their factors.  
 
Emissions arising from the supply chain of NHS England were calculated by undertaking an 
input-output analysis of the NHS [Sustainable Development Commission, 2008]. This used an 
input-output table comprising of 178 industrial sectors, which was provided by Stockholm 
Environment Institute. The input-output analysis was combined with GHG emissions provided by 
the National Statistics of Environmental Accounts 
(http://www.statistics.gov.uk/STATBASE/ssdataset.asp?vlnk=9640). The emissions factors are 
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listed in the report [Sustainable Development Commission, 2008]. The same emissions factors 
for pharmaceuticals and medical equipment were subsequently used in an assessment of the 
carbon footprint of clinical trials [Lyle et al., 2009]. 
 
Therefore it appeared that the two sets of emissions factors had been developed using similar 
methodologies. Given that they were both based upon economic input-output tables using 2004 
prices, it was assumed that the use of both sets of emissions factors would be susceptible to the 
same degree of error resulting from changes in the structure and emissions intensity of the supply 
chain since the time of the production of the emissions factors. Further analysis of the 
methodologies was considered to be unlikely to ascertain which methodology had produced 
emissions factors most applicable to the requirements of this study. 
 
Instead, the problem was approached from the other direction, and an attempt was made to 
ascertain the carbon burden of medical equipment using physical rather than economic data. 
Firstly, a sub-group of the medical equipment subsector of procurement within the Dorset Renal 
Service was identified (namely, the purchase of medical equipment, for the renal inpatient ward, 
from NHS Supplies, during the accounting period). These data contained the orders placed, for 
differing quantities, for a total of 182 different items of medical equipment. Next, for each 
different item purchased, the following data were collected or directly measured: the number of 
the items purchased during the accounting period, the weight of each item, and the material from 
which the item was predominantly made. Finally, emissions factors relating to this material were 
then applied to convert these weights to CO2 emissions. These emissions factors were taken from 
an independent database, the Inventory of Carbon and Energy (ICE, version 1.6a) [Hammond & 
Jones, 2008]. Produced by the University of Bath, this is an inventory of embodied carbon for 
building materials, and the data are derived from secondary resources in the public domain, such 
as journal articles, life cycle assessments and conference reports. The result of this calculation, 
the total CO2 emissions attributable to the procurement of medical equipment for the inpatient 
ward from NHS Supplies, was then compared against data calculated from the financial 
expenditure on this sub-group of the medical equipment subsector and the emissions factors 
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sourced from both DEFRA and the National Statistics of Environmental Accounts. The results 
are shown in the Table 4. 
 
Table 4. The variation in the CO2 emissions attributable to the procurement of medical 
equipment for the inpatient ward when determined using different emissions factors. 
Database from which the emissions factors 
are taken. 
CO2 emissions resulting from the procurement of 
medical equipment for the inpatient ward from 
NHS Supplies between 1/4/08 and 31/3/09. (kg 
CO2) 
ICE 1.6a [Hammond & Jones, 2008] 11,300 
DEFRA [DEFRA, 2009] 14,487 
National Statistics of Environmental 
Accounts [Sustainable Development Commission, 2008] 
7,726 
 
These calculations therefore suggested that the DEFRA emissions factor overestimated the 
emissions attributable to the procurement of medical equipment, whilst the emissions factor 
provided by the National Statistics of Environmental Accounts underestimated it. However, it is 
important to note that the calculations relate only to the components of the products, and do not 
include other aspects of their life-cycle such as transportation to factories or users. 
 
A comparison has been made of the use of different emissions factors for the procurement of 
items of medical equipment for the inpatient ward. The items in question were those typically 
found on a renal ward and, as such, the majority of these items were not specific to the provision 
of renal care, but would be found on the majority of inpatient wards. Were a similar assessment 
of the items procured for the provision of the haemodialysis or peritoneal dialysis services (rather 
than for the provision of inpatient care to patients with renal conditions) to have been undertaken, 
it is likely that the results obtained using emissions factors from the ICE database would be closer 
to those derived from the application of DEFRA emissions factors than to those arising from the 
use of emissions factors quoted by the National Statistics of Environmental Accounts. In short, 
the carbon burden of the medical equipment specific to the provision of RRT is likely to be at the 
higher end of the spectrum. Whilst the assessment of this hypothesis through the undertaking of a 
similar assessment on dialysis equipment would be problematic as many more of the items are 
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composed of multiple materials, it is supported by carbon footprinting work undertaken 
independently within the renal industry. The carbon footprint of a one litre intravenous fluid bag 
(Viaflo, produced by Baxter Healthcare) has been calculated at 0.613 kg CO2eq (personal 
communication with David Jiggins, Sustainability & Producer Responsibility Coordinator, 
European EHS Affairs, Baxter Healthcare Ltd, by email, April 29th, 2010). This cradle to grave 
assessment included the embodied emissions of the components and packaging, transportation of 
components and packaging from manufacturers to Baxter manufacturing sites, Baxter premises 
activities (rolled stock film production, fill up and sterilisation), transportation of finished 
products to the Baxter storage and distribution centre, delivery of finished products to customer 
base and final disposal of the products. The current list price for a one litre Viaflo bag of sodium 
chloride is £1.27. The carbon intensity is therefore 0.48 kg CO2eq per £, which is very similar to 
the figure quoted by DEFRA of 0.45 kg CO2eq per £ [DEFRA, 2009].  
 
Another point of note is that, although the emissions factors used in the NHS England Carbon 
Footprinting Study commissioned by the NHS Sustainable Development Unit (SDU) were 
provided by the National Statistics of Environmental Accounts, more recent work by the NHS 
SDU has used the DEFRA emissions factors for the procurement of medical equipment and 
pharmaceuticals [Eastern Region Public Health Observatory, 2010].   
 
The emissions factors quoted by DEFRA for the procurement of medical equipment were 
therefore used in this study. However, the impact upon the overall carbon footprint of the Dorset 
Renal Service of using the emissions factors provided by the National Statistics of Environmental 
Accounts is considered in greater detail in the discussion (under the heading, ‘Uncertainty of the 
Results’). The use of these two factors demonstrates the variation, and also the potential error, 
inherent in this form of environmental accounting.  
 
Aside from the belief that the DEFRA emissions factors more accurately reflect the emissions 
attributable to the procurement of medical equipment specific to renal healthcare, the choice has 
also been influenced by the wider recognition of, and ease of access to, the DEFRA emissions 
factors.   
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The sub-sector of pharmaceuticals does not lend itself to a similar assessment of the emissions 
factors quoted by the two databases. The emissions factor quoted by DEFRA for this sub-sector 
was therefore used in order to maintain consistency.   
 
The Emissions Factors for Waste Management 
The uncertainty that exists with regard to the respective carbon burdens of the disposal of waste 
by landfill and incineration was described in Chapter 2. Furthermore, DEFRA emissions factors 
for the incineration of different materials do not account specifically for the incineration of 
clinical waste, a process which is typically undertaken at higher temperatures than other forms of 
incineration. However, the emissions factors provided by DEFRA represent the most appropriate 
range of factors for the purposes of this study, as they address the disposal of different types of 
waste by the three main routes of disposal employed within healthcare. Therefore, to reflect the 
increased emissions that are likely to result from the incineration of clinical waste, the highest 
available emissions factor for incineration was applied to each of the constituents. 
 
 
The Emissions Factors used in this Study 
 
The emissions factors used in the assessment of the carbon footprint of the Dorset Renal Service 
are provided in Tables 5-8.  
 
Table 5. The emissions factors applied to building energy use activity data. 
Source of Energy 
Emissions factor to convert to GHG emissions 
(kg CO2eq per kWh) a 
Electricity  0.54418 
Heating / hot water from gas 0.18396 
Heating / hot water from oil 0.27652 
Heating / hot water from coal 0.33920 
 
a
 Emissions factors from DEFRA (2009) [DEFRA, 2009].  
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Table 6. The emissions factors applied to staff, patient and visitor travel, and freight 
transport, activity data. 
Travel Modality 
Emissions factor to convert to GHG emissions 
(kg CO2eq per km) f 
Active travel (walking, cycling) 0.0 
Car a 0.20487 
Bus b 0.10462 
Train c 0.06113 
Air Travel (domestic) d 0.17283 
Freight Transport e 0.80201 
 
a
 This emissions factor refers to an average car, running on diesel or petrol, and undertaking 
average journey lengths, within the United Kingdom. 
b This emissions factor refers to an average public bus in the United Kingdom. 
c
 This emissions factor refers to an average emission passenger diesel or electric train in the 
United Kingdom. 
d
 This emissions factor was used as the vast majority of all air travel undertaken was using 
domestic flights. Although suggested by the DEFRA guidance [DEFRA,2009], an uplift factor 
was not applied to the distance prior to the use of this emissions factor in order to maintain 
consistency with PAS2050 [British Standards, DEFRA, Carbon Trust, 2008].  
e
 This emissions factor, which refers to the average rigid (non-articulated) heavy goods vehicle in 
the United Kingdom, was used to calculate the emissions relating to the transport of laundry to 
privately run, off site, laundry services. 
f
 Emissions factors from DEFRA (2009) [DEFRA, 2009]. 
 
 
 90 
Table 7. The emissions factors applied to procurement activity data.    
 
Source of 
emissions factor 
Emissions factor to convert to GHG emissions 
Pharmaceuticals  DEFRA [DEFRA, 2009] 0.81 kg CO2eq per £ 
Medical Equipment DEFRA [DEFRA, 2009] 0.57 kg CO2eq per £ 
Diagnostic Investigations 
(Pathology) 
 
No emissions factor available. An individual blood 
test has been assigned a nominal carbon cost of 0.05 
kg CO2eq.  
Diagnostic Investigations 
(Radiology) 
 
No emissions factor available. An individual blood 
test has been assigned a nominal carbon cost of 0.1 
kg CO2eq.  
Paper and Office Supplies DEFRA [DEFRA, 2009] 1.30 kg CO2eq per £ 
Food and Catering   
Dried goods 0.49 kg CO2eq per £ 
Frozen, chilled, dried 0.49 kg CO2eq per £ 
Bread 0.35 kg CO2eq per £ 
Dairy 0.92 kg CO2eq per £ 
Fish 0.58 kg CO2eq per £ 
Fresh Fruit & Vegetables 0.53 kg CO2eq per £ 
Potatoes 0.53 kg CO2eq per £ 
Meat  0.77 kg CO2eq per £ 
Coffee 0.32 kg CO2eq per £ 
Sugar 0.80 kg CO2eq per £ 
Biscuits 0.35 kg CO2eq per £ 
Paper Cups 
 
 
 
 
 
National Statistics 
of Environmental 
Accounts [Sustainable 
Development Commission, 
2008]
 
 
0.60 kg CO2eq per £ 
Construction DEFRA [DEFRA, 2009] 0.54 kg CO2eq per £ 
Information Technology DEFRA [DEFRA, 2009] 0.58 kg CO2eq per £ 
Water DEFRA [DEFRA, 2009] 0.276 kg CO2eq per cubic metre of water 
Sanitation Products DEFRA [DEFRA, 2009] 0.80 kg CO2eq per £ 
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Table 8. The emissions factors applied to waste collection, treatment and disposal activity 
data. 
Waste Disposal Method Waste Constituent 
kg CO2eq emitted 
per tonne of waste 
constituent a 
Paper 
Plastics 
Cardboard 
Glass 
Other waste 
INCINERATION 
Metal 
1800 b 
Paper -713 
Plastics -1500  
Cardboard -713  
Glass -315  
Other waste -259  
RECYCLING 
Metal -9000  
Paper 550  
Plastics 40  
Cardboard 550  
Glass 10  
Other waste 81 
Metal 10  
Organic waste (food) 365  
LANDFILL 
Organic waste (non food) 230  
 
a
 Emissions factors from DEFRA (2009) [DEFRA, 2009]. 
b
 DEFRA emissions factors for incineration of different materials do not account for the 
incineration of clinical waste, which must be undertaken at higher temperatures. To reflect the 
increased emissions that are likely to result from the incineration of clinical waste, the highest 
available emissions factor for incineration was applied to each of the constituents. 
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Data Accuracy 
 
When calculating a carbon footprint, measures should be taken to ensure that all input, output and 
waste streams are accounted for and that no ‘double counting’ of emissions has occurred. Whilst 
a common approach to this is to undertake a ‘mass balance’, the mix of economic and physical 
data collected in this study renders this approach impractical. This problem, which is relatively 
common when calculating the carbon footprint of a service rather than a product, may be 
surmounted by performing an activity based assessment. For a given activity, all processes and 
materials flowing into and out of that activity stage must be analysed for their GHG emissions. 
When calculating the carbon footprint of a healthcare service, as is the case in this study, an 
activity based assessment might best be undertaken at the level of the individual patients. 
Unfortunately, the heterogeneity of patient demographics and uptake of activities within the 
service presents problems with data availability and again renders the approach impractical for 
this study. The authors are aware of the issues pertaining to the double accounting of emissions 
and all reasonable efforts have been made to overcome them during the design and data 
collection stages of this study.  
 
The variables identified by the authors as being the greatest potential sources of error are the 
emissions factors used for medical equipment and pharmaceuticals. The methodology used to 
ensure that the most accurate emissions factors were used for these subsectors has been 
previously described (under the heading, ‘The Choice of Emissions Factors’) and its potential 
impact is discussed later (under the heading, ‘Uncertainty in the Results’).  
 
 93 
Results 
 
 
The Carbon Footprint of the Dorset Renal Service 
 
Primary Sector Results 
The total emissions associated with the Dorset Renal Service comprise the sum of emissions from 
three primary sectors; building energy use, travel and procurement. The calculated emissions for 
these primary sectors are given below in Table 9 and displayed in Figure 2.  
 
Table 9. Primary Sector Breakdown of the Carbon Footprint of the Dorset Renal Service. 
Sector 
GHG Emissions 
(kg CO2eq) 
% of GHG Emissions a 
Building Energy Use 381,331 13% 
Travel  461,886 15% 
Procurement 2,163,403 72% 
Total Dorset Renal Service Emissions (Kg) 3,006,620 100% 
Total Dorset Renal Service Emissions (tonnes) 3,007 100% 
 
a
 Values rounded to nearest 1%. 
 
Figure 2. Primary sector breakdown of the GHG emissions of the Dorset Renal Service. 
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Sub-sector Results 
The three primary emissions sectors have constituent sub-sectors. The calculated emissions for 
these sub-sectors are given in Table 10 and displayed in Figures 3, 4a and 4b.  
 
Table 10. Sub-sector breakdown of the GHG emissions of the Dorset Renal Service. 
Sector Subsector 
GHG Emissions 
(kg CO2eq) 
%age of GHG 
Emissions 
Building Energy Use  381,331 12.68 
 Total for Building Energy Use 381,331 12.68 
      
Staff Commuting 143,774 4.78 
Staff Business 17,774 0.59 
Patient travel  279,293 9.29 
Visitor travel 20,448 0.68 
Travel 
Other travel 598 0.02 
 Total for Travel 461,886 15.36 
      
Pharmaceuticals 1,043,660 34.71 
Medical Equipment 752,862 25.04 
Diagnostics (Radiology) 209 0.01 
Diagnostics (Pathology) 4,720 0.16 
Paper 9,401 0.28 
Food 6,933 0.23 
Laundry Services 14,070 0.47 
Construction 31,692 0.94 
IT  5,908 0.18 
Water 6,169 0.20 
Sanitation Products 1,954 0.06 
Procurement 
Waste 291,125 9.68 
 Total for Procurement 2,163,403 71.95 
      
Kg 3,006,620 100% 
Overall Totals 
Tonnes 3,007 100% 
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Figure 3. Procurement subsector GHG emissions within the Dorset Renal Service. 
 
 
 
Figure 4a. Travel subsector GHG emissions within the Dorset Renal Service. 
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Figure 4b. Travel subsector GHG emissions within the Dorset Renal Service (using a scale 
consistent with that used in Figure 3). 
 
 
Carbon Emissions per Unit of Healthcare Activity 
 
Table 11: GHG emissions directly attributable to the provision of haemodialysis and 
peritoneal dialysis within the Dorset Renal Service. Due to the aggregated nature of some of 
the activity data, it is possible that these figures underestimate the true contributions of these 
components of the Dorset Renal Service. 
Sector 
GHG Emissions attributable 
to the provision of 
haemodialysis and 
peritoneal dialysis (kg 
CO2eq) 
GHG Emissions expressed 
as a % of the total emissions 
of the Dorset Renal Service 
Building Energy Use 278,398 9.3% 
Travel a 507,225 16.9% 
Procurement (excluding 
waste) 
917,552 30.5% 
Waste 262,128 8.7% 
Total 1,965,305 65.4% 
a
 Return travel by patients to attend haemodialysis treatments produces 173,248 kg CO2eq, which 
represents 34.2% of the overall travel emissions, and 5.76% of the overall emissions, of the 
Dorset Renal Service. 
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Table 12: GHG emissions attributable to the provision of outpatient appointments within 
the Dorset Renal Service. These values should be considered to be indicative only, as they are 
calculated from aggregated activity data.  
Sector 
GHG Emissions attributable 
to the provision of 
outpatient care within the 
Dorset Renal Service (kg 
CO2eq) 
GHG Emissions expressed 
as a % of the total emissions 
of the Dorset Renal Service 
Building Energy Use 15,992 0.53% 
Total Travel 104,490 3.48% 
Staff commuting travel 22,157 0.74% 
Staff business travel 4,144 0.14% 
Patient travel 78,189 2.6% 
Procurement (excluding 
waste) 
45,848 1.52% 
Waste 5,641 0.18% 
Total 171,971 a 5.72% 
a
 Within the Dorset Renal Service, a total of 171,971 kg CO2eq  result from approximately 7,800 
appointments per year. This equates to an indicative carbon burden of 22 kg CO2eq per outpatient 
appointment.    
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Table 13: GHG emissions attributable to the provision of inpatient care within the Dorset 
Renal Service. These values should be considered to be indicative only, as they are calculated 
from aggregated activity data.  
Sector 
GHG Emissions attributable 
to the provision of inpatient 
care within the Dorset Renal 
Service (kg CO2eq) 
GHG Emissions expressed 
as a % of the total emissions 
of the Dorset Renal Service 
Building Energy Use 63,432 2.1% 
Total Travel 121,306 4.0% 
Staff commuting travel 77,390 2.6% 
Staff business travel 7,446 0.2% 
Patient travel 17,620 0.6% 
Visitor travel 18,850 0.6% 
Procurement (excluding 
waste) 
587,153 19.5% 
Waste 52,125 1.7% 
Total 824,016 a 27.4% 
a
 Within the Dorset Renal Service, a total of 824,016 kg CO2eq  result from an estimated 5,110 
bed days per year. This equates to an indicative carbon burden of 161 kg CO2eq per bed day.   
 
 
An Estimation of the Carbon Footprint of the Provision of Renal Services across 
England 
 
The carbon footprint of the Dorset Renal Service is 3,006 tonnes of CO2eq per annum. The 
application of an uplift factor of 1.234567 to this figure provides a value (3,711 tonnes of CO2eq 
per annum) that was considered to be representative of the carbon footprint of a typical renal 
service in England. The Renal Registry lists 53 ‘hub’ units co-ordinating adult renal services 
across England. The total carbon burden of the delivery of renal healthcare to adults across 
England is therefore estimated to be 196,688 tonnes of CO2eq per annum. This represents 0.93% 
of the 21.28 million tonnes of GHG emissions attributed to NHS England [Sustainable 
Development Commission, 2008]. 
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Discussion 
 
 
The Carbon Footprint of the Dorset Renal Service 
 
The total GHG emissions of the Dorset Renal Service in 2008 have been calculated to be 3,007 
tonnes CO2eq. This is almost certainly an underestimate of the true value as the process analysis 
approach predisposes to truncation errors.  
 
Carbon reduction strategies often focus on building energy use. However, this contributes only 
13% of the overall emissions of the Dorset Renal Service. This is considerably lower than the 
22% contribution that building energy use made to the NHS England carbon footprint 
[Sustainable Development Commission, 2008]. This discrepancy is probably the result of two 
factors. Firstly, whilst the overall building energy use attributable to business services was 
accounted for in the NHS England study, the study excluded the proportion of building energy 
use attributable to the hospital business services that might reasonably have been allocated to the 
carbon footprint of the Dorset Renal Service (as it was not quantifiable). Secondly, and more 
importantly, the emissions resulting from the high level of procurement of pharmaceuticals and 
medical equipment within the Dorset Renal Service will have impacted upon the balance of the 
contributions of the different primary sectors. Overall, the results of this study support the 
assertion, proposed in the introduction to Chapter 2, that measures to reduce building energy use, 
although important, should form only part of strategies intended to reduce the carbon footprint of 
renal healthcare.  
 
Similarly, even with the inclusion of staff commuting travel, overall travel emissions contribute 
only 15% of the carbon footprint of the Dorset Renal Service (a figure very similar to their 
contribution of 16% to the NHS England carbon footprint [Sustainable Development 
Commission, 2008]). Patient travel contributes 60% of the overall travel emissions. That this is 
greater than the contribution (44%) made by patient travel to the overall travel emissions of NHS 
England is not unexpected given that the most common form of RRT, ICHD [Byrne, Steenkamp 
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et al., 2010], requires that patients undertake return journeys to their dialysis facility three times 
per week. However, the two figures are not truly comparable as patient travel emissions 
associated with hospital transport services (as opposed to private travel) are not included in the 
patient travel emissions in the NHS England study.  
 
The discrepancy between the contribution of patient travel emissions to the carbon footprint of 
the Dorset Renal Service (60% of overall travel emissions) and to that of NHS England (44%) is 
lessened by the provision of dialysis at satellite units, which reduce the travel undertaken by 
dialysis patients. In this regard, the Dorset Renal Service is typical in that it has 3 such units (the 
mean number of satellite units per hub unit in England is 3.02, range 0 – 10, calculated using data 
from the Twelfth Annual Renal Registry Report [Byrne, Steenkamp et al., 2010]). The 
contribution of dialysis-related patient travel is of interest. Whilst patient travel to haemodialysis 
is responsible for 173 tonnes of CO2eq, which represents 34% of overall travel emissions, this 
amounts to only 6% of the overall emissions of the Dorset Renal Service. Given that the Dorset 
Renal Service provides ICHD in a relatively rural population, and to a higher than average 
proportion of the patients requiring RRT within that area (49.8%, mean within England = 39.6%, 
range = 7.2 – 72.2%, calculated using data from the Twelfth Annual Renal Registry Report 
[Byrne, Steenkamp et al., 2010]), these results indicate that, whilst necessary, initiatives to reduce 
the emissions associated with dialysis related patient travel are unlikely to impact significantly 
upon the overall carbon footprint of renal services.  
 
A key finding of this study was that procurement provides the remaining 72% of the overall 
emissions of the Dorset Renal Service, a proportion which is in keeping with a service sector 
organisation (rather than one within the manufacturing industry). Pharmaceuticals and medical 
equipment generate 60% of all emissions arising from the Dorset Renal Service. This is double 
the contribution of these subsectors to the NHS England carbon footprint, and represents 83% of 
all procurement emissions of the Dorset Renal Service. This figure would have been greater still 
had not only those medications prescribed by clinicians working in the Dorset Renal Service been 
included in the analysis, but also the many repeat prescriptions of medications originally 
commenced by the Dorset Renal Service that are subsequently provided by Primary Care. 
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However, such an all-encompassing boundary would have required an individual assessment of 
whether to include each individual medication prescribed to each individual patient. Not only 
would this have been impractical, difficulties would also have been encountered when 
determining a consistent approach to deciding which of a patient’s medications should be 
considered to be part of the treatment of a patient’s renal condition, as the roles of similar 
medications may vary on a patient by patient basis.  
 
As has been discussed in the earlier chapters, the most common technologies currently used to 
provide haemodialysis result in renal services using vastly more water than most other clinical 
specialties. The Dorset Renal Service uses approximately 22 million litres of mains water per 
year in the provision of haemodialysis alone. However, this water use produces only 6 tonnes of 
GHG emissions and contributes less than 1% of the overall carbon footprint of the Dorset Renal 
Service. These figures illustrate that, whilst water is a finite natural resource, the environmental 
arguments for its conservation are based predominantly around preventing the depletion of 
natural resources rather than reducing carbon emissions. As such, an ecological footprint might 
confer a greater weighting upon the contribution of the water use to the environmental impact of 
a renal service than a carbon footprint study such as this. It should also be noted that, whilst this 
volume of water use is far greater than in other clinical specialties, it pales into insignificance 
when compared to the use of water in agriculture and is far less than that used in the laundry 
departments of many hospitals.   
 
The contribution of waste (10%) to the overall emissions of the Dorset Renal Service is 
considerably higher than its contribution to the carbon footprint of NHS England (3%) 
[Sustainable Development Commission, 2008], although both studies assigned the carbon 
embedded at the time of manufacture to the procurement of the products rather than to their 
disposal. The high contribution of waste to the carbon footprint of the Dorset Renal Service 
perhaps reflects the fact that the increasing availability of dialysis has been dependent upon 
single-use, pre-packaged products, with both peritoneal and haemodialysis producing large 
amounts of clinical waste [Hoenich et al., 2005]. Disposal of clinical waste is most commonly by 
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incineration, to which a higher carbon burden than disposal to landfill is attributed by the DEFRA 
emissions factors [DEFRA, 2009].  
 
The subsector of food makes a minimal contribution to the carbon footprint of the Dorset Renal 
Service, primarily because food is only generally provided to patients on the acute ward (who 
represent a tiny proportion of the overall patients accessing the Dorset Renal Service).   
 
 
The Carbon Footprint of the Provision of Renal Healthcare to Adults across 
England 
 
The total carbon burden of the delivery of renal healthcare to adults across England is estimated 
to be 196,688 tonnes of CO2eq per annum. This equates to 0.93% of the overall GHG emissions 
attributable to NHS England, and 2.16% of the 9.1 million tonnes of CO2eq attributed to 
secondary care in England per annum [Eastern Region Public Health Observatory, 2010]. 
 
This high-level estimation is intended only to provide context to the study. Its accuracy is 
undoubtedly compromised by a methodology which extrapolates data collected from a single 
renal service. Renal services provide care to differing numbers of patients, with differing social 
and medical demographics, and the proportions of these patients accessing the different 
components of the services (haemodialysis, peritoneal dialysis, inpatient care, outpatient care, 
transplantation) also varies greatly [Byrne, Steenkamp et al., 2010]. The extrapolation 
methodology accounts only for the absolute numbers of patients receiving renal replacement 
therapies under the care of the different renal services.  
 
It has not been possible to account for the variation in the proportions of patients accessing the 
different components of the services. Although these data are available (at least for 
haemodialysis, peritoneal dialysis and transplantation, if not for patients not receiving renal 
replacement therapies) for each of the renal services across England, the difficulties of 
disaggregating the activity data collected from the Dorset Renal Service across its component 
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parts (particularly within the different forms of RRT) prevent an approach in which the relative 
sizes of the components of the different services across England are afforded an accurate 
weighting in accordance with the contribution made by the corresponding component to the 
carbon footprint of the Dorset Renal Service.  
 
Not all of the carbon footprint of NHS England can be attributed to clinical specialties. Indeed, a 
significant proportion of the carbon footprint of NHS England is not directly attributable to any 
of the clinical specialties. Examples of such areas might be the emissions arising from the 
Finance Departments or the Patient Liaison Services of hospitals incorporating renal services. 
Were carbon footprint assessments similar to this study to be undertaken for different specialties, 
it is likely that these emissions would again be considered to lie outside their boundaries. 
Therefore the carbon footprint of renal healthcare is greater than 0.93% of the carbon footprint of 
the clinical specialties, but the extent to which this is the case is not clear in the absence of data 
regarding the carbon footprints of the other specialties.  
 
 
Carbon Emissions Per Unit of Healthcare Activity 
 
But is renal medicine a carbon intensive specialty? Again, without results from other specialties 
for comparison, this is difficult to ascertain. The NHS England emissions of 21.28 million tonnes 
of CO2eq per annum result from the provision of care to 51.4 million people (0.41 tonnes per 
patient per year) [Sustainable Development Commission, 2008]. Data regarding the proportion of 
the population of England accessing renal services are not available, and neither is similar data 
for the population covered by the Dorset Renal Service. However, data from the Renal Registry 
confirms that the proportion of the population of England receiving either haemodialysis or 
peritoneal dialysis is extremely small (0.04%) [Byrne, Steenkamp et al., 2010]. Yet, it is to be 
expected that the majority of the emissions arising from renal services result from the provision 
of these two forms of RRT, and indeed these two components of the Dorset Renal Service 
contribute 65.4% of its overall carbon footprint (Table 11). The provision of haemodialysis and 
peritoneal dialysis by the Dorset Renal Service to just 277 patients, from a population of 865,000, 
 104 
results in 1,965 tonnes of CO2eq, equating to an emissions burden of 7.09 tonnes of CO2eq per 
dialysis patient per year. Therefore, just as renal medicine is considered to be a ‘high cost, low 
volume’ specialty in financial terms, it seems likely that it is also a carbon intensive specialty 
when considered in terms of the numbers of patients treated with RRT.  
 
This line of thinking is supported by the finding that a total of 824 of the 3006 tonnes of CO2eq 
attributable to the Dorset Renal Service result from the provision of an estimated 5,110 inpatient 
bed days per year. This equates to a carbon burden of 161 kg CO2eq per bed day (Table 13). 
Whilst this estimate was derived from aggregated activity data, and should therefore be 
considered to be indicative only, it is considerably higher than the only other published figure of 
this nature; the previously mentioned NHS SDU study [Eastern Region Public Health 
Observatory, 2010] estimated the GHG emissions associated with one bed day (within all clinical 
specialties) to be 80 kg CO2eq through the application of four methodologies to data from the 
NHS England Carbon Footprinting report [Sustainable Development Commission, 2008]. The 
discrepancy appears to be largely due to the emissions arising from the procurement of 
pharmaceuticals and medical equipment, and is therefore perhaps explained in part by the 
provision of RRT to patients on the inpatient renal ward. Interestingly, although inpatient care is 
provided at a single site (DCH), the contribution of patient and visitor travel to the emissions 
associated with the provision of inpatient care is relatively small (4.4%).  
 
The carbon emissions attributable to an outpatient appointment in the Dorset Renal Service have 
been calculated to be 22 kg CO2eq (Table 12). This figure is based upon aggregated activity data 
and should also be considered to be indicative only. However, given the lack of carbon 
footprinting studies within healthcare, it is of note that this estimation, produced by a ‘bottom up’ 
approach, is comparable in magnitude to that of the only other published data, again from the ‘top 
down’ NHS SDU study [Eastern Region Public Health Observatory, 2010]. The NHS SDU study 
applied three different methodologies to data from the NHS England Carbon Footprinting report 
[Sustainable Development Commission, 2008] and reported estimations of 24, 38 and 78 kg 
CO2eq per outpatient appointment. The figure reported here lies at the lower end of this range, 
perhaps reflecting the exclusion of pharmaceuticals prescribed from primary care.  
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Uncertainty in the Results 
 
The nature of carbon footprinting methodology, in which every input has some degree of 
uncertainty associated with the assumptions and estimations relating to it, means that every 
carbon footprint has some degree of variation inherent within it. The higher the uncertainty, the 
lower the confidence with which the carbon footprint can be interpreted, and, in particular, used 
for comparison.  
 
The process analysis and input-output approaches to carbon footprinting have different 
uncertainty profiles, and their use in isolation can present difficulties in interpreting these 
profiles. For example, the extent of any truncation error, which occurs within process analysis as 
a result of the exclusion of components of the service or product, can only be estimated using a 
top-down model. Conversely, the magnitude of aggregation uncertainty, which occurs in input-
output assessments, can only be considered through comparison with process analysis data. These 
problems highlight a further benefit of the hybrid LCA approach. As this study is processed 
based, uncertainty exists around the possibility of truncation error.  
 
Aside from uncertainty arising as a result of the methodology, uncertainty may derive from two 
further sources in any carbon footprint. Natural uncertainty results from changes within the 
product or service being assessed. As such, it may not easily be identified or quantified, can 
sometimes be ameliorated through adequate sampling, and is accounted for in the understanding 
that a carbon footprint is a representative rather than exact figure. Technical uncertainty results 
from flawed calculations (for example, as a result of incorrect assumptions or poor quality data) 
and may amenable to analysis. However, as the analysis is of only a single renal service, it is not 
possible to estimate variation at this level. Furthermore, as data have been collected from a single 
year, there is no scope to measure variation or error.  
 
Further uncertainty arises from the use of supply chain emissions factors calculated from input-
output economic tables based upon 2004 prices. Whilst the economic activity data have been 
deflated to maintain consistency with the emissions factors, emissions in more recent years may 
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have changed because of subsequent changes in the structure and emissions intensity of the 
supply chain itself.  
 
The measures taken to identify the most appropriate emissions factors for this study have been 
outlined previously. However, the considerable variation between emissions factors quoted by 
different sources for the medical equipment and pharmaceutical supply chains, and the extent to 
which these subsectors contribute to the carbon footprint, means that uncertainty is conveyed to 
the final results. Appendix 3 includes the complete results of the carbon footprint of the Dorset 
Renal Service derived using emissions factors for these subsectors from the National Statistics of 
Environmental Accounts, and also using values averaged between the emissions factors quoted 
by DEFRA and National Statistics of Environmental Accounts. Meanwhile Figure 5, below, 
illustrates the extent to which the use of the different factors influences not only the overall result 
but also the impact of the different sectors within the total. 
 
Figure 5. The impact of the use of different emissions factors for the medical equipment and 
pharmaceutical subsectors upon the overall carbon footprint and the impact of the different 
sectors. (Emissions factors sourced from A. DEFRA, B. averaged figures, and C. National 
Statistics of Environmental Accounts). 
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Accurate carbon footprinting studies are vital to inform strategies to reduce the considerable 
environmental impact of healthcare. These results are presented to highlight the need for future 
research to refine the emissions factors relevant to the supply chains supporting the provision of 
healthcare. These emissions factors should ideally be tailored to use within the different 
specialties of medicine.   
 
 
 
Recommendations  
 
 
Recommendations to Reduce Emissions Associated with the Provision of Renal 
Healthcare 
 
The results of this study should inform strategies to reduce the emissions arising from the 
delivery of renal healthcare. Measures to reduce emissions arising from the procurement of 
pharmaceuticals and medical equipment should be prioritised and these might take a number of 
forms. Firstly, the renal community should explore possibilities to reduce its consumption of 
pharmaceuticals, for example, through measures to improve compliance and reduce wastage. 
Similarly, opportunities to reduce the consumption of medical equipment should also be 
investigated, for example through the re-evaluation of the extent to which risk management 
defines infection control policies, such that the increasing trend towards single-use, disposable 
items might be reversed in favour of re-usable items (where these have been proven to be 
acceptably safe and to have a lower environmental impact). Secondly, the reduction of GHG 
emissions arising within the supply chains for these procurement subsectors should be 
incentivised. Research is therefore required to develop effective sustainability criteria for 
inclusion in the procurement contracts tendered by renal services. Such criteria should pay 
particular attention to the manufacturing stage, as the majority of pharmaceutical and medical 
equipment procurement emissions are believed to relate to building energy use during their 
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manufacture [Sustainable Development Commission, 2008]. Finally, external influences, such as 
the Carbon Reduction Commitment, may also reduce manufacturing emissions.  
 
In contrast to their lower financial costs, medical equipment and pharmaceuticals manufactured 
outside of Organisation for Economic Co-operation and Development (OECD) countries have 
higher embedded energy costs [Sustainable Development Commission, 2008]. Therefore, 
strategies to incentivise renal services to procure medical equipment and pharmaceuticals that 
were manufactured in OECD countries might be anticipated to reduce supply chain emissions, 
although such an approach would require the consideration of the wider ethical issues.  
 
 
Recommendations to Improve the Use of Carbon Footprinting Studies within 
Healthcare 
 
Further research, including carbon footprinting studies, is required to better understand the 
environmental impacts of healthcare technologies, treatments and pathways, such that these 
impacts can be considered during service reconfigurations. The experiences of the authors whilst 
undertaking this study prompt the following recommendations.  
 
More specific emissions factors are required. 
More specific emissions factors are required to facilitate accurate modelling of the effects of 
strategies designed to reduce the carbon footprint of renal medicine. This is particularly true for 
the procurement subsectors of pharmaceuticals and medical equipment, which contribute heavily 
to the carbon footprints of both NHS England and the Dorset Renal Service. Whilst there is likely 
to be considerable variation in the carbon intensities of the different types of pharmaceutical and 
medical equipment that exist within these subsectors, this is not reflected in the emissions factors 
currently available. For example, whilst the emissions factors used in this study for these 
subsectors are derived from a multi-region input-output model and therefore take some account 
of the emissions relating to the production of imported goods, future iterations of carbon footprint 
assessments of renal units should, if possible, identify where products are produced and will 
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therefore require more specific carbon intensity values to reflect this. A practical approach may 
be to produce emissions factors for these subsectors specific to the different specialties of 
medicine. 
 
Waste management represents another area in which the accuracy of carbon footprinting studies 
might be improved through the production of emissions factors that are more specific to 
healthcare. For example, the incineration of healthcare waste differs from the incineration of 
municipal waste. Not only is it likely to be undertaken at higher temperatures, but the materials 
being incinerated are likely to be different in nature to those of municipal waste. Such factors will 
influence the GHG emissions associated with the process, for example through their impact upon 
opportunities for energy recovery. It is unclear how well the emissions factors that are presently 
available for waste management represent the disposal techniques used in healthcare. 
  
Improved accessibility to high quality primary data is required to increase the accuracy and ease 
of future carbon footprinting studies. 
The accuracy of a carbon footprint is reliant upon the quality of the primary data available. This 
could be widely improved through simple measures, such as sub-metering of electricity 
consumption in renal units, regular auditing of waste disposal, and the use of more refined 
procurement data recording systems.  
 
Standardisation of the methodologies used for carbon footprinting within healthcare is required. 
Carbon footprinting methodologies are increasingly subject to standardisation. This report 
adheres to the principles and definitions defined within PAS2050 [British Standards, DEFRA, 
Carbon Trust, 2008]. However, it was considered pragmatic to depart from this methodology in 
particular areas, in order to more accurately reflect the carbon footprint of what a renal service is 
more widely understood to include. For example, the emissions attributable to patient and staff 
travel have been included in this study, although strict adherence to PAS2050 would dictate their 
exclusion. It would be preferable for future healthcare carbon footprinting studies to follow a 
unified methodology in order to ease their comparison and understanding. The advantages of 
adhering more rigidly to a proven and already widely used methodology such as PAS2050 
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(primarily simplicity) must be weighed against the advantages of the development of more 
healthcare-specific methodologies (arguably, that the definition of the service or treatment under 
study may be set to more accurately reflect the form that it is most widely perceived to take by 
the healthcare community).  
 
 
Conclusions 
 
Very few carbon footprinting studies have been published within the medical literature, despite a 
pressing need to develop an evidence base with which to support carbon reduction strategies 
within healthcare. This chapter has presented the first assessment of the carbon footprint of an 
individual specialty service to include both direct and indirect emissions, identifying the 
contributions of the three primary sectors (travel, building energy use and procurement). The 
GHG emissions of the provision of renal healthcare across England have been estimated from 
these results. 
 
The methodology employed in this study can be translated to other renal services and might be 
used to inform similar studies in other specialties. The results of this study might be used to 
inform carbon reduction strategies in renal services.   
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Chapter 5. 
 
The Greenhouse Gas Emissions associated with the Provision of Home and 
In-centre Maintenance Haemodialysis in the United Kingdom. 
 
 
Introduction 
 
The lack of evidence to support the implementation of carbon reduction strategies within the 
provision of renal healthcare was highlighted in Chapters 2 and 3. Chapter 4 has begun to address 
this deficit by reporting the carbon footprint of an individual renal service, in which the provision 
of healthcare to patients requiring dialysis was identified as a substantial contributor to the 
overall GHG emissions. An opportunity for clinical transformation might therefore exist within 
the delivery of haemodialysis to patients with ESRD. Within the United Kingdom, haemodialysis 
forms the cornerstone of most RRT programmes and the prevalence of haemodialysis patients is 
increasing year on year [Byrne, Steenkamp et al., 2010]. Haemodialysis is provided either in 
dialysis facilities (‘in-centre haemodialysis’, ICHD) or in patients’ own homes (‘home 
haemodialysis’, HHD). The uptake of HHD varies dramatically between and within countries, 
and has declined considerably in many regions [MacGregor et al., 2006]. This is the case in the 
United Kingdom, where, on the 31st December 2008, 43% of prevalent patients on RRT 
programmes received ICHD whilst just 1.1% undertook HHD [Byrne, Steenkamp et al., 2010]. 
The decline in the numbers of patients undertaking HHD in the United Kingdom has been not 
only a relative one (the result of increases in the numbers of patients receiving the alternative 
forms of RRT, such as transplantation, ICHD and peritoneal dialysis) but also an absolute one 
(with reductions in the actual numbers of patients receiving HHD). Significant expansion of 
existing HHD programmes is likely to be possible in many countries, including the United 
Kingdom, and technological advances in haemodialysis machines should help to facilitate this.  
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The National Institute for Health and Clinical Excellence (NICE) has advocated that all suitable 
patients should be offered the choice between HHD and ICHD [National Institute for Health and 
Clinical Excellence, 2002], and has suggested that, based upon assumptions regarding patient’s 
likely preferences, renal services should be able to provide HHD to 15% of patients requiring 
dialysis. Furthermore, it is also likely that the rising numbers of patients dialysing at home will, 
for clinical reasons,† be encouraged to dialyse more frequently (consuming more single-use 
equipment and producing more plastic and packaging waste) and for longer (requiring more 
electricity and water). The point at which the increase in GHG emissions that result from the 
more frequent and longer dialysis treatments that are likely to be undertaken by HHD patients 
outweigh the reduction in the travel emissions of these patients, compared to those receiving 
ICHD, is not clear.  
 
In anticipation of the changing face of haemodialysis programmes in the United Kingdom, this 
chapter reports the undertaking of a study designed to improve our understanding of the 
environmental impacts of the differing modalities and regimens of haemodialysis treatments. 
 
 
Aims 
 
The primary aim of this study is to determine the carbon footprints of the differing modalities and 
treatment regimes commonly used to deliver maintenance haemodialysis, in order to inform 
decision-making around the provision of haemodialysis services. The secondary aim is to 
calculate the contributions of the constituent components of haemodialysis treatments to these 
carbon footprints, in order to inform carbon reduction strategies at the level of individual 
treatments.  
 
                                                 
†
 Relatively large oscillations occur in a patient’s weight (which represents fluid retention between dialysis sessions) and blood metabolite 
concentrations when dialysis treatments are provided three times a week, and these are known to be a major cause of morbidity [Ing et al., 
2006]. More frequent dialysis treatments lessen the extent of these oscillations and, in turn, confer a number of benefits [Lindsay, 2008]. 
Not only are the dialysis treatments themselves better tolerated, but other indicators of morbidity (including anaemia, blood pressure 
control, nutritional status) are also improved, and patients typically require fewer hospitalisations and enjoy a higher quality of life. 
Meanwhile, similar benefits result from the improved fluid balance achieved through increases in the duration of dialysis treatment times 
(for example, nocturnal dialysis) [Twardowski, 2007]. 
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Methodology 
 
Haemodialysis Services 
ESRD is defined as irreversible and total (or near-total, see Appendix 1) loss of kidney function 
and may result from progressive disease of the kidneys or, less commonly, from an acute kidney 
injury. Patients with ESRD are likely to experience clinical symptoms as a result of the retention 
of waste products and toxins, and also as a result of anaemia, hypertension, oedema and acidosis. 
When a patient’s renal function declines to the point at which their kidneys are considered to be 
unable to support life in the longer term, consideration must be given to commencing RRT.  
 
RRT programmes typically include a number of different treatment modalities and patients with 
ESRD may switch between these over time (Figure 6). Kidney transplantation is the treatment of 
choice for many patients. However, not all patients are suitable for transplantation. This, in 
conjunction with other factors such as the constraints on donor organ availability, results in 
around half of all those patients receiving RRT in the United Kingdom undertaking dialysis. This 
is most commonly haemodialysis (44.1% of prevalent RRT patients), with smaller numbers 
undertaking peritoneal dialysis (9% of prevalent RRT patients) [Byrne, Steenkamp et al., 2010]. 
In contrast to renal transplantation, both haemodialysis and peritoneal dialysis replace only the 
primary functions of the kidneys – namely the maintenance of fluid balance and the removal of 
the waste products of metabolism. Furthermore, these treatments undertake these functions far 
less effectively than healthy kidneys. The point at which patients with ESRD will benefit from 
RRT remains an area of uncertainty in clinical practice, and the introduction of RRT should be 
considered on an individual patient basis.  
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Figure 6. The different modalities of RRT. 
 
As was previously mentioned, haemodialysis may be provided in centre (ICHD) or at home 
(HHD). At present, the haemodialysis machines used in both ICHD and HHD are broadly similar 
and are referred to in this study as ‘standard’haemodialysis machines. However, new technology 
has resulted in the recent availability of dialysis machines with particular advantages for HHD 
patients. 
 
The pathway followed by the majority of patients commencing haemodialysis is shown in Figure 
7. Dialysis ‘access’ (either a fistula or central venous catheter) must be created prior to the first 
treatment, and is required to connect the patient to the haemodialysis machine and enable regular 
treatments. Patients typically commence ICHD, and those wishing to pursue HHD will learn to 
do so at the ICHD facility.  
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Figure 7: A process map of the provision of repeated treatments of ICHD and HHD. 
 
Patients may switch between the different forms of RRT. Patients established on either 
haemodialysis or peritoneal dialysis might, for clinical reasons, switch to the alternative form of 
dialysis or they may receive a kidney transplant. Likewise, transplanted patients may later require 
haemodialysis or peritoneal dialysis. It should also be remembered that patients on RRT may die.  
 
 
Process Mapping a Single Treatment Session of Haemodialysis to an 
Individual Patient 
 
Within the haemodialysis pathway, it is anticipated that the majority of the emissions will result 
from the repeated treatment sessions of either ICHD or HHD. It is therefore essential to 
appreciate the processes and products involved in the provision of a single haemodialysis 
treatment to an individual patient, and to note the similarities and differences that exist between 
the provision of HHD and ICHD.  
  
Travel 
For patients receiving ICHD, a session of haemodialysis treatment begins with the patient 
travelling to the site at which the dialysis treatment is provided and ends with their travel home. 
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This travel may be undertaken privately or may be provided by the hospital providing their 
overall care. Patients undertaking HHD do not travel to undertake dialysis.  
 
The provision of ICHD also routinely requires that staff members travel to the haemodialysis 
facility, including nursing staff, renal technicians, administration and domestic staff. Nursing 
staff and renal technicians will undertake occasional visits to the homes of patients undertaking 
HHD.  
 
The Dialysis Environment  
The environments in which patients undergo haemodialysis are therefore very different. Facilities 
for ICHD vary in size, but may typically have between 8 and 30 ‘stations’ at which individual 
patients will simultaneously receive haemodialysis. The infrastructure used, and building energy 
use required, to provide the necessary space, lighting, heating, ventilation and air conditioning 
will vary between facilities (and, of course, over time), but a degree of standardisation might be 
expected to result from the guidance that exists in this regard [Renal Association, 2009; NHS 
Estates, 2004]. In contrast, greater variation in these parameters is likely to be evident in the 
dialysis environments of the patients undertaking HHD.  
 
Healthcare professionals are present in dialysis facilities at all times, and a single nurse will 
typically be responsible for the care of either three or four patients undergoing ICHD at any one 
time. Although HHD patients are usually encouraged not to dialyse when alone, they are often 
trained to provide all aspects of their care by themselves.  
 
Water 
Large quantities of high grade water are required to provide haemodialysis using standard 
machines. Although variations will exist between dialysis facilities, a typical approach to water 
purification and storage might be as follows. Mains water is first pressurised by a pump before 
passing through a pre-treatment system (usually including carbon filtration and water softening 
treatments) and subsequently a reverse osmosis system. Although reverse osmosis systems vary 
in efficiency, significant volumes of good quality ‘reject water’ are lost-to-drain in the vast 
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majority of United Kingdom facilities and homes. Meanwhile, the majority of the purified water 
is delivered by direct feed to the haemodialysis machines, where it is used to produce dialysate, 
whilst the remainder is stored in a tank and maintained at 60 °C prior to its use for periodic ‘loop 
disinfections’. During these ‘loop disinfections’, discussed below, this stored water is heated 
from 60 to 90 °C and a volume is flushed through the pipe work supplying the haemodialysis 
machines. Electrical energy is therefore required to power the pumps and heaters used in these 
processes.  
 
For those patients undertaking HHD using standard machines, a smaller reverse osmosis system 
is used to purify water on demand. Loop disinfections, and therefore water storage systems, are 
not required. 
 
Acid 
Dialysate production also requires a supply of acid (a concentrated solution of salts – including 
sodium, potassium, calcium, magnesium, chloride and dextrose - which is mixed in proportion 
with purified water to form dialysate). This acid is commonly provided in six litre plastic 
canisters and proportioned in the individual dialysis machines. However, some facilities 
providing ICHD use a central acid delivery system, in which the acid required to make the 
dialysate is delivered into a central tank within the dialysis facility and then distributed to the 
dialysis machines during treatments via a piped loop system with outlets at each dialysis station. 
This system is present in approximately half of United Kingdom dialysis facilities and negates 
the need for the acid to be provided in individual canisters.   
 
Bicarbonate 
To complete the production of the dialysate, a buffer is also added to the solution. Bicarbonate is 
now preferred to acetate for this role. The bicarbonate is supplied in a separate plastic container.  
 
Priming and Disinfection Regimes 
Prior to every treatment, all standard haemodialysis machines must be primed with purified 
water. Regular disinfections are also required. The timing and nature of these disinfections varies 
 118 
across haemodialysis facilities. For an ICHD facility, a typical regime might be as follows: a heat 
disinfection is undertaken prior to the first patient of the day; a combined heat and citric acid 
disinfection is undertaken prior to the second patient of the day; further heat disinfections are 
undertaken prior to, and after, the final patient of the day; once a week, a chemical (cold bleach) 
disinfection is undertaken after the final patient of the day.  
 
Similarly, the disinfection regimes undertaken by patients using standard machines to provide 
HHD will vary, but a typical regime will involve a heat disinfection prior to a treatment session, a 
combined heat and citric acid disinfection after a treatment session, and a chemical (cold bleach) 
disinfection once a week.  
 
Connecting to the Haemodialysis Machine 
The patient is connected to the dialysis machine (‘putting the patient on’). This is most 
commonly achieved by ‘needling the fistula’  - inserting a needle into a surgically created 
anastamosis between a vein and an artery, usually in the patient’s arm - and connecting the needle 
to the blood lines that run to and from the haemodialysis machine. Alternatively, the patient may 
have a central venous catheter in situ, to which the blood lines can be connected directly. The 
method used to connect the patient to the machine will influence both the items of medical 
equipment that are used (most of which are disposable single-use products) and the plastic and 
packaging waste that is generated. Whilst most patients undertaking HHD will learn to perform 
this procedure themselves, it will be performed by members of the dialysis nursing staff for the 
majority of patients receiving ICHD.  
 
The Dialysis Treatment 
During haemodialysis, blood is removed from the patient, travels down a blood line and is 
pumped through a dialyser. Inside the dialyser, waste products in the blood diffuse across a 
membrane into the ‘dialysate’ fluid, a blend of treated water and chemicals. The blood is then 
returned to the patient through a second blood line. Blood continues to cycle between the patient 
and the dialysis machine throughout the duration of the treatment session.  
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Dialysis relies upon the principle of diffusion of solutes across a semi-permeable membrane 
down a concentration gradient. In this way, solutes may move out of the blood, for example the 
removal of urea or creatinine, or into the blood, for example the replenishment of serum 
bicarbonate. Modern dialysis membranes (‘dialysers’) are commonly synthetic and, in the United 
Kingdom at least, are single-use (a topic discussed in Chapter 2). As such, dialysers represent 
another example of the many consumable products involved in the provision of haemodialysis, 
each of which is associated with plastic and packaging waste as well.  
 
The principle of ultra-filtration, in which the convective flow of water and dissolved solutes 
results from a pressure gradient caused by hydrostatic and osmotic forces, is utilised to drive 
water through the dialyser and remove it from the patient as necessary. This fluid is lost-to-drain.  
 
At its simplest, therefore, a standard dialysis machine consists of a blood pump, a system to 
deliver ‘dialysate’ fluid (a blend of treated mains water and chemicals), a heater, and safety 
monitors. A dialysis facility, or home environment, supporting the use of standard dialysis 
machines will also require a water purification system.  
 
The end of the Treatment 
At the end of the session, the patient is disconnected from the dialysis machine. The blood lines, 
dialyser and, in the case of patients dialysing through fistulas, the needles, are disposed of in the 
clinical waste stream. Those patients receiving, and those staff providing, ICHD must, of course, 
then travel home.  
 
The standard haemodialysis machines are rinsed after every use. In addition to the heat, citric 
acid and chemical disinfections detailed previously, a further disinfection process is undertaken 
in ICHD facilities. This ‘loop’ or ‘integrated’ disinfection is required to disinfect the pipe work 
running between the water purification system and the water outlets to each haemodialysis 
station. The frequency with which this disinfection process is undertaken varies between daily 
and weekly across ICHD facilities. 
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New Technologies 
Dialysis technologies evolve continuously and recent advances have produced machines with 
clear advantages for patients undertaking HHD. One such example is the NxStage System OneTM 
dialysis machine [Clark & Turk, 2004]. The availability of this device is considered to be playing 
a major role in the increasing uptake of HHD in the US. At the end of 2007, there were 2,196 
patients in the US using NxStage equipment for short daily dialysis [Blagg, 2010]. This figure 
has now risen beyond 3,000 patients (information provided by Kimal plc, United Kingdom 
distributor for NxStage, by verbal communication, 15th May 2010), although the numbers of 
patients using NxStage equipment in the United Kingdom remain very small. The principal 
benefit of the machine is that it is transportable.  
 
The NxStage System OneTM machine is the smallest haemodialysis system approved by the US 
Food and Drug Administration agency for home use and is considerably smaller than standard 
haemodialysis machines. The dialyser and blood lines are provided together, in a pre-packaged 
plastic cassette. The NxStage System OneTM machine is designed to be used with the NxStage 
PureFlowTM SL device, which prepares up to 60 litres of dialysate (a volume sufficient for 
between two and three treatments, and which can be stored for up to 72 hours) in a ‘SAK’ (a 
plastic container) from mains water within a six hour running time, using a pre-packaged 
disposable filtering system (a ‘PAK’) which must be replaced every 12 weeks. Although it 
removes the need for a reverse osmosis water purification system, and therefore also for 
plumbing modifications, the NxStage PureFlowTM SL device itself is not portable. Therefore, 
when patients travel with the NxStage System OneTM machine, they instead derive the dialysate 
from pre-made five litre bags, of which between four and six are required for each short daily 
dialysis treatment. 
 
There are therefore two treatment scenarios for patients using the NxStage equipment. When 
dialysing at home, they will pre-prepare 60 litres of dialysate from mains water using the 
NxStage PureFlowTM SL device after every second or third treatment. The NxStage PureFlowTM 
SL device will draw electricity from the National Grid during all periods of dialysate production 
and storage. The patient will connect to, and disconnect from, the NxStage System OneTM 
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machine in the manner described for a standard haemodialysis machine. During their treatment, 
both the NxStage PureFlowTM SL device and the NxStage System OneTM machine will be 
drawing mains electricity. After each treatment they will dispose of the waste in clinical and 
domestic waste streams. In the second treatment scenario, when the patient is travelling away 
from home, the NxStage PureFlowTM SL device will not be used. The procedure will be as 
described, with the exception that the dialysate will be hung above the NxStage System OneTM 
machine in four to six pre-packaged fluid bags.  
 
Consumables 
The increased availability of haemodialysis has been dependent upon the use of pre-packaged, 
single-use, disposable items of medical equipment. These ‘consumable goods’ enter the process 
at different stages and subsequently produce waste. The consumables used during the provision 
of a treatment of ICHD include the blood lines, the dialyser, syringes, needles, acid canisters, 
bicarbonate cartridges or bags, sterile gloves, aprons, face masks and dressing towels.  
 
As has been mentioned previously, both longer treatment times and increased dialysate flow rates 
increase the volume of dialysate required. When the acid for dialysate is supplied in canisters, 
these changes can lead to the need for a second canister. The amount, and nature, of the 
remainder of the consumables involved in a single treatment session using a standard 
haemodialysis machine are likely to be similar regardless of either the treatment duration or 
whether it is undertaken as HHD or ICHD. However, these consumables are very different to 
those required for a single treatment using Mobile HHD equipment.  
 
 
Treatment Regimes: the Frequency and Duration of Haemodialysis Sessions 
 
Both the duration and frequency of haemodialysis treatment sessions can be varied and represent 
important considerations when ensuring that patients receive a satisfactory ‘dose’ of dialysis. The 
majority of patients receiving ICHD are prescribed thrice weekly sessions, each lasting 240 
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minutes. This scenario is considered to provide the optimal balance between the constraints 
imposed by limitations in the resources available and the clinical requirements of the patients.  
 
However, the situation is very different for patients undertaking HHD and who are in a position 
to determine for themselves, with guidance from their physician, how frequently and for how 
long to undergo dialysis. HHD patients are increasingly encouraged to dialyse more frequently 
than three times a week, and sometimes for longer (for example, nocturnal dialysis).  
 
The situation is different again for patients using NxStage machines, in which the slower 
dialysate flow rates necessitate longer treatment times (with six hours of dialysis providing a dose 
approximately equivalent to four hours of dialysis using a standard haemodialysis machine). 
However, this is offset by the improved convenience of the system, and patients will typically 
make up these hours by dialysing more frequently rather than for longer periods. 
 
Given these variations in treatment durations and frequencies, this study assesses a selection of 
the more common regimes followed by patients undertaking treatments from the different 
modalities of haemodialysis (see Table 14).  
 
Table 14: The dialysis regimes assessed within this study. 
Regime 
Modality  Machine Type 
Frequency of Treatments Duration of  Treatments 
ICHD Standard Three days a week 4 hours 
HHD Standard Three days a week 4 hours 
HHD Standard Four days a week 4.5 hours 
HHD Standard Five days a week 4 hours 
HHD Standard Six days a week 2 hours a 
HHD Standard Six nights a week 7 hours c 
HHD Standard Three nights a week 7 hours c 
HHD Mobile, NxStage Five and a half days a week b 3 hours a 
HHD Mobile, NxStage Six nights a week 7 hours c 
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a
 Three hour treatments using a NxStage System OneTM machine provide a dialysis dose 
approximately equivalent to that provided by a 2 hour treatment using a standard haemodialysis 
machine. 
b  This figure is derived from the fact that treatment regimes using NxStage System OneTM 
machines most commonly have a treatment frequency of 5 or 6 days a week. 
c
 Patients undertaking nocturnal regimes will typically dialyse for between 6 and 8 hours. 
 
 
Previous Studies to Assess the Environmental Impact of Haemodialysis 
 
Whilst consideration has been given to both the environmental impact of the use of consumables 
within haemodialysis and the financial implications of providing HHD and ICHD [Upadhyay et 
al., 2007; Hoenich et al., 2005; Baboolal et al., 2008], only one study has attempted to determine 
the respective environmental impacts of HHD and ICHD [James, 2007]. Methodological 
difficulties in analysing the absolute carbon footprints of these two modalities prompted the 
adoption of a comparative approach in which quantification of the differences in their 
environmental impacts was attempted. In this study, data relating to transport and water use 
(including both its supply and subsequent treatment) were acquired and HHD was found to 
produce less emissions (0.207 tonnes of CO2) than ICHD (1.404 tonnes of CO2) per patient per 
year. This discrepancy was predominantly attributed to the absence of emissions related to patient 
travel in HHD. These findings should be interpreted with caution as several potentially 
significant sources of emissions were excluded. These exclusions understandably included areas 
of commonality between HHD and ICHD, such as the use of similar haemodialysis machines, 
and also the highly variable aspects of building energy use such as heating and lighting. 
However, in the light of the findings of the study reported in Chapter 4, perhaps the most 
important exclusion was that of the emissions arising within the supply chains and attributable to 
the manufacture of the consumable products (predominantly clinical supplies) required for the 
provision of haemodialysis. The emissions associated with the disposal of these products were 
also not determined. Furthermore, no consideration was given to the variations in treatment 
regimes that exist between HHD and ICHD patients. The data were collected from small numbers 
 124 
of patients, and, importantly, the study pre-dated the emergence of the newer dialysis 
technologies.  
 
A single session of ICHD might be anticipated to produce considerably more GHG emissions 
than a single outpatient appointment. The aforementioned study assumes that patients undergo 
dialysis thrice weekly for 52 weeks a year, and reports that these 156 sessions result in 1,404 kg 
CO2 emissions – or 9 kg CO2 emissions per session [James, 2007]. It must be assumed that these 
figures describe only the CO2, rather than all GHG, emissions. However, this figure is still 
considerably lower than the indicative carbon burden attributed to a single outpatient 
appointment by both the study reported in Chapter 4 (22 kg CO2eq) and the work of others (50 kg 
CO2eq) [Eastern Region Public Health Observatory, 2010], a finding which probably results, at 
least in part, from the exclusions detailed above.  
 
 
Emissions Terminology  
 
The Kyoto Protocol recognises six GHGs in its targets [United Nations Framework Convention 
on Climate Change, 2008]. CO2 is released from both natural events (such as volcanism) and the 
burning of fossil fuels by man. As a result of the latter, CO2 is, by some margin, the most 
prevalent anthropogenic GHG within the atmosphere aside from water vapour. Emissions of 
GHGs may be quantified in terms of their global warming potential - the global warming 
potential of 1 kg of the gas in question being equivalent to the amount of a reference gas that 
would produce an effect of similar magnitude over a defined time period. The IPCC recognises 
three time periods, of which the most commonly used is 100 years. CO2 is the gas most 
commonly used as the reference gas. Therefore the emissions of other gases are frequently 
expressed in the units of CO2eq. Within the US Health Care Sector, approximately 80% of the 
total global warming potential has been attributed to CO2 emissions [Chung & Meltzer, 2009]. 
Similarly, over 85% of the NHS England GHG emissions were CO2 emissions [Sustainable 
Development Commission, 2008]. Furthermore, this remained uniform between sectors and 
subsectors, with minor exceptions being food procurement and waste, which have increased 
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GHG emissions due to production and degradation of organic material. This figure of 85% is also 
comparable to the CO2 proportion from all United Kingdom emissions. However, the remaining 
five GHGs recognised by the Kyoto Protocol have higher global warming potential than CO2 and 
therefore contribute significantly to climate change, even if emitted in small volumes. The study 
includes the two of these GHGs (methane (CH4) and nitrous oxide (N2O)) anticipated to be of the 
greatest relevance to healthcare-associated emissions. 
 
 
Unit of Measurement 
 
Total emissions, including CO2 and non-CO2 (CH4 and N2O) GHGs, have been calculated across 
the components of the different haemodialysis modalities and are reported in tonnes of CO2eq per 
year.  
 
 
Boundary Setting 
  
The sources of emissions included in this study were identified after consideration of, firstly, the 
individual components of the process of providing repeated treatment sessions of haemodialysis 
(outlined previously, and including dialysis access surgery) and, secondly, the impact of these 
components in terms of building energy use, travel and transport, and procurement (including 
waste). The sources of emissions included in this study are shown in Figure 8. 
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Figure 8: Schematic representation of the boundaries of this study. 
 
 
 
Building Energy Use  
 
The building energy use, and associated emissions, directly attributable to the provision of 
haemodialysis has been included in this study. This energy use includes, but is not limited to, the 
electricity required to power the haemodialysis machines, water purification systems, and water 
storage systems. Emissions arising from the building energy use related to the heating, cooling, 
and lighting of the environment in which the haemodialysis treatments are provided have not 
been included (as this energy use is likely to vary at different sites and points in time).  
 
 
Travel and Transport 
 
Emissions arising from staff and patient travel are included within the boundary.  
 
Staff Travel 
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The emissions arising from the travel of all staff required to provide a treatment of dialysis is 
included. This includes dialysis nursing staff, administrative staff, technicians and domestic staff. 
Where staff may contribute to the provision of more than one haemodialysis treatment, the 
emissions arising from their travel are allocated proportionately.  
 
Although PAS2050 [British Standards, DEFRA & Carbon Trust, 2008] demands that the system 
boundary of the service should exclude GHG emissions associated with the travel of employees 
to and from their normal place of work, this report includes the commuting travel of all staff (as 
well as their business travel) in order to maintain consistency with the NHS England Carbon 
Footprinting Study [Sustainable Development Commission, 2008].  
 
Patient Travel 
PAS2050 demands that the system boundary of the service should exclude GHG emissions 
associated with the travel of ‘consumers’ (in this case, patients) to and from the point of service 
use (the dialysis facility and home environment for ICHD and HHD respectively) [British 
Standards, DEFRA & Carbon Trust, 2008]. However, the travel of patients to receive ICHD was 
considered to be an integral component of the delivery of an ICHD programme, and also to 
represent a significant source of emissions. Therefore, all travel undertaken by patients to attend 
haemodialysis treatments has been included.  
 
Transport 
The transport of the consumable goods required to provide haemodialysis has been included in 
this study.  
 
 
Procurement 
 
As the footprint includes both direct and indirect emissions, those emissions relating to the 
procurement of the consumable products required to provide a haemodialysis treatment have 
been included; namely, the procurement of medical equipment, paper and office supplies, laundry 
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services, construction, water, sanitation products (including chemicals for the external 
decontamination of haemodialysis machines), and the collection, treatment and disposal of waste.  
 
 
Specific Boundaries Set Within Procurement 
 
Medical Equipment 
 
The items of medical equipment required to provide single treatments of ICHD and HHD are 
detailed in full in Appendices 4 and 5.  
 
Waste 
The disposal of all forms of waste produced during the provision of haemodialysis is included. 
The domestic waste that is recycled requires further comment as, since the recycling process is 
not undertaken within the renal services providing the haemodialysis, the carbon recovered is 
arguably realised outside of the boundary of this carbon footprint study. However, in order to 
maintain consistency in the approach to waste management, the DEFRA emissions factors for 
recycling were applied to this waste (in preference to considering the disposal of this waste to 
have no impact upon the overall carbon footprints of the different haemodialysis regimes).  
 
Construction 
A dedicated area within the appropriate built environment is integral to the provision of both 
ICHD and HHD (although this is arguably less true for the Mobile HHD technologies), and the 
emissions arising from the construction work required to both install and maintain such an area 
have therefore been included within this report. It should be noted that PAS2050 excludes all 
capital goods, including buildings, and it might therefore be reasonable to assume that emissions 
associated with the installation and maintenance of such capital goods should also be excluded 
[British Standards, DEFRA & Carbon Trust, 2008]. However, the inclusion of these emissions 
sources is considered necessary to facilitate an accurate comparison of the ICHD and HHD 
modalities.   
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Universal Exclusions 
 
The following sources of emissions were considered to lie outside of the boundary of this study; 
the production of machinery used repeatedly (including haemodialysis machines and information 
technology hardware); pharmaceuticals; visitor travel; food; scientific research into renal 
medicine; staff and patient training; water use other than that used in haemodialysis; heating and 
lighting; business services; and immaterial emissions sources (those anticipated to be less than 
1% of total footprint). The exclusion of particular emissions sources merits further comment. 
 
Machinery 
The emissions attributable to the production of haemodialysis machines have been excluded from 
this study. This is in keeping with the recommendations of PAS2050 [British Standards, DEFRA 
& Carbon Trust, 2008]. It is acknowledged that the carbon footprints determined in this study are 
accordingly smaller than would be the case had these emissions been included. However, 
although it is commonplace for an individual haemodialysis machine to be used to provide 
haemodialysis to multiple in-centre patients, but to only one HHD patient, it is considered 
unlikely that the exclusion of these emissions will unduly bias the results in favour of the 
provision of HHD using standard haemodialysis machines. The explanation for this is as follows. 
Current United Kingdom guidelines suggest that haemodialysis machines are replaced at between 
25,000 and 40,000 hours of use or after a period of 10 years of use (whichever comes sooner) 
[Renal Association, 2009]. A machine being used by a HHD patient for four hours thrice weekly 
would accrue 624 hours of use a year, and would therefore have to be retired from service after 
10 years (having performed only 6,240 hours of dialysis – 33,760 hours less than the machine 
might be safely used for). Meanwhile, a machine being used to provide ICHD might be used for 
up to 12 hours a day (providing three patients with four hour treatments) for six days a week, 
thereby accruing 3,744 hours of dialysis a year and requiring retirement from service at just under 
11 years. In order to maximise the efficient use of a fleet of dialysis machines, the dialysis 
technician of a renal service will therefore commonly rotate the machines such that each machine 
spends the majority of its working life providing ICHD and smaller periods of time providing 
HHD. However, it must also be acknowledged that the emissions attributable to the production of 
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standard haemodialysis machines and NxStage equipment may differ and the results of this study 
do not account for this. 
 
The emissions related to the consumable items of medical equipment (those with an anticipated 
life-span of less than one year) used within haemodialysis machines are included.  
 
Pharmaceuticals  
Polypharmacy is common amongst patients with renal disease. This is reflected in the finding, of 
the study reported in Chapter 2, that 35% of the emissions attributable to a renal service result 
from the procurement of pharmaceuticals, in comparison to their contribution of 21% of the 
overall emissions of NHS England [Sustainable Development Commission, 2008]. However, 
emissions arising from the procurement of pharmaceuticals have been excluded from this study 
for two reasons. Firstly, most renal services would allocate the provision of pharmaceuticals and 
haemodialysis to two discrete and separate financial budgets. Secondly, although there is 
evidence to suggest that switching patients to the more intensive haemodialysis treatment regimes 
may facilitate reductions in the overall pharmaceutical burdens they experience [McGregor et al., 
2001; Kuhlmann, 2010], accurate data regarding the extent to which this occurs across the 
different modalities and regimes is not available.  
 
It should be noted that the acid and alkali fluids used in haemodialysis are not generally 
considered to be pharmaceuticals (as is evidenced by the fact that they are procured by Supplies 
Departments rather than Pharmacy Departments) as they do not enter the human body. However, 
as these fluids are produced to pharmaceutical grade quality, the emissions factors for 
pharmaceuticals have been used in calculations relating to the emissions attributable to these 
fluids (with the emissions attributable to the canisters containing them being calculated 
separately).  
 
Blood Tests 
It is standard practice for patients receiving haemodialysis to undergo monthly blood tests. The 
results inform the prescription of both future haemodialysis treatments and medications. The 
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previously reported study, in which the carbon footprint of a renal service was determined, has 
included the emissions attributable to these blood tests. In the absence of an appropriate 
emissions factor, an individual blood test was assigned a nominal carbon cost of 0.05 kg CO2eq. 
The application of a similar value in the context of this study identified that the contribution of 
the emissions attributable to blood tests to the carbon footprint of the provision of haemodialysis 
was less than 1%, and this emissions source has therefore been excluded. 
 
Staff and Patient Training  
This study reports the carbon footprint of the provision of maintenance haemodialysis to patients 
established on the respective modalities and regimes. The initial few months of haemodialysis 
treatment might be anticipated to be more resource intensive, particularly for patients undertaking 
HHD. This might explain the finding that the financial costs of HHD are slightly higher during 
the first few months of treatment [Baboolal et al., 2008]. However, the study includes only those 
components of a service required to provide haemodialysis to patients already established on the 
treatment. Aspects such as, for example, patient training, are therefore not included.  
 
 
Accounting Period 
 
This study calculates the total emissions arising from the provision of haemodialysis using 
different modalities over one year. Data has been collected from the most recent sources available 
(2009/2010 for the majority of data). 
 
 
Data Sources and Assumptions 
 
In order that this report is truly meaningful, and to facilitate replication, the assumptions made in 
the methodology and data collection are outlined here. 
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General Assumptions 
 
Most renal services in the United Kingdom currently provide ICHD to the significant majority of 
their patients receiving haemodialysis, with a far smaller proportion of patients undertaking 
HHD. Whilst the numbers of HHD patients might be anticipated to increase over the coming 
years, it is inconceivable that the facilities required to provide ICHD will become redundant. In 
most services, these facilities currently contribute to the care of HHD. For example, the 
administration work to coordinate the care of HHD patients is commonly undertaken by the 
administration team based in the ICHD facility. For the purposes of this study, it has been 
assumed that these services will continue to be provided in this way.  
 
It has been assumed that an in-centre dialysis facility consists of 15 stations and runs three shifts 
per day to full capacity, thereby providing ICHD to 45 patients each day.  
 
It has been assumed that a patient undergoing ICHD receives 3 sessions per week and, therefore, 
156 sessions per year. 
 
It has been assumed that patients receive haemodialysis rather than haemodiafiltration. Although 
this latter form of treatment, which utilises higher hydrostatic pressures across the semi-
permeable membrane to achieve further solute clearance by convection, consumes approximately 
20% more water, the results of the study reported in Chapter 4 indicated that water consumption 
was unlikely to make a significant contribution to the overall carbon footprint of the provision of 
haemodialysis.  
 
It has been assumed that the process of priming a standard machine for HHD will take 20 
minutes. It has been assumed that the priming time increases to 40 minutes for a standard 
machine being used to provide ICHD, on the basis that all machines will perform a self test at 
start up lasting approximately 15 minutes. During this time, blood lines can be primed and 
fistulas needled – however it is common for the treatment to commence up to one hour later (as 
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this sequence is designed to ensure that the machine is ready for use as soon as the patient 
arrives).  
 
With the exceptions of the assumptions made regarding the successful creation of dialysis access 
that are detailed later, it has been assumed that no unforeseen clinical or technological 
complications arise during the provision of haemodialysis.   
 
 
Travel 
 
Patient Travel to ICHD 
 
Data regarding patient travel to attend for ICHD were derived from the data collated for the 
Patient Transport Survey Report undertaken as part of the National Kidney Care Audit [Health 
and Social Care Information Centre, 2010]. These data were collected from all patients receiving 
haemodialysis in participating units on the 15th and 16th of October 2008. These dates were 
chosen because they captured weekday journeys, avoided school or national holidays, and were 
considered to be representative of ‘average days’. Two consecutive days were chosen to ensure 
that all patients receiving ICHD on three or more days per week (and many of the small number 
of patients who receive ICHD only twice per week) in participating units were captured once. At 
the time of the survey there were 247 separate locations for ICHD in England, Wales and 
Northern Ireland. Of these, 216 adult ICHD facilities provided sufficient data to be included in 
the survey and there was an overall patient response rate of 67.2%.  
 
The following items of data were accessed for 11,285 adult patients. 
 
1. the modes of transport used by each patient for their outward and return journeys; 
namely, hospital transport vehicle, ambulance services vehicle, car, public transport, taxi, active 
travel (walking or cycling), or other modalities. For the purposes of this study, those patients 
reporting to have travelled by ‘public transport’ were assumed to have travelled by bus. Those 
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patients reporting to have travelled by ‘other’ modalities were excluded from the data used in this 
report. Where data regarding the modality of travel were provided for only the outward or return 
journey, the modality was assumed to be the same for both journeys. Where data regarding the 
modality of travel were not provided for either journey, the patient’s data were not included.  
 
2. the distance travelled by each patient. For 87.9 percent of the 11,285 patients, this was 
calculated ‘as the crow flies’ from the patient’s home postcode to their dialysis facility, and, as 
such, might be anticipated to underestimate the overall distances travelled. A further 9.2 percent 
of patients provided an estimate of the distance travelled in place of a postcode. The remainder of 
the patients did not provide data regarding the distance travelled to their dialysis facility. These 
patients were excluded from the data used in this study.  
 
After exclusion of incomplete datasets, data for a total of 11,211 patients were available for 
further analysis. For each of these patients, an emissions factor appropriate to their modality of 
travel was applied to the distance travelled for both the outward and homeward legs of the 
journey. In this way, the overall emissions attributable to the travel of the 11,211 ICHD patients 
to and from their dialysis facility were determined, from which the average emissions per patient 
was established. This was then multiplied by 156, the number of dialysis treatments received per 
year by a patient attending thrice weekly, to calculate the emissions associated with the travel of a 
typical patient to and from ICHD each year. 
 
The advantages of using data collected for the Kidney Care Patient Transport Audit include the 
large patient numbers, the geographical scope, and the inclusion of travel modality data [Health 
and Social Care Information Centre, 2010]. No alternative data were identified that would better 
represent the travel undertaken by ICHD patients in the United Kingdom. Furthermore, it would 
be beyond the scope of this report to collect more accurate data prospectively. However, it should 
be noted that this methodology does not account for the fact that some patients will travel to their 
dialysis facility together. This occurs most commonly when hospital transport vehicles are used. 
However, any overestimation in the emissions attributable to patient travel to ICHD is likely to 
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be compensated for by the underestimation resulting from calculating the distances ‘as the crow 
flies’ rather than by road.   
 
 
Staff Commuting for ICHD 
 
It has been assumed that the distance travelled by staff commuting to work at a dialysis facility 
was 8.7 miles each way, which was found to be the average distance commuted to work from a 
sample of 19,490 people in the national travel survey 2006 [Department of Transport, 2006].  
 
It has been assumed that the breakdown of the modalities of travel utilised by staff when 
commuting to ICHD facilities would be similar to that of United Kingdom commuters in general, 
and have therefore determined this breakdown from data reported by the National Travel Survey 
2006 [Department of Transport, 2006]. It has been assumed that 14% of journeys were made by 
active travel (walking or cycling), 71% were made by car (or motorbike), 7% were made by bus 
and 7% were made by rail.  
 
In order that staff travel emissions may be appropriately apportioned, the following assumptions 
have been made. 
 
One dialysis staff nurse will typically simultaneously provide care to 3 patients undergoing 
ICHD, and will therefore provide care to 6 patients undergoing haemodialysis in the course of a 
single nursing shift. The travel emissions of one dialysis nurse are therefore divided between 6 
patients. 
 
An in-centre dialysis facility will require one technician, one member of the administration staff, 
and two members of the domestic staff, to attend each day. The travel emissions of each of these 
members of staff are therefore divided between 45 patients. 
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Patient and Staff Travel for HHD 
 
It has been assumed that a patient will undertake quarterly return travel to their local dialysis 
facility for review by a doctor (a process assumed, for those patients undertaking ICHD, to 
coincide with one of their routine attendances for ICHD). It has been assumed that no domestic or 
administration staff travel is necessary. It has been assumed that a renal technician visits a HHD 
patient every 6 months (once for annual electrical safety checks and preventative maintenance 
and once for equipment failures), and that a dialysis nurse visits a HHD patient every 3 months. It 
has been assumed that these staff members travel to and from the patient’s local dialysis facility. 
For both patients and staff, this distance has been assumed to be equal to that of the average 
distance travelled by a patient receiving ICHD, and has been determined from the Patient 
Transport Survey Report undertaken as part of the National Kidney Care Audit [Health and 
Social Care Information Centre, 2010]. It has been assumed that this travel is undertaken 
exclusively by car. 
 
 
Building Energy Use 
 
Electricity Consumption 
 
The electricity used by the water systems (in the water treatments, water storage and loop 
disinfections) and by the haemodialysis machines (in each of the different phases of a treatment 
session) has been determined for the different regimes and modalities of dialysis. DEFRA 
emissions factors have been applied to these activity data [DEFRA, 2009].   
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Electricity Consumed by Water Treatment Systems in ICHD Facilities 
 
The water treatment system in place at the Dorset County Hospital haemodialysis facility has 
been used to inform the assumptions and facilitate the direct measurements necessary during the 
collection of activity data.  
 
A pump is used to pressurise mains water. This has been assumed to have a 1.5 kWh motor and 
to run at 90% capacity for 20 hours a day. It has been assumed to idle for the remaining four 
hours, during which time power consumption has been assumed to be negligible. The electricity 
drawn by the pump and attributable to the provision of 156 ICHD treatments to a single patient 
over the course of one year has been calculated to be 153 kWh (Appendix 6).  
 
The water pre-treatment system has been assumed to consume a negligible amount of energy. 
Data for the electricity consumption of the reverse osmosis system has been based upon that of a 
system in which two Gambro 104s reverse osmosis plants run in tandem, drawing a combined 
total of 5 kWh. It has been assumed that they run for 17.25 hours and 14.25 hours on alternate 
days, six days a week, in order to provide 165 patient treatments per week. It should be noted that 
this set-up is slightly over-powered for the number of treatments it is delivering (in order to 
facilitate expansion) and it is possible that reverse osmosis systems in other units may be more 
efficient. It should also be noted that energy consumption would be anticipated to be less in those 
dialysis facilities with variable or ‘demand-dependent’ reverse osmosis systems (rather than fixed 
power systems). The electricity drawn by the reverse osmosis system and attributable to the 
provision of 156 ICHD treatments to one patient over the course of one year has been calculated 
to be 447 kWh (Appendix 6).  
 
 
Electricity Use Water Storage Systems in ICHD Facilities 
 
In most dialysis facilities, the purified water used to provide dialysate for haemodialysis 
treatments arrives at the haemodialysis machines by direct feed from the reverse osmosis system, 
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whilst the purified water used for loop disinfections is heated and stored in a tank. For the 
purposes of this study, it has been assumed that the purified water used for loop disinfections is 
stored in a 330 litre tank and that this water is delivered to the tank at room temperature. Energy 
is therefore required to heat this water from room temperature to 60 °C. Storage tanks are 
supplied in standard sizes and, in most dialysis facilities, a significant volume of unused water 
remains in the tank after each loop disinfection. This water is cooling from 90 °C at the time that 
the new water enters the tank. The energy required to heat the new water to 60 °C has therefore 
been assumed to come from its mixing with the water already in the tank, and no further 
electricity consumption has been attributed.  
 
In order to maintain the stored water temperature above 60 °C, it has been assumed that the water 
is heated to 63 °C eight times each day (and allowed to cool spontaneously) on six days of the 
week, and six times on the day of the ‘loop disinfection’ cycle. Making the assumption that the 
process is 100% efficient, the energy required for this process has been calculated using the 
formula Energy Used = C x M x ∆ T, where: C = specific heat capacity of water (4.19 J g-1 K-1); 
M = the mass of water being heated, in g (330 litres of water equates to 330 kg or 330,000 g); and 
∆T = the change in temperature required, in °K or °C (3 °C). The energy attributable to storing 
heated water to provide one patient with one year of ICHD treatment (156 sessions) has been 
calculated to be 59 kWh (Appendix 6). 
 
 
Electricity Use during Loop Disinfection in ICHD Facilities 
 
During the periodic ‘loop disinfections’, the stored water is heated from 60°C to 90 °C and 
pumped through the pipe-work supplying the haemodialysis machines. It has been assumed that 
loop disinfection is undertaken on a weekly basis and that the process described is 100% 
efficient. The energy required to heat the water has once again been calculated using the formula 
Energy Used = C x M x ∆ T, where ∆T is now equal to 30 °C. The energy use attributable to the 
loop disinfections entailed in the provision of ICHD to one patient for one year has been 
calculated to be 12 kWh (Appendix 6). 
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Electricity Use during the Treatment and Storage of Water for HHD machines. 
   
Standard HHD Machines 
When used to provide HHD, standard haemodialysis machines are commonly fitted with a 
dedicated reverse osmosis system providing purified water for dialysate and disinfection on 
demand. No energy is therefore consumed in the storage (ie heating or pumping) of this water. 
The electricity used by the reverse osmosis system has been included in the energy consumption 
of the haemodialysis machine. 
 
Mobile HHD Machines  
Purified water may be stored for up to 72 hours in disposable containers (‘SAKs’) for use by 
mobile HHD machines. No disinfections or heating are undertaken. The energy consumption of 
the water purification system has been included in the energy consumption of the haemodialysis 
machine. 
 
 
Electricity Use by Standard Haemodialysis Machines during the Provision of ICHD 
 
Assumptions about the manner or pattern of the use of haemodialysis machines to provide ICHD 
have been based on the practices undertaken in the Dorset County Hospital dialysis facility. 
Mention has been made of any areas in which these data might not be considered typical of the 
majority of United Kingdom dialysis facilities.   
 
Activity data for electricity consumed by standard haemodialysis machines have been determined 
from a number of sources: 
 
The electricity consumption, for each of the component stages of a dialysis treatment (heat 
disinfection, priming, 4 hour treatment, combined heat and citrate disinfection and chemical 
disinfection), have been measured during simulated treatments for 3 of the most commonly used 
brands and models of standard haemodialysis machines: 
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1. a single Fresenius 5008 machine presently in use at Dorset County Hospital 
 
2. a single Gambro AK200S machine presently in use at Dorset County Hospital. The data 
collected for this machine were validated by comparison with data published by the 
manufacturer. 
 
3. five B-Braun Dialog+ machines (with heat exchangers) presently in use at the Maidstone 
dialysis facility (these data were originally collected for a separate study [Campbell et al, 2010]). 
 
The electrical energy used was measured directly using a power monitor fitted between the wall 
socket and the machine plug. The data from the Fresenius and Gambro machines were combined 
with averaged readings from the five B-Braun machines to provide a dataset considered to be 
representative of a standard haemodialysis machine used in a United Kingdom dialysis facility.  
 
 
Electricity Use by Standard Haemodialysis Machines during the provision of HHD 
 
Using an identical methodology to that outlined above, the electricity consumption has been 
measured for a single Gambro AK200S machine set up in the manner used for HHD. The 
electricity consumption of the portable reverse osmosis system (Gambro WRO300C) has been 
measured separately. The measurements have been validated against the basic information 
provided for machines produced by four separate manufacturers [Centre for Evidence-based 
Purchasing, 2010]. 
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Electricity Use by Mobile HHD Machines during the provision of HHD 
 
The electricity consumption has been determined for the different stages of the two different 
treatment scenarios used by patients when dialysing with the NxStage Mobile HHD machines at 
home or whilst travelling (Table 15). 
 
Table 15. The different treatment stages for which the electricity consumption of the 
NxStage equipment has been measured.  
Treatment Stage Active Devices Stage Duration 
1.  Standby mode.  NxStage PureflowTM SL device. 
Assumed to be 15 minutes. Not 
included when patient dialyses 
away from home. 
2.  
Dialysate production 
(assumed to be 
required prior to 
alternate treatments 
undertaken at home).  
NxStage PureflowTM SL device. 
6 hours. Not included when patient 
dialyses away from home. 
3.  Standby mode.  
NxStage PureflowTM SL device 
& NxStage SystemTM One 
machine. 
The PureflowTM SL device has 
been assumed to be in standby at 
all times that dialysate is being 
stored but no treatment is being 
administered, in order to heat the 
dialysate. This is estimated at 93 
hours a week for the 5.5 weekly (3 
hour treatment) regime, and 84 
hours  a week for the 6 nightly (7 
hour treatment) regime. 
4. 
Priming of the 
cassette. 
NxStage PureflowTM SL device 
& NxStage SystemTM One 
machine. 
15 minutes. 
5. Treatment session. 
NxStage PureflowTM SL device 
& NxStage SystemTM One 
machine. 
3 or 7 hours. 
6. 
Draining the dialysate 
from the PAK 
(required after 
alternate treatments). 
NxStage PureflowTM SL device 
& NxStage SystemTM One 
machine. 
Assumed to take 1 hour. 
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The electrical energy used during each stage was determined from measurements taken during a 
simulated treatment using a power monitor fitted between the wall socket and the machine plug. 
A single set of measurements were taken from a single machine at the Lister Hospital, Stevenage, 
on July 20th 2010. Where possible, these data were validated by comparison with limited data 
published by the United Kingdom suppliers for NxStage. 
 
 
Water Consumption 
 
The volume of pure water required to provide one haemodialysis treatment has been determined 
from the water required for each of the stages of a haemodialysis treatment (priming, heat 
disinfection, treatment, combined heat and citrate disinfection, and bleach disinfection). For each 
haemodialysis modality and regime, these data have then been uplifted in accordance with the 
efficiency of the reverse osmosis system in place. Finally, any additional water consumption 
(such as pre-treatment systems) has then been considered. DEFRA emissions factors have been 
applied to these activity data [DEFRA, 2009].  
 
For patients using standard haemodialysis machines, dialysate flow rates have been assumed to 
be 300 millilitres per minute for those undertaking 7 hour long treatments, and 600 millilitres per 
minute for all other patients. 
 
 
Water Consumption in ICHD Facilities 
 
The water pre-treatment system has been estimated to use 1400 litres of water per week (carbon 
filter 200 litres per week, water softener 200 litres per day six days per week).  
 
Data regarding water use during the priming and treatment phases of a dialysis treatment 
provided by a standard haemodialysis machine have been determined from: 
 
 143 
1. assumptions, outlined previously, regarding the duration of the priming phase, 
2. the differing durations of the treatment phases across the different regimes included in this 
study, 
3. an assumed dialysate flow rate of 600 millilitres per minute. 
 
The resulting data have been uplifted to reflect the assumption that the reverse osmosis systems 
in ICHD facilities will reject 40% of all water presented to them.  
 
The water consumed during the heat disinfections, combined heat and citrate disinfections and 
chemical disinfections, has been measured during simulated treatments for 2 of the more 
commonly used brands and models of standard haemodialysis machines (a Fresenius 5008 
machine and a Gambro AK200S machine), both presently in use at Dorset County Hospital. 
Where possible, the data collected have been validated by comparison with data published by the 
manufacturer. Once again, the readings have been uplifted to reflect the assumption that the 
reverse osmosis systems in ICHD facilities will reject 40% of all water presented to them.  
 
 
Water Consumption during HHD using Standard Haemodialysis Machines 
 
Data regarding water use during the priming and treatment phases of a dialysis treatment 
provided by a standard haemodialysis machine used to provide HHD have been determined using 
a similar approach to that described above. However, the resulting data have been uplifted to 
reflect the assumption that the reverse osmosis systems in HHD facilities will reject 40% of all 
water presented to them.  
 
The water consumed during the heat disinfections, combined heat and citrate disinfections and 
chemical disinfections, has been measured during simulated treatments using a Gambro AK200S 
machine. Where possible, the data collected has been validated by comparison with data 
published by the manufacturer. Once again, the readings have been uplifted to reflect the 
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assumption that the reverse osmosis systems in ICHD facilities will reject 40% of all water 
presented to them.  
 
It has been assumed that no water is consumed by pre-treatment processing.  
 
 
Water Consumption during HHD using Mobile Haemodialysis Machines 
 
The water consumption for the provision of a year of HHD using the two regimes for Mobile 
haemodialysis machines included in this study has been calculated on the basis of the number of 
treatments undertaken and the assumption that each treatment requires 30 litres of mains water. 
The emissions attributable to the use of pre-packaged fluids are included within their 
procurement, and therefore only those treatments for which the dialysate has been derived from 
mains water are included in the determination of water consumption. No uplift factor has been 
applied as no reverse osmosis system is utilised.  
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Procurement 
 
Medical Equipment 
 
Calculation of Procurement Emissions 
 
The ability of renal services to provide haemodialysis to increasing numbers of patients has been 
dependent upon the availability of single-use, pre-packaged items of medical equipment. 
Emissions arising from the production, consumption and disposal of these consumables are 
included in this study.  
 
Emissions associated with the consumption of these goods are included within the sectors of 
building energy use and travel. Emissions arising prior to the consumption phase (emissions 
arising from the point of extraction of the raw materials, the manufacture of the goods and 
packaging, and their transport to the site of use), and from waste disposal (emissions arising from 
the collection, treatment and disposal of these items and their packaging), are included within the 
‘medical equipment’ and ‘waste’ subsectors of the procurement emissions respectively.  
 
 
Calculating Medical Equipment Procurement Emissions from Economic Activity Data 
 
Emissions arising from the procurement of medical equipment have been shown in the preceding 
chapter to contribute significantly to the carbon footprint of a renal service, and have been 
determined through the application of emissions factors to economic activity data. However, the 
following reservations were identified when considering the adoption of a similar approach in 
this study.  
 
Firstly, neither of the two sets of emissions factors currently available for medical equipment are 
specific to the needs of this study [Sustainable Development Commission, 2008; DEFRA, 2009]. 
Although, in Chapter 4, it has been shown that the DEFRA emissions factors are applicable to the 
 146 
medical equipment used by a renal service, the inventory of medical items used in the provision 
of haemodialysis is far more refined than in a renal service as a whole, and the use of these 
factors might be anticipated to introduce unacceptable levels of error. 
 
Secondly, the financial costs of the consumables required to provide haemodialysis are 
influenced not only by the costs incurred in their production but also by other factors. Hence, the 
costs of the consumables used in the mobile dialysis technologies, which have only recently been 
introduced to the United Kingdom market, might be influenced by both the increased marketing 
expenses of launching a new modality and also the reduced overall expense to the purchaser of a 
system of care in which patients undertake far less travel for their treatment and use less hospital 
resources.  
 
In short, the economic costs of the consumable items of medical equipment required for the 
different modalities of haemodialysis considered in this study cannot be anticipated to reflect the 
emissions attributable to the respective products with equivalent accuracies. For these reasons, 
the emissions attributable to the procurement of the medical equipment have been determined 
from physical activity data collected for their constituent materials (which will be referred to as 
‘the constituent materials method’ hereafter). This decision is supported by a comparison of the 
use of the two methods to determine the medical equipment emissions arising from a single 
treatment session delivered with a standard haemodialysis machine (Appendix 7).   
 
 
The Constituent Materials Method for Calculating Medical Equipment Procurement 
Emissions 
 
An inventory of the items of medical equipment required to provide a single treatment for each of 
the modalities of haemodialysis was created, and a similar inventory was created for the 
packaging of these items (Appendices 4 & 5).   
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Each item, and its packaging, was weighed, and the contributions of the constituent materials to 
this weight were either determined or, occasionally, estimated. Emissions factors relating to this 
material were then applied to convert these weights to CO2 emissions. These emissions factors 
were taken from the independent ICE database (see Chapter 4, under the heading The Choice of 
Emissions Factors, for a description of this database) [Hammond & Jones, 2008].  
 
It is important to consider the boundaries used in the determination of the embodied carbon of a 
material within this database, in order to ensure consistency with the approach undertaken in this 
study. In many cases, the ideal boundaries might be ‘cradle to grave’ (beginning at the point of 
extraction of the raw material, encompassing the emissions arising from interim processes such 
as manufacture, transport, and use, before ending at the point of disposal). For the purposes of 
this study, in which the emissions associated with the use and disposal stages of the life-cycle of 
medical equipment (and, therefore, its constituent materials) are considered separately, the 
optimal boundaries might be ‘cradle to site’ (which includes all emissions until the product 
arrives at its point of use). However, within the ICE database, the boundary conditions for the 
materials of interest for this study were specified as ‘cradle to gate’ (which includes all emissions 
until the product leaves the factory). Given that these materials have relatively high embodied 
carbons (ie high embodied energies and densities) in comparison to those of, for example, 
aggregates and sand, it might be argued that the difference between the embodied carbon when 
measured from ‘cradle to gate’ or ‘cradle to site’ might be considered negligible.  
 
When applying the ICE data, particular care has also been taken to ensure consistency between 
the recycling methodology quoted within ICE for each material and boundaries of this study. The 
exclusive use of ICE data within the procurement sector of this study is anticipated to have 
further reduced the chances of mixing recycling methodologies.  
 
The model used in this study therefore assigns the carbon embedded in items of medical 
equipment to their manufacture and, as such, it is included within the emissions attributable to 
their procurement (with the emissions associated with their disposal being considered separately). 
However, the manufacture of a given quantity of a product is likely to require more than this 
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quantity of material. The extent of manufacturing waste, and what happens to it (re-use, recycling 
or disposal) has been excluded from this study. Furthermore, some highly fabricated and intricate 
items of medical equipment will have energy-intensive manufacturing processes, but more 
detailed exploration of this has been considered to lie outside the scope of this report.  
 
Therefore, in recognition of the emissions resulting, firstly, from the material wastage and energy 
use during the manufacturing process, and, secondly, during the transportation of the raw 
materials and final products, an uplift factor of 10% has been applied to the emissions determined 
by the constituent materials method for the procurement of the items of medical equipment 
required to provide haemodialysis.  
 
 
Assumptions made regarding Consumables and their Constituent Materials 
 
The ICE database provides emissions factors for the CO2 emissions alone. The GHG emissions of 
a constituent material have therefore been assumed to be commensurate with the CO2 emissions. 
This approach undoubtedly underestimates the overall GHG emissions arising from medical 
equipment. However, the extent of this underestimation is anticipated to be small, as the products 
are almost exclusively produced from plastics and metals.  
 
 
ICHD and HHD using Standard Haemodialysis Machines 
 
The emissions attributable to the procurement of the pharmaceutical grade fluids (saline, acid and 
alkalis) required to provide a haemodialysis treatment have been determined from economic 
activity data and the application of DEFRA emissions factors for pharmaceuticals [DEFRA, 
2009].  
 
It has been assumed that the acid for ICHD will be delivered in canisters rather than by a central 
acid delivery system. 
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Mobile HHD Technologies 
 
The canisters in the PAK contain an ion exchange resin (assumed to be polyethylene) and 
activated carbon. In the absence of data regarding the embedded carbon in the activated carbon 
used for medical purposes, it has been assumed that it is a product of combustion (rather than, for 
example, acid washing) and have taken an average of the embedded carbon in three other 
materials produced by combustion (lime, clay tiles, and cement). The ion exchange resin and 
activated carbon have been assumed to be present in equal proportions. It has been assumed that a 
new PAK is required every 10 weeks.  
 
For patients using the Mobile HHD systems, it has been assumed that one ‘SAK’ will be used for 
every two treatments. Although some patients may require a dialysis dose sufficiently small that 
three treatments may be provided from the dialysate produced in one ‘SAK’, it was anticipated 
that these patients would be in the minority. Furthermore, as the dialysate within one ‘SAK’ must 
be used within 72 hours, there will be occasional wastage. 
 
The pre-packaged fluid bags have been assumed to be made from the same combination of 
plastics as the one litre saline bags. Their packaging has been assumed to be polythene. The 
tubing has been assumed to be made from polyvinylchloride. 
 
It has been assumed that five, five-litre, pre-packaged, fluid bags will be required to provide one 
three hour treatment.  
 
 
Assumptions made regarding patient travel for non-medical reasons (and the relationship of 
this travel with the procurement emissions) 
 
The emissions arising from patient travel to and from their dialysis facility have already been 
considered. However, patients may travel away from their home for other reasons. Such travel 
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may influence one or both of their dialysis modality and regime, and impact upon the 
procurement emissions.  
 
Patients Using Standard Haemodialysis Machines 
Although patients undertaking ICHD can undertake haemodialysis at alternative dialysis 
facilities, such ‘holiday dialysis’ is uncommon (less than one week per year for most patients), 
and is not anticipated to significantly influence the emissions attributable to their haemodialysis 
as the modality (ie ICHD) remains unchanged. 
 
The size and weight of standard haemodialysis machines is such that patients using them for 
HHD must organise ‘holiday dialysis’ sessions (essentially ICHD at a non-local dialysis facility) 
in order to travel. Again, as the availability of ‘holiday dialysis’ is extremely limited, this is not 
anticipated to significantly influence the emissions of patients undertaking HHD with standard 
machines.  
 
Patients Using Mobile HHD Machines 
Conversely, the size and nature of the Mobile HHD NxStage equipment is such that patients can 
travel more easily. However, the consumables used by such patients when away from home will 
vary. For these reasons, travel must be incorporated. It has been assumed that a patient 
undertaking Mobile HHD will holiday away from home for 3 weeks of the year, and travel away 
from home for two nights every third week. When away from home, it has been assumed that 
they will undertake short daily dialysis using pre-packaged fluid bags.  
 
For a patient following the NxStage nocturnal dialysis regime (7 hr sessions, six nights a week), 
this equates to 279 nocturnal treatments (all undertaken at home, using dialysate produced by the 
Pureflow system), 48 short (3 hour) treatments (all undertaken away from home, using dialysate 
from pre-packaged fluid bags), and 37 days without dialysis. 
 
For a patient following the NxStage short daily dialysis regime (3 hr sessions, 5.5 days a week), 
this equates to 286 short daily treatments (an average of 5.5 per week), of which 253 will be 
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undertaken at home (using dialysate produced by the Pureflow system) and 33 will be undertaken 
away from home (using dialysate from pre-packaged fluid bags). These patients will have 78 
days without dialysis.  
 
 
Waste 
 
The use of disposable, pre-packaged, items of medical equipment during haemodialysis results in 
the production of waste. The collection, treatment and disposal of this waste contribute to the 
carbon footprints of the different haemodialysis regimes. The model used in this study assigns the 
carbon embedded in products and packaging to the manufacturing process, and it is therefore 
included within the emissions attributable to their procurement. It is important that this carbon is 
not then ‘double counted’ during the calculation of the emissions arising from the disposal of 
these products and packaging. Therefore, the ‘end of life’ carbon footprint has been calculated 
using the DEFRA emissions factors for waste treatment processes [DEFRA, 2009], as opposed to 
the sum of the ‘end of life’ and ‘production’ carbon footprints.  
 
Waste arising from haemodialysis is categorised as being either clinical or domestic waste. The 
results of the survey reported in Chapter 3 illustrated that waste management strategies and 
practices vary amongst renal services, and optimal practice is rarely attained. Although newer 
technologies are emerging for the disposal of clinical waste, at present this waste is almost 
always incinerated. However, it is not uncommon for some domestic waste to undergo 
incineration as well, although, for most items of domestic waste, the optimal method of waste 
disposal is probably recycling, with the remainder being sent to landfill. The majority of 
packaging waste (cardboard, paper and plastic film) is recyclable although, in practice, it is rarely 
recycled.   
 
Primary activity data, in the form of the weight and constituent materials of the waste produced 
for each haemodialysis regime, have been identified by direct measurement (Appendices 4 and 
5). 
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Given the known variability in waste management strategies and practice, and the absence of 
published studies reporting current practice to the detail required for this study, it has been 
assumed that optimal waste management strategies are implemented within reasonable and 
practical limits. Therefore, for standard haemodialysis machines, it has been assumed that: all 
blood lines, dialysers, fistula needles, syringes, gloves, aprons, kidney dishes and gauze packs 
undergo incineration; all intravenous fluid bags, intravenous administration sets, bicarbonate 
cartridges (or bags), and plasters are sent to landfill; and all packaging, acid canisters and paper 
towels are recycled. For mobile HHD machines, it has been assumed that: the disposable filter 
system (PAK) is sent to landfill (although some components are recyclable, it is impractical for 
staff or patients to break down the outer casing and segregate the components); the cartridge 
(containing the dialyser, blood lines, cassette tray and a plastic wallet) is incinerated (although 
some components, are recyclable, the nature of the product again renders a segregation approach 
impractical); the SAK is sent to landfill as it is not currently recyclable (information provided by 
Kimal plc, United Kingdom distributor for NxStage, by email, June 1st, 2010); the pre-packaged 
fluid bags are sent to landfill (in the absence of data indicating that they are recyclable); all 
packaging is recycled; and all fistula needles, syringes, gloves, aprons, kidney dishes and gauze 
packs undergo incineration. 
 
DEFRA emissions factors have been applied to the activity data collected for waste.  
 
 
Construction 
 
The emissions arising from both the installation and maintenance construction work required to 
ensure dialysis environments are fit for purpose were determined from activity data that were 
economic and secondary (determined by methods other than direct measurement) in nature, and 
to which DEFRA emissions factors were applied [DEFRA, 2009]. Economic data were used as 
physical data was not available.  
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Installation Construction Work for ICHD 
Due to differences in size, property costs and potential for future expansion, considerable 
variation exists within the financial costs reported for the construction of new satellite dialysis 
facilities in the United Kingdom. The average cost, per dialysis station, of the 11 satellite dialysis 
facilities that opened during 2006 was £47,890 [Department of Health, 2007]. Assuming inflation 
rates have averaged 2.5% between 2006 and 2009, this equates to a cost of £51,659 (calculated at 
http://www.bankofengland.co.uk/education/inflation/calculator/flash/index.htm).  
 
A typical dialysis station has been assumed to provide two and three treatments per day on 
alternate days, six days per week, equating to 780 treatments per year. Assuming a depreciation 
period of 20 years, the initial financial outlay of £51,659 per station therefore provides 15,600 
treatments - a cost per treatment of £3.31147. A patient receiving ICHD undergoes 156 
treatments per year. The financial cost attributable to the construction work required to set up an 
ICHD facility has therefore been calculated to be £516.59 per patient per year.  
 
DEFRA emissions factors have been applied to the economic activity data for installation 
construction [DEFRA, 2009]. 
 
Maintenance Construction for ICHD 
Emissions data relating to maintenance construction were calculated from estimations derived 
from data provided by the Dorset County Hospital Estates Department detailing the expenditure 
per square metre on maintenance construction, and DEFRA emissions factors. It has been 
assumed that this data is representative of the expenditure per square metre for a dialysis facility. 
A typical dialysis facility has been assumed to be 270 square metres and to provide 225 
treatments per week.  
 
 
Installation Construction Work for HHD using Standard Machines 
Pre-existing accommodation, that may be rendered suitable for the provision of HHD using 
standard haemodialysis machines with only minor construction work, is presently often a 
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prerequisite for patients to be considered for HHD in many renal services. Therefore, the 
emissions associated with any installation construction work are likely to represent only a small 
proportion of the overall emissions attributable to the provision of HHD. Nevertheless, these 
emissions have also been included in this report. 
 
In the absence of published data, the installation cost, per patient home, has been estimated at 
£3000 on the basis of informal reports from individual renal services. The depreciation time has 
been assumed to be 5 years, a figure chosen to reflect a balance between the results of an analysis 
of data from the Renal Registry (showing that half of patients commencing HHD in the United 
Kingdom will receive a transplant within 20 months) and the four-fold reduction in life-
expectancy of patients on maintenance haemodialysis [Ansell, 2008; United States Renal Data 
Systems, 2007]. Economic activity data, in the form of the financial cost attributable to the 
installation construction work required per HHD patient per year, have been calculated and 
DEFRA emissions factors have been applied to this [DEFRA, 2009]. 
 
 
Maintenance Construction Work for HHD using Standard Machines 
As the room in which patients undertake HHD commonly becomes dedicated to the provision of 
haemodialysis, and is often no longer available for other activities of daily living, the emissions 
attributable to the maintenance of the room, including the necessary plumbing, electrical and 
structural modifications, have been included in this study and are estimated to be £100 per patient 
per year. DEFRA emissions factors have been applied to this economic activity data. 
 
 
Installation Construction Work for HHD using Mobile HHD Technologies  
The nature of the mobile HHD technologies is such that it has been assumed that no plumbing, 
electrical or structural modifications are required for this modality and, as such, the emissions 
attributable to setting up the environment have been considered to be negligible. 
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Maintenance Construction Work for HHD using Mobile HHD Technologies  
Although it is perhaps less common for the room in which patients undertake HHD to be 
dedicated solely to the provision of haemodialysis when mobile HHD technologies are used, the 
emissions attributable to maintenance construction for such a room have again been included in 
this report, however, as there are no plumbing, electrical or structural modifications, the costs 
have been estimated at just £50 per patient per year. DEFRA emissions factors have been applied 
to this economic activity data. 
 
 
Laundry 
 
Emissions attributable to the laundry resulting from haemodialysis treatments have been 
considered to arise from transport (to private laundry companies, in the case of ICHD), washing 
and drying.  
 
ICHD 
HD treatments may have a cooling effect on core body temperature, and it has been assumed that 
half of patients undertaking ICHD will choose to cover themselves with a blanket. Dialysis 
stations are used repeatedly by different patients and it has been assumed that half of ICHD 
facilities will cover each station with a new sheet prior to a patient’s treatment (with the 
remainder assumed to have vinyl ‘wipe clean’ stations). Based upon these assumptions, the 
weight of linen laundered per patient per year was calculated from direct measurements.  
 
It has been assumed that all laundry requirements arising from the provision of ICHD will be 
contracted out to private laundry companies (as most hospitals now have small, or no, laundry 
departments, and no satellite dialysis units were considered unlikely to launder their linen on 
site). It has been assumed that the laundry travels in rigid, diesel, heavy goods vehicles which run 
at the United Kingdom average capacity. It has been assumed that the one way distance between 
the dialysis facility and the laundry service is 8 miles (based upon data from a sample of dialysis 
facilities in Dorset and Somerset). As the Dorset Renal Service laundry forms a component of the 
 156 
local sites overall laundry burden, it has been assumed that the number of journeys made is 
equivalent to the total weight of laundry produced per year, divided by the maximum capacity of 
the vehicles used.  
 
In the absence of more accurate data, it has been assumed that the washing and drying machines 
have energy efficiencies, per kg load, equivalent to that of standard domestic machines.  
 
HHD 
It has been assumed that patients undertaking HHD will not use a sheet. It has been assumed that 
only one quarter of patients undertaking HHD will use a blanket, and that this will be washed in 
the own home once a fortnight, and dried using a drying machine in 25% of cases. 
 
 
Paper and Office Supplies 
 
The emissions attributable to the procurement of paper and office supplies are calculated from 
economic activity data. The annual expenditure of the Dorset County Hospital haemodialysis 
Department on paper, and office supplies (including printer cartridges) was determined for 
2008/09 from the records of the Procurement Department at Dorset County Hospital. Office 
supplies were further sub-divided into machinery, plastic goods and metal goods. DEFRA supply 
chain emissions factors were applied to these data [DEFRA, 2009]. The emissions per treatment 
were determined by dividing the total emissions arising from the procurement of paper and office 
supplies by the number of haemodialysis treatments provided annually. The emissions per 
treatment were then extrapolated up for each haemodialysis regime, on the basis of the number of 
treatments provided annually. It was assumed that the emissions, per treatment, attributable to 
paper and office supplies are similar for ICHD and HHD.  
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Sanitation Products 
 
It has been assumed that both standard and mobile haemodialysis machines require external 
decontamination after every treatment session. It has been assumed that the machines are first 
cleaned using a wipe soaked in detergent (diluted from concentrate), before being disinfected 
using 70% isopropyl alcohol wipes. It has been assumed that the amount of these products 
required will be similar for all types of haemodialysis machine. 
 
Primary activity data, by way of the annual expenditure on these cleaning products, have been 
determined from the Procurement Department records for the Dorset County Hospital 
haemodialysis unit for 2008/09, from which the cost per treatment has been calculated. DEFRA 
emissions factors have been applied to these data [DEFRA, 2009].  
 
 
Dialysis Access Surgery 
 
The use of central venous catheters as haemodialysis access results in the use of very slightly 
higher rates of consumables during each dialysis treatment. However, in the United Kingdom, 
only 22% of patients receiving maintenance haemodialysis do so via a central venous catheter 
[Oxford Handbook of Dialysis, 2009]. For the purposes of this study, it has therefore been 
assumed that all patients dialyse through arteriovenous fistulae.  
 
The data sources and assumptions used when considering the emissions attributable to dialysis 
access surgery are outlined below.  
 
It has been assumed that fistula surgery is undertaken as a day case procedure under local 
anaesthetic. It has been assumed that a patient will spend 6 hours on the day case ward and one 
hour in theatre and recovery. 
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The distance and modality of travel, for patients attending for access surgery, have been assumed 
to be similar to those of a patient travelling to receive ICHD, and have therefore been determined 
from the data collated for the Patient Transport Survey Report undertaken as part of the National 
Kidney Care Audit [Health and Social Care Information Centre, 2010]. DEFRA emissions factors 
have been applied to these activity data [DEFRA, 2009]. 
 
It has been assumed that the distance travelled by the staff directly involved in the access surgery 
(day case ward nursing and administrative staff, surgeons, anaesthetists, theatre and recovery 
nurses) was 8.7 miles each way, as this is the average distance commuted to work [Department 
for Transport, 2006], and that these journeys were all made by car. The emissions of the 
individual staff members have been determined by the application of DEFRA emissions factors 
to these activity data [DEFRA, 2009], and allocated in proportion to the number of patients that 
these staff members have been assumed to care for.  
 
The building energy use per square meter of day case ward and theatre space has been estimated 
from primary activity data collected from Dorset County Hospital, and the assumptions that the 
energy use of the day case ward will be comparable to that of the average energy use in Dorset 
County Hospital, whilst the energy use in theatres will be twice this. DEFRA emissions factors 
have been applied to these activity data [DEFRA, 2009].  
 
The emissions attributable to the procurement of anaesthetics and surgical equipment and 
pharmaceuticals have been determined from estimations of the financial cost of these items and 
the application of DEFRA emissions factors to these economic data [DEFRA, 2009].  
 
It has been assumed that the emissions attributable to the waste produced from one operation are 
comparable to those of the waste produced by one session of ICHD using a standard 
haemodialysis machine.  
 
It has been assumed that dialysis access surgery will be unsuccessful in every third patient (to 
account for primary failures and the failure of some fistulas to mature), but that a second 
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operation will always be successful. It has been assumed that fistula survival will be 4 years and 
that no interventions are undertaken to achieve this.  
 
From these data sources and assumptions, the emissions attributable to the formation of a 
functioning fistula have been determined, and this figure has been in terms of emissions per 
patient year of haemodialysis.   
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Emissions Factors 
 
The emissions factors used in the calculation of the carbon footprints of the different forms of 
haemodialysis are provided in the Tables 16,17,18 and 19. 
 
Table 16. The emissions factors applied to staff, patient and visitor travel, and freight 
transport, activity data. 
 
Emissions factor to convert to GHG emissions 
(kg CO2eq per km)  
Active travel (walking, cycling) 0.0 
Car a 0.20487 
Taxi b 0.15965 
Bus c 0.10462 
Train d 0.06113 
Ambulance e 0.26866 
Hospital transport vehicle f 0.22608 
Freight Transport g 0.80201 
 
a
 This emissions factor refers to an average car, running on diesel or petrol, and undertaking 
average  journey lengths in the United Kingdom [DEFRA, 2009]. 
b This emissions factor refers to a regular taxi (not a black cab) in the United Kingdom [DEFRA, 
2009]. 
c This emissions factor refers to an average public bus in the United Kingdom [DEFRA, 2009]. 
d
 This emissions factor refers to an average emission passenger diesel or electric train in the 
United Kingdom [DEFRA, 2009]. 
e In the absence of a specific emissions factor for travel by ambulance, that of an average van (up 
to 3.5 tonnes) in the United Kingdom has been used [DEFRA, 2009]. 
f In the absence of a specific emissions factor for travel by hospital transport vehicle (as opposed 
to car, taxi or ambulance), that of a multiple person vehicle in the United Kingdom has been used 
[DEFRA, 2009]. 
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g
 This emissions factor, which refers to the average rigid (non-articulated) heavy goods vehicle in 
the United Kingdom, was used to calculate the emissions relating to the transport of laundry to 
privately run, off site, laundry services [DEFRA, 2009]. 
 
 
Table 17. The emissions factors applied to building energy use activity data. 
 Emissions factor to convert to GHG emissions (kg CO2eq per kWh)  
Electricity 0.50748 a 
a
 These emissions factors refer to the conversion of purchased electricity to GHG emissions 
[DEFRA, 2009]. 
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Table 18. The emissions factors applied to procurement activity data. 
 
Emissions factor to convert to 
GHG emissions 
Constituent Materials of Medical Equipment & Packaging  
General Plastics 2.53 kg CO2 per kg b 
Low density polyethylene 1.7 kg CO2 per kg b 
High density polyethylene 1.6 kg CO2 per kg b 
General polyethylene 1.94 kg CO2 per kg b 
Polypropylene 2.7 kg CO2 per kg b 
Polyurethane 3 kg CO2 per kg b 
Polycarbonate  6 kg CO2 per kg b 
Polyvinylchloride 2.41 kg CO2 per kg b 
Paper 1.5 kg CO2 per kg b 
Stainless steel 6.15 kg CO2 per kg b 
Rubber 3.18 kg CO2 per kg b  
Copper  3.83 kg CO2 per kg b  
Activated Carbon (Polymer coated) 0.67 kg CO2 per kg c 
Pharmaceuticals 0.80 kg CO2 per £ a  
Cardboard 1.32 kg CO2 per kg b 
Construction 0.54 kg CO2eq per £ a 
Water 0.276 kg CO2eq per m3 a 
Plastic Products (Office Supplies) 1.13 kg CO2eq per £ a 
Metal Products (Office Supplies) 1.18 kg CO2eq per £ a 
Office Machinery and computers 0.58 kg CO2eq per £ a 
Paper Products  1.30 kg CO2eq per £ a 
Sanitation Products 0.80 kg CO2eq per £ a 
a
 Source of Emissions Factor: DEFRA [DEFRA, 2009]. 
b
 Source of Emissions Factor: ICE [Hammond & Jones, 2008]. The ICE database provides 
emissions factors for the CO2 emissions alone. The GHG emissions of a constituent material have 
been assumed to be commensurate with the CO2 emissions. 
 
c
 Assumed to be comparable to the average of embedded carbon in lime, clay tiles and cement 
(0.74, 0.46 and 0.83 kg CO2 per kg, respectively b) 
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Table 19. The emissions factors applied to waste collection, treatment and disposal activity 
data. 
Waste Disposal Method Waste Constituent 
kg CO2eq emitted 
per tonne of waste 
constituent a 
Paper 
Plastics 
Rubber 
INCINERATION 
Metal 
1800 b 
Paper -713 
Plastics (film) -1000  
Plastics (dense) -1500 
RECYCLING 
Cardboard -713  
Plastics 40  
LANDFILL 
Metal 10  
a
 Emissions factors from DEFRA [DEFRA, 2009]. 
b
 DEFRA emissions factors for incineration of different materials do not account for the 
incineration of clinical waste, which must be undertaken at higher temperatures [DEFRA, 2009]. 
To reflect the increased emissions that are likely to result from the incineration of clinical waste, 
the highest available emissions factor for incineration was applied to each of the constituents. 
 
 
Data Accuracy 
 
When calculating a carbon footprint, measures should be taken to ensure that all input, output and 
waste streams are accounted for and that no ‘double counting’ of emissions has occurred. Whilst 
a common approach to this is to undertake a ‘mass balance’, the mix of economic and physical 
data collected in this study renders this approach impractical. This problem, which is relatively 
common when calculating the carbon footprint of a service rather than a product, was therefore 
surmounted by performing an activity based assessment. For the given activity (an individual 
haemodialysis treatment), all processes and materials flowing into and out of that activity stage 
have been analysed for their GHG emissions.  
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Results 
 
The carbon footprints attributable to the provision of uncomplicated maintenance haemodialysis 
to a single patient using the differing haemodialysis modalities and regimes are presented in 
Table 20 and illustrated in Figure 9.  
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Table 20: The Carbon Footprints of the Provision of Maintenance Haemodialysis to a Single Patient Using Differing Haemodialysis Modalities and Regimes.  
  ICHD 
Standard HHD  
(3 x 4 hrs) 
Standard HHD  
(4 x 4.5 hrs) 
Standard HHD  
(5 x 4 hrs) 
Standard HHD  
(6 x 2 hrs) 
Standard HHD  
(6 x 7 hrs) 
Standard HHD 
(3 x 7 hrs) 
Mobile HHD  
(5.5 x 3 hrs) 
Mobile HHD  
(6 x 7 hrs Nocturnal) 
Sector Sub-Sector 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of 
Total 
GHG 
Emissio
ns 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of Total 
GHG 
Emissions 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of Total 
GHG 
Emissions 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of Total 
GHG 
Emissions 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of Total 
GHG 
Emissions 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of Total 
GHG 
Emissions 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of Total 
GHG 
Emissions 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of Total 
GHG 
Emissions 
Annual 
GHG 
Emissions 
(kg 
CO2eq) 
% of 
Total 
GHG 
Emissions 
Energy 
Use 
 796 20.8 1148 34.7 1647 37.9 1882 36.8 1458 28.0 3436 47.8 1742 44.7 169 9.2 263 12.4 
Staff 175 4.6 28 0.8 28 0.6 28 0.6 28 0.5 28 0.4 28 0.7 28 1.5 28 1.3 
Travel 
Patient 747 19.6 19 0.6 19 0.5 19 0.4 19 0.4 19 0.3 19 0.5 19 1.1 19 0.9 
Med Equipment                   
Consumables 1399 36.6 1399 42.3 1865 42.9 2332 45.5 2798 53.7 2798 38.9 1399 35.9 1084 58.8 1223 57.4 
Packaging 22 0.6 22 0.6 29 0.7 36 0.7 43 0.8 43 0.6 22 0.6 26 1.4 33 1.6 
Water 14 0.4 23.3 0.7 34 0.8 46 0.9 32 0.6 40 0.6 22 0.6 2 0.1 2 0.1 
Paper  7 0.2 7 0.2 10 0.2 12 0.2 15 0.3 15 0.2 7 0.2 14 0.7 15 0.7 
Laundry 53 1.4 10 0.3 10 0.2 10 0.2 10 0.2 10 0.1 10 0.3 10 0.6 10 0.5 
Construction                   
Installation 279 7.3 324 9.8 324 7.5 324 6.3 324 6.2 324 4.5 324 8.3 0 0.00 0 0.00 
Maintenance 52 1.4 54 1.6 54 1.2 54 1.0 54 1.0 54 0.8 54 1.4 27 1.5 27 1.3 
Sanitation 26 0.7 26 0.8 35 0.8 43 0.9 52 1.0 52 0.7 26 0.7 48 2.6 52 2.5 
Waste Disposal                   
Clinical 
(incinerated) 
208 208 278 347 417 417 208 313 358 
Domestic 
(recycled) 
-80 -180 -107 -133 -160 -160 -80 -19 -22 
Procur
e-ment 
Domestic 
(landfill) 1 
3.4 
1 
3.9 
1 
4.0 
1 
4.2 
2 
5.0 
2 
4.0 
1 
3.3 
4 
16.2 
4 
15.9 
Access Surgery 30 0.8 30 0.9 30 0.7 30 0.6 30 0.6 30 0.4 30 0.8 30 1.6 30 1.4 Other  
Sectors
  
Outpatient 
Appts 
88 2.3 88 2.7 88 2.0 88 1.7 88 1.7 88 1.2 88 2.3 88 4.8 88 4.1 
  Total 3818 100 3308 100 4346 100 5121 100 5210 100 7197 100 3901 100 1844 100 2131 100 
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Table 21: The impact of dialyser reuse upon the carbon footprint of thrice-weekly ICHD. 
Single-Use of Dialyser Dialyser Reuse 
  
GHG 
Emissions 
(kg CO2eq) 
%age of 
Total 
GHG 
Emissions 
GHG 
Emissions (kg 
CO2eq) 
%age of 
Total 
GHG 
Emissions 
Building Energy Use 796 20.1 796 23.1 
Staff Travel 175 4.6 175 5.1 
Patient Travel 747 19.6 747 21.7 
Medical Equipment     
Consumables 1399 36.6 1109 32 
Packaging 22 0.6 18 0.5 
Water Consumption 14 0.4 14 0.4 
Paper Consumption 7 0.2 7 0.2 
Laundry 53 1.4 53 1.6 
Construction     
Installation 279 7.3 279 8.1 
Maintenance 52 1.4 52 1.5 
Sanitation 26 0.7 26 0.8 
Waste Management     
Clinical Waste 208 129 
Recycled Domestic Waste -80 -78 
Domestic Waste to Landfill 1 
3.4 
1 
1.5 
Dialysis Access Surgery 30 0.8 30 0.9 
Outpatient Appointments 88 2.3 88 2.6 
Total 3818 100 3448 100 
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Table 22. A comparison of the GHG emissions attributable to the provision of thrice weekly, four 
hour sessions of haemodialysis in the ICHD and HHD (standard and NxStage equipment) 
settings.  
ICHD (Standard 
Haemodialysis 
Machine) 
HHD (Standard 
Haemodialysis 
Machine) 
HHD (NxStage 
Equipment) 
  
 
GHG 
Emissions (kg 
CO2eq) 
 
%age of Total 
GHG 
Emissions 
 
GHG 
Emissions (kg 
CO2eq) 
 
%age of Total 
GHG 
Emissions 
 
GHG 
Emissions (kg 
CO2eq) 
 
%age of Total 
GHG 
Emissions 
Building Energy Use 796 20.8 1148 34.7 116 10.1 
Staff Travel 175 4.6 28 0.8 28 2.4 
Patient Travel 747 19.6 19 0.6 19 1.7 
Medical Equipment       
Consumables 1399 36.6 1399 42.3 612 53.1 
Packaging 22 0.6 22 0.6 17 1.4 
Water Consumption 14 0.4 23.3 0.7 1 0.1 
Paper Consumption 7 0.2 7 0.2 7 0.6 
Laundry 53 1.4 10 0.3 10 0.9 
Construction       
Installation 279 7.3 324 9.8 0 0 
Maintenance 52 1.4 54 1.6 27 2.3 
Sanitation 26 0.7 26 0.8 26 2.3 
Waste Management       
Clinical Waste 208 208 179 
Recycled Domestic Waste -80 -180 -11 
Domestic Waste to Landfill 1 
3.4 
1 
3.9 
2 
14.8 
Dialysis Access Surgery 30 0.8 30 0.9 30 2.6 
Outpatient Appointments 88 2.3 88 2.7 88 7.6 
Total 3818 100 3308 100 1151 100 
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Discussion 
 
This is the first study to report the individual carbon footprints of a comprehensive range of 
maintenance haemodialysis modalities and regimes. The most common form of dialysis undertaken by 
patients in the United Kingdom, thrice weekly ICHD [Byrne, Steenkamp et al., 2010], has a carbon 
footprint of 3.8 tonnes CO2eq per patient per year, with the majority of the emissions arising within the 
medical equipment (37%), building energy use (21%) and patient travel (20%) sectors (Table 20). 
 
Meanwhile, the delivery of HHD using standard haemodialysis machines results in the release of 
between 3.9 and 7.2 tonnes CO2eq per patient per year depending on the regime (Table 20). Therefore 
the choice of regime may have a two fold impact on the carbon footprint. Undertaking a six-nightly 
nocturnal HHD regime, to which this latter figure relates, is therefore likely to almost double the 
carbon footprint of a typical United Kingdom resident [Carbon Trust, 2006].  
 
This is also the first study to report the direct and indirect emissions associated with the provision of 
haemodialysis. The inclusion of indirect emissions - for example, those arising within the supply chains 
of the consumable items of medical equipment required for haemodialysis – explains, in part, the 
considerable discrepancy between the results of this study and those of the only previous study to 
estimate the carbon footprint of haemodialysis treatments [James, 2007]. 
 
The results of this study show that the delivery of haemodialysis is associated with considerable GHG 
emissions. Yet the number of prevalent haemodialysis patients in the United Kingdom continues to rise 
year on year [Byrne, Steenkamp et al., 2010]. Strategies to reduce the environmental impact of 
haemodialysis, without compromising the quality of the treatment, must therefore be identified.  
 
Furthermore, although the decline in the proportion of prevalent dialysis patients on HHD is ongoing, 
the absolute numbers of patients on HHD are no longer falling and, indeed, there is now evidence of a 
slow increase in these numbers [Byrne, Steenkamp et al., 2010]. This growing momentum is 
underpinned by evidence that HHD is arguably more cost-effective [Baboolal et al., 2008; McGregor et 
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al., 2000; Honkanen & Rauta, 2008; Mowatt et al., 2003], offers an improved quality of life 
[Finkelstein et al., 2007; Evans et al., 1985], and confers greater health benefits. With regard to this last 
point, although robust evidence of improved patient outcomes by way of randomised controlled trials is 
lacking (primarily as a result of the difficulties presented by the selection bias inherent in comparisons 
of the outcomes of patients able to train for and perform HHD with the outcomes of other patient 
groups), the benefits of the more frequent and longer treatment times, that become feasible with HHD, 
are also increasingly championed by clinicians [Kliger, 2009]. It is to be anticipated, therefore, that not 
only will the prevalence of patients undertaking haemodialysis increase, but that many of these patients 
will dialyse more frequently and for longer than is presently the case. So how might this affect the 
environmental impact of haemodialysis programmes? 
 
This study shows that the reduction in patient travel emissions associated with the provision of HHD 
offers the possibility of a clinically significant increase in dialysis treatment time beyond that of thrice-
weekly ICHD, without a significant increase in the overall emissions. The model of thrice-weekly 
nocturnal HHD offers 9 hours more dialysis per week than ICHD, yet the two regimes have 
comparable carbon footprints (3.9 and 3.8 tonnes CO2eq respectively).  
 
However, the production of medical equipment is carbon intensive, and the reduction in patient travel 
emissions is soon offset by an increase in the frequency of haemodialysis treatments and the associated 
increase in the use of equipment. Indeed, the provision of six two-hour HHD treatments per week has a 
carbon footprint of 5.2 tonnes CO2eq – considerably greater than the 3.8 tonnes attributable to the 
delivery of the same total weekly treatment time by thrice-weekly ICHD.  
 
The findings of this study suggest that the rising uptake of HHD, in its current form and using standard 
machines, is likely to increase, rather than decrease, the carbon footprint of haemodialysis programmes. 
So, how might the emissions associated with each treatment session be reduced? 
 
Emissions arising within the supply chains of the consumable items of medical equipment contribute 
significantly to the carbon footprint of the provision of haemodialysis (representing 37% of the 
emissions associated with ICHD). Although the inclusion of sustainability criteria within the contracts 
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tendered by renal services is anticipated to drive down these emissions over time, shorter term 
strategies are also required. Opportunities to reduce the items of medical equipment are limited and, 
although the findings of the survey reported in Chapter 3 suggest that considerable scope exists to 
implement more sustainable waste management practices within United Kingdom dialysis facilities, the 
carbon footprints reported here already reflect optimal recycling practice (within the constraints of 
practicality). However, the possibility of re-using items of medical equipment, and dialysers in 
particular, might offer more significant environmental benefits [Upadhyay et al., 2007]. Although 
currently prohibited within the United Kingdom, dialyser reuse remains commonplace within the US, 
where it has been driven primarily by financial considerations. This is the first study to report the 
potential reductions in emissions arising from dialyser reuse and to consider them in the context of the 
overall emissions attributable to haemodialysis.  
 
The re-use of dialysers over 10 treatments reduces the carbon footprint of the provision of thrice-
weekly ICHD by 9.7%, from 3818 to 3448 kg CO2eq per patient per year (Table 21). This significant 
carbon saving derives not only from reductions in the supply chain emissions of the dialysers (290 kg 
CO2eq) and associated packaging (4 kg CO2eq), but also from reductions in the waste management 
emissions (primarily a reduction of 79 kg CO2eq in the emissions attributable to incineration). 
 
Although these calculations exclude emissions arising from re-use related increases in the procurement 
and disposal of consumables required to reprocess the dialysers (such as gloves, aprons and test strips) 
and the energy costs of the process itself (which includes heating water), a significant carbon saving 
remains likely. These results suggest that a full environmental analysis, to better understand the 
concerns arising from the use of chemicals (including paracetic acid and aldehydes) to reprocess the 
dialysers, is warranted.  
 
Electricity consumption also contributes significantly to the carbon footprint of the provision of 
haemodialysis using standard machines, representing 21% and 48% of the emissions associated with 
ICHD and six nightly nocturnal haemodialysis respectively. With standard machines, the lower 
electricity consumption of ICHD treatments results primarily from the greater efficiency of central 
water purification plants compared to that of the individual reverse osmosis systems used with HHD 
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machines. The use of heat exchangers to reduce building energy use emissions will be described in 
Chapter 6. The use of solar power to run dialysis machines and water purification systems is now being 
piloted [Agar JW, 2010]. Further technological advances are required.  
 
This study suggests that the newer haemodialysis technologies may offer a solution. The provision of 3 
hour treatments on 5.5 days a week using the NxStage equipment has a carbon footprint of just 1.9 
tonnes CO2eq per patient per year – less than half of that of thrice weekly ICHD. Meanwhile, six 
nightly nocturnal HHD using the NxStage equipment results in just 2.1 tonnes CO2eq per patient per 
year – less than one third of the emissions of a comparable HHD regime using a standard 
haemodialysis machine. However, although one study, including only 32 patients and run over only a 
few weeks, has suggested that NxStage equipment may provide safe and effective daily short HHD 
[Krauss et al., 2007], more robust clinical outcomes data for these treatments are not yet available. The 
ongoing FREEDOM study will begin to address this uncertainty by prospectively comparing NxStage 
patient experiences to a matched cohort undergoing thrice weekly ICHD, with the primary endpoint 
being the number of all-cause hospital admissions [Jaber BL et al., 2009]. Meanwhile, in the light of 
the findings, research to determine the carbon footprints of the provision of haemodialysis using the 
other forthcoming mobile haemodialysis technologies should be undertaken. 
 
Finally, this study was primarily designed to compare the GHG emissions attributable to those regimes 
commonly in use in clinical practice with standard and NxStage haemodialysis machines (Table 20). 
However, the emissions attributable to the provision of a consistent regime (thrice-weekly, four-hour 
haemodialysis treatments) using standard and NxStage haemodialysis machines are also of interest 
(Table 22). Although the use of NxStage equipment again results in lower emissions, it should be noted 
that this regime would rarely be considered to provide a dialysis dose equivalent to that realised using a 
similar regime using a standard haemodialysis machine. 
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Uncertainty in the Results 
 
As was discussed in Chapter 4, the nature of carbon footprinting, in which every input has some degree 
of uncertainty associated with the assumptions and estimations relating to it, means that every carbon 
footprint has some degree of variation inherent within it. As the extent of this uncertainty increases, the 
confidence with which the carbon footprint can be interpreted diminishes. 
 
This was a process based study and uncertainty therefore exists as a result of possible truncation errors. 
As an input-output approach cannot be applied to this study, the extent of any such error is not readily 
quantifiable.  
 
Uncertainty arises from changes within the product or service being assessed. As such, it may not 
easily be identified or quantified, can sometimes be ameliorated through adequate sampling, and is 
accounted for in the understanding that a carbon footprint is a representative rather than exact value.  
 
Technical uncertainty results from flawed calculations (for example, as a result of incorrect 
assumptions or poor quality data) and may amenable to analysis. A comparison of the results of this 
study with those of the study reported in Chapter 2 suggests that the calculations undertaken in this 
study are sound. When the emissions attributable to aspects of the further care of these patients, such as 
their medications, are also taken into account, the magnitude of the results of this study are 
commensurate with the indicative carbon burden previously attributed to the provision of all forms of 
dialysis (peritoneal dialysis as well as haemodialysis) that has been derived from data collated at the 
level of an individual renal service. 
 
 
Limitations 
 
The source of activity data for patient travel was intended to provide the most accurate model of the 
travel emissions of a patient undertaking ICHD in the United Kingdom [Health and Social Care 
Information Centre, 2010]. However, significant differences might exist between regions or 
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internationally. Similarly, the electricity emission factors used in this study are based on the United 
Kingdom grid average mix of different types of generation, and the contribution of energy consumption 
to the emissions of haemodialysis treatments may therefore vary internationally [DEFRA, 2009].  
 
The recognition that patients using NxStage equipment have the facility to travel was considered 
important in the light of the influence of such travel upon the consumables and electricity used. 
Although the need to make assumptions regarding the frequency of such travel, which might vary 
considerably between individual patients, might be perceived as a limitation, it appears to have a 
minimal effect on the overall results, as a patient undertaking no travel uses slightly more electricity (in 
powering the PAK to produce dialysate at home), but the resulting saving in GHG emissions is 
balanced by a rise in emissions attributable to consumables. The emissions attributable to a patient 
undertaking 5.5x weekly dialysis but never travelling (1,841 kg CO2eq) are almost identical to those of 
a patient undertaking 5.5x weekly dialysis and travelling in line with the assumptions made in this 
study (1,844 kg CO2eq). 
 
Although those emissions attributable to the creation and revision of access surgery have been 
included, it has not been possible to include emissions arising as a result of the potential complications 
of the provision of haemodialysis (such as hospitalisations resulting from line infections, for example).  
 
The extent to which the exclusion from this study of the emissions attributable to the production of 
haemodialysis machines may be seen as a limitation has been discussed with the Methods section of 
this chapter.  
 
 
Conclusions & Recommendations 
 
The provision of haemodialysis has a considerable carbon footprint. Although this is a function of both 
the treatment frequency and duration, the influence of the former is the greater. The anticipated rise in 
the prevalence of HHD patients, who are able to dialyse more frequently and for longer than ICHD 
patients, will disproportionately increase the emissions associated with the provision of haemodialysis 
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programmes. The incorporation of emerging technologies, such as NxStage equipment, into 
haemodialysis programmes might offer a possible solution to this problem, and the carbon footprints of 
forthcoming technologies should be evaluated. Studies to determine the emissions attributable to the 
production of the differing types of haemodialysis machine are also required. However, research into 
opportunities to reduce the emissions at the level of individual treatments is also required. The extent of 
the reductions achievable through dialyser reuse suggest that the wider environmental and health 
implications of this practice merit further evaluation. 
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Chapter 6.  
 
Case Studies from Renal Services in the United Kingdom.  
 
 
Introduction 
 
The preceding chapters have explored the extent of the environmental impact associated with the 
delivery of renal healthcare. Although a number of opportunities to reduce this impact have been 
outlined within these chapters, these opportunities have not been described in detail. In this chapter, 
four such opportunities are reported in greater depth and presented as case studies of good 
environmental practice within renal healthcare. The examples have been chosen to highlight how 
measures to reduce the environmental impact of renal healthcare may also facilitate improvements in 
the quality of patient care and reductions in the financial costs of delivering of this care. The barriers 
that might be encountered by renal services wishing to implement these initiatives are also considered. 
 
 
The First Case Study. Heat Exchangers and Haemodialysis Machines. 
 
The study reported in Chapter 5 identified that the electricity consumed in the provision of 
haemodialysis treatments was responsible for almost 21% of the GHG emissions attributable to the 
treatment of a patient undertaking thrice-weekly, in-centre treatments of four hours each.  
 
 
The Role of Heat Exchangers in Haemodialysis 
 
During haemodialysis, blood is removed from the patient and pumped through a dialyser before being 
returned to the patient. Inside the dialyser, the blood is exposed to a dialysate (a blend of treated water 
and chemicals at physiological levels) across a semi-permeable membrane. Pores in the membrane 
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allow many of the waste products of metabolism to diffuse down their concentration gradients into the 
dialysate. However, if the dialysate is too cool, the blood may be unintentionally cooled and the patient 
may become uncomfortably cold. Cool dialysate also reduces the rate of diffusion, rendering the 
dialysis treatment less efficient. For these reasons, the dialysate is commonly warmed to just below 
body temperature. In the majority of standard haemodialysis machines, a thermostat determines the 
demand for heat by comparing the required dialysate temperature (a preset variable) with the measured 
temperature, and activates the heater accordingly.  
 
Standard haemodialysis machines may also have a heat exchanger incorporated into the system before 
this heater (Figure 10). The heat exchanger recaptures energy, in the form of heat, from the dialysis 
effluent (‘used’ dialysate) and transfers it to the incoming, cold, dialysate, before it reaches the heater. 
This pre-warming reduces the energy consumed by the heater and reduces the environmental impact of 
a haemodialysis treatment.  
 
Figure 10. The role of a heat exchanger in haemodialysis.  
 
 
 
A Case Study to Illustrate the Use of Heat Exchangers 
 
The Kent and Canterbury renal service has predominantly purchased Braun Dialog+ haemodialysis 
machines, and these have been supplied without heat exchangers. However, the purchase of a number 
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of haemodiafiltration machines (which are similar to haemodialysis machines but utilise higher 
hydrostatic pressures across the semi-permeable membrane to achieve additional solute clearance by 
convection) with built-in heat exchangers highlighted the potential financial and environmental savings 
that heat exchangers can offer. The following study was therefore designed to evaluate the potential 
financial and environmental savings attributable to the fitting of heat recovery devices to Braun 
Dialog+ dialysis machines.  
 
 
Methods 
 
Five standard haemodialysis machines (Dialogs 1 to 5) and one haemodiafiltration machine (HDF) 
(with pre-fitted heat exchanger) were selected at random from those in regular use at the Maidstone 
dialysis unit. Simulated four hour treatments were undertaken on each machine before and after the 
fitting of the heat exchanger device. A number of measurements were taken on each run.  
 
The ambient room temperature was recorded to ensure consistency in the test environment, as 
variations in the room temperature might be anticipated to influence heater demand. For a similar 
reason, the inlet temperature (the temperature of the water immediately prior to entering the dialysis 
machine) was also recorded. This water has been stored in tanks, filtered, purified in the reverse 
osmosis plant, and distributed around the dialysis unit to the station at which the machine is positioned. 
The temperature of the water will therefore have increased since its arrival from the local water 
supplier, but the extent of this increase will vary both seasonally and with demand. The electrical 
energy consumed during the treatment was measured directly using an energy monitor fitted between 
the wall socket and the machine plug. The treatment cost was calculated using an electricity rate of 
£0.089 per kWh.  
 
The average heater output was also determined. This represents the demand for heat required by the 
machine. It is expressed as a percentage, with 100% indicating maximal heater output. An average for 
each simulated treatment was obtained by recording the heater output at regular intervals. It was 
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hypothesised that the addition of a heat exchanger would be reflected in reductions of the average 
heater output and the energy consumed per treatment.  
 
 
Results 
 
The results of the study are shown in Table 23. 
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Table 23. The electrical energy consumed during simulated haemodialysis treatments using different machines before and after the addition of a heat exchanger.  
Machine 
Type & 
Number 
Before & 
After Heat 
Exchanger 
Ambient 
Temp 
(ºC) 
Inlet 
Temp 
(ºC) 
Average 
Heater 
Output 
(%) 
Energy 
Consumed 
Per Treatment 
 (kWh) 
Energy 
Saving Per 
Treatment 
(kWh) 
Energy Saving 
expressed as a 
percentage of 
Energy Consumed 
Treatment 
Cost (£) 
Before 21 18.7 47 4.94 0.44 
Dialog 1 
After 21 18.7 37 3.92 
1.02 20.6 
0.35 
Before 21 18.7 45 4.71 0.42 
Dialog 2 
After 21 18.7 36 4.05 
0.66 14.0 
0.36 
Before 22 19.2 44 4.84 0.43 
Dialog 3 
After 21 18.2 33 3.78 
1.06 21.9 
0.34 
Before 22 19.2 44 4.58 0.41 
Dialog 4 
After 21 18.2 35 3.68 
0.90 19.7 
0.33 
Before 22 20.2 44 4.76 0.42 
Dialog 5 
After 22 19.2 37 4.08 
0.68 14.3 
0.36 
Before n/a n/a n/a n/a n/a 
HDF a 
After 22 19.2 35 3.70 
n/a n/a 
0.33 
Average      0.86 18.1  
a
 The results obtained using the haemodiafiltration machine are included for reference.
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Discussion 
 
Local and National Reductions in Greenhouse Gas Production 
 
The average reduction in the energy required for each treatment was 0.86 kWh, representing an 18.1% 
increase in efficiency. Assuming that each machine is used twice daily for four hours, six days a week 
for 52 weeks of the year, an annual energy saving of 536.64 kWh per machine (2 * 6 * 52 * 0.86) is 
predicted. Applying a conversion factor of 0.50748 kg CO2eq per kWh [DEFRA, 2009], this in turn 
equates to an annual saving of 272.33 kg (0.272 tonnes) of CO2eq per machine per year. For the 83 
machines in use across the Kent and Canterbury renal service, this equates to an annual energy saving 
of 44,541 kWh and an annual reduction in GHG production of 22.6 tonnes of CO2eq.  
 
The environmental benefits of installing heat exchangers can be placed into context by approximating 
their impact upon the carbon footprint of the Dorset Renal Service, which was determined in Chapter 4. 
The Dorset Renal Service provides regular haemodialysis treatments to 227 patients (including two 
home haemodialysis patients) using dialysis machines from a number of manufacturers. The vast 
majority of these machines, if not all, are fitted with heat exchangers. If it is assumed that, firstly, these 
227 patients all receive thrice-weekly, four-hour treatments and that, secondly, the service uses only 
Braun Dialog+ machines fitted with heat exchangers, then the energy saving resulting from the heat 
exchangers is (227 * 3 * 52 * 0.86) 30,454 kWh per year. Applying a conversion factor of 0.50748 kg 
CO2eq per kWh [DEFRA, 2009], this in turn equates to an annual saving of 15,455 kg (15.5 tonnes) of 
CO2eq per year. Were heat exchangers not used, the carbon footprint of the Dorset Renal Service 
would therefore rise from 3,006 tonnes to 3,021 tonnes, an increase of 0.5%.  
 
There are approximately 1,150 Braun Dialog+ machines in operation in the United Kingdom at present 
(correspondence with Ian Smyth, BBraun Avitum, United Kingdom, by email, December 16th, 2009). If 
each of these were to be fitted with a heat exchanger, and assuming once again that each machine is 
used twice daily, six days a week for 52 weeks of the year, an annual saving of 313 tonnes CO2eq 
would be realised.  
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Although PAS2050 suggests that the emissions associated with the manufacture of machinery that is 
used repeatedly during a process are not included in the assessment of the emissions attributable to that 
process [British Standards, DEFRA, Carbon Trust, 2008], it is acknowledged that the manufacture of 
heat exchangers would incur a carbon cost in itself. However, this is estimated to amount to less than 
one percent of the carbon savings derived from the improved energy efficiency in the first year of use 
alone.  
 
 
Financial Costs and an Investment Appraisal  
 
Assuming an electricity rate of £0.089 per kWh, the lower energy usage translates to financial savings 
of £0.077 per treatment (0.089 * 0.86), and an annual financial saving of £48.05 per machine (if used 
twice daily, six days a week, for 52 weeks of the year). The unit cost of a heat exchanger device for a 
Braun Dialog+ dialysis machine (£189) could be recouped within four years (£189/£48.05) and a 
saving made thereafter.  
 
Fitting heat exchangers to the 83 dialysis machines in the Kent and Canterbury renal service would 
require an initial investment of £15,687, with an annual saving of £3988.15 (£48.05 * 83) being made 
once this had been recouped at four years (with the expected working lifespan of these machines being 
up to 10 years or 25,000 hours of dialysis).   
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The Second Case Study. The Salvage of Reject Water in a Haemodialysis Unit. 
 
The preceding chapters have shown that the GHG emissions attributable to the water use for 
haemodialysis amount to 0.2% of the emissions of a typical renal service and 0.4% of the emissions of 
a four hour, in-centre treatment using a standard haemodialysis machine. The impact of water use upon 
the carbon footprint of renal healthcare is therefore small in comparison to that of many of the other 
resources used. However, the volume of water consumed by standard haemodialysis machines remains 
a striking feature of the treatment, and the environmental arguments for water conservation are based 
predominantly around preventing the depletion of natural resources rather than reducing emissions. 
Indeed, the same water stores that were available to the 300 million human beings inhabiting the earth 
during Roman times are now shared amongst a global population of 6.7 billion people, more than one 
third of whom now live in water-stressed countries [Food and Agriculture Organization of the United 
Nations, 2007]. There is therefore a need to use water wisely, yet it was established in Chapter 3 that 
the simple water-saving methodology reported in this case study is presently in place in only two of the 
58 surveyed renal services in the United Kingdom.  
 
 
Water Use and Haemodialysis 
 
When haemodialysis is undertaken using standard machines, water is required to produce the dialysate, 
undertake pre-dialysis priming and post-dialysis rinsing, and to re-process the dialysis membranes. A 
patient with a target dialysate flow rate of 500 millilitres per minute, undergoing a four hour (240 
minute) dialysis session, will require 120 litres of dialysate, which in itself requires the production of 
high grade water from mains water. Approximately 400 litres of mains water will be required to 
produce the required volume of high grade water (although this will vary depending on the efficiency 
of the reverse osmosis system employed). Inclusion of priming and rinsing volumes boosts this 
requirement to a figure approaching 500 litres of mains water per patient per dialysis session.  
 
High grade water is produced from mains water by a multi-stage process starting with the passage of 
mains water through sand micro-filters to extract particulate matter. It is then passed over activated 
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carbon to adsorb chlorine and organic contaminants. Calcium, magnesium, iron and manganese may be 
removed by ion exchange for sodium cations to soften the water. This water is then processed by 
reverse osmosis to remove residual salts, during which approximately two thirds of the water presented 
to the reverse osmosis system is rejected. The volume of this ‘reject water’ arising from the production 
of a given volume of dialysate varies with differing reverse osmosis systems. However, for the patient 
described above, dialysing thrice weekly for four hours, this commonly amounts to over 250 litres of 
water per session. The term ‘reject water’ is somewhat misleading; although this high-grade water is 
not legally acceptable for drinking, it commonly meets potable water criteria [Agar JWM et al., 2009]. 
It does not at any stage come into contact with the patient and therefore poses no infection risk. Yet in 
all but two renal services in the United Kingdom (and in the majority of services worldwide), these 
large volumes of good quality reject water are presently lost-to-drain. Simple methodology exists to 
capture reject water, which can then be recycled for alternative uses such as irrigation, laundry, 
sanitation or low-pressure boiler feed.   
 
 
Case Studies to Illustrate Methodology 
 
In 1997, two new reverse osmosis units were installed to supply an existing dialysis unit in Canterbury 
(Kent, United Kingdom). In order to achieve back up and redundancy within the system, these were 
installed in parallel. The suspicion that the volumes of reject water being visibly lost-to-drain from this 
system were substantial was confirmed through the use of simple flow meters, prompting consideration 
of its salvage. With the support of the hospital’s Estates department, a system to recover this water at a 
rate of 800 litres per hour was implemented by 1999 at a cost of £15,000.  
 
The system is extremely simple (Figure 11). It was installed under a ‘small works’ policy and has been 
running satisfactorily for ten years. It should be appreciated that pressure cannot be applied directly to 
the ‘output-to-drain’ of a reverse osmosis system; reject water must be allowed to flow freely away to 
the tank, and subsequently onwards to the drain if it is genuinely surplus. In the system described here, 
where the distance between the reverse osmosis unit and the water tank necessitates a pump, the 
solution is to allow the salvaged reject water to flow initially to a recovery tank in the basement, before 
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it is pumped up to a second water tank on the roof. In other systems where a pump is not required, the 
reject water might simply be allowed to flow from the reverse osmosis to a single water tank. In the 
system reported here, the second water tank supplies the toilets, with 7 litres of water used for each 
toilet flush.   
 
Figure 11. A schematic representation of the water salvage system in place at the Canterbury 
haemodialysis unit.  
 
 
The system is controlled by float switches. Should the second water tank become full (for example, 
during the twilight dialysis session when fewer toilets are being flushed), the float switches divert the 
reject water to flow to drain, thereby preventing the recovery pump from running unnecessarily in the 
absence of demand for water. This plant required chemical disinfection on a monthly basis. Diverter 
valves were therefore employed to direct water (and chemicals) draining from the reverse osmosis 
system to the drain after each disinfection.  
 
When the dialysis unit was redeveloped and expanded in 2007, the new plant was connected into the 
reject water recovery system. However, the configuration of the reverse osmosis system was amended 
from parallel to series, with each individual reverse osmosis system remaining capable of supporting 
the dialysis unit independently. Whilst the reject water from the first reverse osmosis system is 
salvaged as it flows to drain, the reject water from the second is recycled back into the first reverse 
osmosis system. In this way, the new configuration is both larger and more efficient. The realisation of 
the system’s potential to salvage up to 1,300 litres of reject water per hour is dependent upon it running 
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at full capacity (45 points of use) and the degree of redundancy (80%) built in. In the new plant, the 
chemical disinfection is required on an annual rather than monthly basis. A simple ‘recycle’ valve 
allows the water from the reverse osmosis system to be lost-to-drain at such times.   
 
Similar water conservation techniques were incorporated into the design brief of a new-build satellite 
dialysis unit situated in nearby Ashford (Kent, United Kingdom). Once again, the two reverse osmosis 
systems lie in series, with reject water from the second revere osmosis system being recycled into the 
first. The system overall has the potential to salvage up to 960 litres of reject water per hour from the 
first reverse osmosis system. The Ashford dialysis unit runs for 15 hours per day, for 312 days per year. 
A potential volume of 14,400 litres of reject water is salvaged each day, equating to 4,492,000 litres per 
year. This is used in its entirety in the local laundry room, where it contributes 10% of the overall water 
use (3,700,000 litres per month). An added environmental and financial benefit is that the softened 
water allows the use of less detergent.  
 
 
Discussion 
 
Financial Savings from Salvaging Reject Water 
 
Current regional water rates are £1.35/1,000 litres during peak hours and £0.75/1,000 litres during off-
peak hours. The average cost of mains water to the dialysis unit, given its operating hours, is 
£1.00/1,000 litres. Waste water is charged at £1.69/1,000 litres for 80% of the volume used. The total 
cost of water and waste is therefore £2.35/1,000 litres (£1 from water, and 0.8 x 1.69 from waste). The 
potential 4,492,000 litres of water conserved annually represents a saving of £10,558.  
 
The salvage pump has a flow rate of 2,400 litres per hour and therefore runs for 6 hours per day. 
Energy consumption is 0.68 kWh. Daily energy use is therefore 3 kW, and yearly energy use is 936 kW 
(312 x 3). Regional electricity rates are £0.06 per kWh. The cost of the electricity to run the salvage 
pump is therefore just (0.06 x 0.68 x 6 x 312) £76.38 per year. The overall potential annual saving is 
therefore £10,481.62.  
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The cost of integrating the water conserving methodology into the new build was £2,500 (tank and 
control panel £1,300; piping £1,200; the piping was laid alongside other services required by the new 
build, so no additional cost was incurred for groundwork).  
 
 
Reductions in GHG Emissions from Salvaging Reject Water 
 
As has been mentioned previously, the environmental arguments for water conservation are based 
predominantly around preventing the depletion of natural resources rather than reducing GHG 
emissions. Water stress varies geographically and is, for example, of greater concern in southern and 
Eastern England than elsewhere in the United Kingdom. A water footprint, rather than a carbon 
footprint, would therefore provide a stronger environmental argument in favour of the methodologies 
advocated here. However, in simple terms and using an emissions factor of 0.276 g CO2eq per litre of 
mains water [DEFRA, 2009], the reduction in GHG emissions derived from the use of 14,400 litres of 
reject water in place of mains water per day, at the Ashford unit described above, is 3.974 kg CO2eq 
per day or 1239.88 kg CO2eq per year (1.24 tonnes).  
 
Using an emissions factor of 0.50748 kg CO2eq per kWh [DEFRA, 2009], the GHG emissions 
attributable to the electricity required to operate the salvage pump is 475.00 (0.5 kWh  x  0.50748  x  6  
x  312) kg CO2eq per year. Therefore the overall reduction in GHG emissions attributable to the 
implementation of this methodology in the single renal unit is (1239.88 – 475) 764.88 kg CO2eq per 
year (0.76 tonnes).  
 
 
Assessing Opportunities to Implement Reject Water-Conservation Methodology 
 
Three opportunities exist to implement reject water conserving methodology. The optimal scenario is to 
integrate the methodology into the design of a ‘new build’ dialysis unit. In such circumstances, a wider 
range of possible uses for the reject water may be considered, and particular consideration should be 
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given to the possibility of locating facilities which might be anticipated to benefit from the reject water 
(for example, the laundry services) in close proximity to the new dialysis unit. Pumping water for 
longer distances or against gravity will incur potentially unnecessary energy costs upon the new 
system.  
 
The second opportunity is during the replacement of existing reverse osmosis systems which may have 
become outdated or unreliable. It should be remembered that, as mentioned earlier, more modern 
reverse osmosis systems are likely to be more efficient and reject less water to drain (therefore reducing 
the potential for reject water salvage). 
 
The third opportunity is simply to retro-fit the reject water conserving methodology to existing reverse 
osmosis systems. In both the second and third scenarios, the range of practical (i.e. money saving) uses 
for the reject water may be more limited, as the costs of delivering the water to the required site may be 
greater. 
  
It should be acknowledged that the implementation of reject water conservation methodology may not 
be possible in all renal units. A number of barriers may be encountered. These may include the 
practical and financial considerations involved in laying the pipe-work required to transfer the 
conserved reject water to the site at which it will be re-used. Secondly, not all renal units will have the 
space required to house the water storage tank. Thirdly, as was illustrated in the description of the 
Canterbury unit, the existing layout of the renal unit may create the need for a further water tank (as 
water cannot be pumped directly out of a reverse osmosis system but must be allowed to drain freely at 
the rate at which it is produced) and this will also require further space. For reasons such as these, it is 
essential for members of a renal service evaluating the possibility of water salvage to gain the support 
of the local Hospital Estates department. 
 
It is also important to ensure that the use to which the reject water is put is supported by a back-up 
mains supply to cover any interruptions (for example during maintenance or disinfection of the dialysis 
unit). 
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Factors Influencing the Potential Volume of Reject Water that can be Salvaged from a Dialysis 
Unit 
 
A number of factors influence the potential volume of reject water that can be salvaged from a dialysis 
unit. The most important determinant is simply the amount of water that the reverse osmosis system 
processes. The higher this value, the greater the volume of reject water that will be produced, and the 
greater the potential for reject water salvage. The amount of water processed will be dependent upon 
variables specific to the individual dialysis unit, including the opening hours, the number of dialysis 
stations (or ‘points of use’), and the capacity at which the unit is run (determined by the number of 
patients and the length of their sessions). A second factor is the design of the plant; twin stream 
systems with reverse osmosis units in parallel typically produce greater volumes of reject water than 
single stream systems. A third factor is the type of plant installed. More modern reverse osmosis 
systems are generally more efficient and reject less water to drain. A fourth factor is the degree of 
redundancy built into the system to accommodate periods of breakdown, service and repair with the 
reverse osmosis systems.  
 
Whilst there is no size below which a dialysis unit becomes too small to make reject water salvage 
practical, the financial benefits from recycling the salvaged reject water must be considered against the 
costs of implementing the methodology, and the ‘breakeven point’ may be further in the future for 
smaller units.  
 
 
Opportunities for the Re-use of Reject Water 
 
Reject water is high grade water. Although it commonly meets potable water criteria [Agar JWM et al., 
2009], it is not legally acceptable for drinking and the precise quality of the reject water produced will 
vary from region to region. Possibilities for its re-use within renal units and hospitals include the local 
sanitation systems, within laundry departments, as low-pressure boiler feed and in the production of 
steam in the sterilisation units. In more arid environments than the United Kingdom it has also be used 
to irrigate land [Agar, 2010]. Practical considerations are important when identifying the most 
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appropriate use. For example, salvaged reject water can only be used in laundry services if the 
plumbing required is feasible and affordable. 
 
 
Further Discussion 
 
The published literature around this subject is very limited, despite the increasing scarcity of water 
worldwide, the increasing numbers of patients receiving haemodialysis globally, the huge advances in 
other areas of dialysis technology and the massive potential environmental and financial savings 
associated with haemodialysis water conservation projects. Only one group has reported a similar water 
conservation project to the one described here [Agar et al., 2009]. The same group has also described 
its use in home haemodialysis [Agar et al., 2008]. A second group has reported a desalination trial of 
un-segregated reject water combined with dialysis effluent for reuse in irrigation [Tarrass et al., 2008]. 
However, the potential for bacterial and viral contamination due to the inclusion of dialysis effluent 
complicates this methodology, and it seems likely that the major savings derive from the salvage of 
reject water – for which the technology is also less expensive to install.  
 
Haemodialysis facilities utilise vast quantities of water and, in the majority of facilities worldwide, 
large volumes are unnecessarily lost-to-drain. Whilst the net environmental savings achievable through 
salvaging reject water from the unit described here are modest when considered in terms of the 
reduction in GHG emissions (0.76 tonnes CO2eq per year), these benefits are achieved alongside a net 
financial saving of over £10,000 per year. Although the implementation of similar reject water 
salvaging methodology may not be as financially viable in every dialysis unit, all units would therefore 
be wise to consider such a project. 
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The Third Case Study. The Follow Up of Renal Transplant Recipients by 
Telephone Consultation: Three Years Experience from a Single Renal Unit in 
the United Kingdom.   
 
Telephone consulting offers clinicians a means by which to meet the challenge of improving quality 
and accessibility despite rising caseloads and heightened patient expectation [Car & Sheik, 2003]. It is 
now utilised to triage patients, manage acute and chronic conditions, enhance compliance, and 
communicate results. When used appropriately, telephone consulting offers the patient and clinician 
multiple benefits, including enhanced access to healthcare, heightened continuity of care, reduced 
travelling and considerable time savings.  
 
Although the potential for reducing the environmental impact of healthcare through tele-health 
initiatives has previously been considered [Smith et al., 2007; Massino et al., 2010], there have been 
very few studies to date that have quantified the potential benefits in terms of reductions in GHG 
production [Wootton et al., 2010]. 
 
Guidelines for nephrologists in the United Kingdom do not suggest a frequency with which stable renal 
transplant recipients should be followed up although most services offer three to six monthly 
appointments. This is in keeping with the guidance of the American Society of Transplantation, which 
notes that there are virtually no scientific data on which to base decisions regarding the optimal 
frequency (or type) of follow up of these patients [Kasiske et al. 2000]. This case study describes the 
use of telephone consulting to provide three monthly follow up to renal transplant recipients in a single 
renal unit over a three and a half year period.  
 
 
Case Study 
 
The University Hospital of Coventry and Warwickshire (UHCW) renal service began to offer 
telephone consultations to provide routine follow up to renal transplant recipients in 2006. The service 
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now provides approximately 350 appointments per year, facilitating follow up to 123 of the 360 
patients in whom transplantation was undertaken more than one year previously.  
 
The service is offered to patients at their physician’s discretion. Most patients are well known to the 
department and all must have demonstrated stable graft function. Patients receive quarterly clinic 
appointments, of which one remains a face-to-face consultation. Consultations commence with the 
patient ringing through to the clinician at a time detailed in their appointment letter, which also requests 
that they provide their weight and blood pressure readings. As with face-to-face consultations, blood 
tests are undertaken beforehand; patients may attend their family practice, the city centre phlebotomy 
service, or their local hospitals. Fifteen minutes are allocated per consultation. Clinic letters are copied 
to the patient, along with any necessary prescriptions, a blood test form and their next appointment 
details. The annual face-to-face consultation allows for physical examination (including urinalysis).  
 
The results of the survey reported in Chapter 3 indicate that this is the only service of its nature in the 
United Kingdom. Informal feedback from patients to clinicians suggests high levels of satisfaction. To 
date, only two patients have opted to return to face-to-face follow up. There have been no reported 
patient safety issues.  
 
 
Discussion 
 
Telephone consulting has mainly been used to manage the demand for care, predominantly out-of-
hours and within the emergency department and primary care settings (where more than half of out-of-
hours calls can be handled by telephone advice alone) [Christensen et al, 1998; Bunn et al., 2004].  
Telephone consulting in other services is less well researched.  
 
A literature search undertaken on February 17th, 2011, through Pubmed for articles published in 
English since 1st January 2000 using the search term (("telemedicine" OR "tele-health") AND 
"transplant") returned no reports of telephone-based care for renal transplant recipients, although 
telemedicine for dialysis patients has been described [Whitten & Buis, 2008; Mitchell et al., 1996; 
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Rumpsfield et al., 2005]. Videoconferencing can facilitate routine consultations between nephrologists 
and dialysing patients [Whitten & Buis, 2008]. Telemedicine offers haemodialysis and peritoneal 
dialysis patients improved access, reduced costs and travel savings [Jennett et al., 2003].   
 
The few studies assessing patients’ and clinicians’ perceptions of telephone clinics are limited to 
primary care. In one study, both groups considered telephone consultations to be convenient, and to be 
best suited to the management of chronic conditions [McKinstry et al., 2009]. In another study, patients 
with chronic diseases managed by telephone care changed their perceptions such that, at end of the two 
year study, they believed that telephone consultations could be used to manage their conditions 
[Wasson et al., 1992]. 
 
 
The Benefits of Telephone Consulting 
 
In Chapter 2 it was noted that high quality healthcare should be safe, timely, effective, efficient, 
equitable, and patient-centred [Institute of Medicine, 2001], but also that it has been argued that 
sustainability should lie at the heart of health service decision-making [Royal College of Physicians, 
2010(a)]. Whilst the model of care reported here delivers in each of these domains, it offers particular 
improvements in efficiency, patient-centred care and sustainability. Those aspects of quality within 
healthcare that are of most relevance to telephone consulting are now discussed, with reference to 
existing literature. 
 
Patient-centred, convenient care 
Many transplanted patients have previously attended the hospital (for example, for haemodialysis 
treatments) with a very high frequency for many years. The experience of the clinicians at the UHCW 
is that these patients perceive a positive health gain from telephone consultations. Whilst this may 
simply reflect the improved convenience, it is also possible that this health gain is attributable to 
heightened patient empowerment resulting from the telephone clinic model; although the relative 
reduction in annual face-to-face appointments is considerable (from four to one), it represents only a 
small absolute reduction in the number of annual face-to-face appointments (just three appointments). 
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Patient empowerment is a key component to the successful management of chronic disease 
[Bodenheimer, 2002]. More research to determine the nature of this under-recognised benefit of 
telephone consulting is required. The use of RenalPatientView, an existing patient empowerment tool 
[Turner, 2006], would compliment the use of telephone consultations. 
 
In the UHCW model, the patients ring in to the clinic at an allocated time, thereby negating the need to 
advise where they will be in advance, and allowing them to ring, for example, from the workplace more 
conveniently. It is likely that the financial cost of their call is usually more than offset by savings in 
fuel costs and parking.  
 
Safe Care 
Clinicians familiar with face-to-face consultations may question the safety of telephone consultations 
and this is indeed an area in which robust evidence is presently lacking. Whilst a review of telephone-
related malpractice suits determined that patient safety is compromised mainly when consultations 
include diagnostic or triaging components [Katz et al., 2008], there is evidence that their use in the 
provision of routine follow up is safe [Wasson et al., 1992]. A systematic review of the literature found 
no increase in adverse effects or use of other services [Bunn et al., 2005].  
 
The care of patients receiving immunosuppression should encompass vigilance for skin lesions, and 
patients followed by telephone consultation should receive regular education around this. In the UHCW 
service, those patients that report lesions and who do not already have open access to the dermatology 
service are advised to seek an urgent dermatology referral through their General Practitioner under the 
‘two-week wait’ system.  
 
One randomised controlled trial, involving 497 patients with chronic diseases being managed in 
primary care, is of particular note [Wasson et al., 1992]. Follow up in a traditional clinic was compared 
against follow up in which the recommended interval for face-to-face follow up was doubled and three 
intervening telephone consultations were arranged. Telephone-care reduced utilisation of medical 
services without adversely affecting patient-reported health. Telephone-care patients had fewer 
scheduled and unscheduled clinic visits than usual-care patients, and fewer and shorter hospital 
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admissions. The estimated expenditure of their care was 28% less in the telephone-care group. When 
new or worsening problems were uncovered during a telephone consultation, the patient was seen at the 
clinic or admitted to hospital in a timely fashion. The patients’ diagnoses and demographics, and the 
degree of continuity of care, were similar across the two groups. This study therefore suggests that the 
increased communication afforded by more frequent contact may be the determinant of the underlying 
health benefits of telephone care.  
 
Sustainable Care 
Chapter 4 described the extent to which patient travel contributes to the carbon footprint of a renal 
service. As the potential reductions in GHG emissions attributable to telephone consulting have not 
previously been studied, the reduction in emissions associated with the UHCW telephone clinic model 
are outlined here. 
 
Data was collected from 30 patients attending two consecutive telephone clinics. It was assumed that, 
had patients attended a face-to-face clinic, they would have travelled from, and returned to, their 
homes. Each patient’s return journey length was calculated from their postcode using GoogleMaps 
(http://maps.google.co.uk). Had these 30 patients attended clinic, they would have travelled a total of 
1,180.10 km (mean 39.34 km, range 1.76 – 241.26 km), with only 64.74 km (5.8%) undertaken by 
public transport (Table 24). The GHG emissions arising from each patient’s travel were calculated 
using DEFRA conversion factors specific to the transport modality that they would use to attend their 
local clinic [DEFRA, 2009]. A mean value of 8.05 kg CO2eq was identified‡.  
 
Of course, the provision of a telephone clinic also generates GHG emissions. The use of a mobile 
telephone for one minute has been reported to generate 0.057 kg CO2eq [Berners-Lee, 2010]. If the 
average duration of the phone call required for a single consultation is estimated to be eight minutes, 
and if it is assumed that patients will ring in to the clinic on mobile telephones (rather than landlines), 
                                                 
‡
 The indicative carbon burden of a single outpatient appointment in the Dorset Renal Service was calculated in 
Chapter 4. Further analysis of the data presented in Table 12 indicates that patient travel was responsible for 9.9 kg 
CO2eq of the 22 kg CO2eq attributed to an individual appointment – a figure comparable to the value of 8.05 kg 
CO2eq determined in this case study. Accepting that geographical and demographical differences exist between the 
populations served by Dorset Renal Service and the UHCW Renal Service, it would appear that the use of a 
telephone clinic service reduces the GHG emissions of a single consultation by approximately one third.  
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then the GHG emissions attributable to the telephone call will be 0.456 kg CO2eq. The remainder of the 
components of the telephone clinic are similar to those of a traditional face-to-face clinic. The annual 
350 telephone consultations therefore result in an estimated reduction in GHG emissions of [(350 * 
8.05) – (350 * 0.456)] 2,658 kg CO2eq.   
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Table 24. Data collected from two consecutive telephone consultation clinics. 
Patient 
Choice of Transport 
Modality 
Return distance 
from patient’s 
home to their 
local renal clinic 
(km) 
DEFRA 
Conversion 
Factor 
[DEFRA, 2009]  
GHG 
Emissions 
(kg CO2eq) 
1 Bus 14.08 0.10462 1.47 
2 Bus 6.14 0.10462 0.64 
3 Bus 13.34 0.10462 1.40 
4 Bus  16.34 0.10462 1.71 
5 Bus 4.56 0.10462 0.48 
6 Bus 10.28 0.10462 1.08 
7 Diesel, Large (over 2.0L) 35.74 0.25762 9.21 
8 Diesel, Large (over 2.0L) 7.04 0.25762 1.81 
9 Diesel, Medium (1.7 - 2.0L) 4.38 0.18939 0.83 
10 Diesel, Medium (1.7 - 2.0L) 98.6 0.18939 18.67 
11 Diesel, Medium (1.7 - 2.0L) 4.48 0.18939 0.85 
12 Diesel, Small (up to 1.7L) 12 0.15277 1.83 
13 Diesel, Small (up to 1.7L) 36.94 0.15728 5.81 
14 Petrol, Large (over 2.0L) 163.74 0.29762 48.73 
15 Petrol, Medium (1.4 to 2.0L) 34.2 0.21493 7.35 
16 Petrol, Medium (1.4 to 2.0L) 110.36 0.21493 23.72 
17 Petrol, Medium (1.4 to 2.0L) 35.5 0.21493 7.63 
18 Petrol, Medium (1.4 to 2.0L) 19.84 0.21493 4.26 
19 Petrol, Medium (1.4 to 2.0L) 38.74 0.21493 8.33 
20 Petrol, Medium (1.4 to 2.0L) 17.98 0.21493 3.86 
21 Petrol, Medium (1.4 to 2.0L) 22.4 0.21493 4.81 
22 Petrol, Medium (1.4 to 2.0L) 22.7 0.21493 4.88 
23 Petrol, Medium (1.4 to 2.0L) 1.76 0.21493 0.38 
24 Petrol, Small (up to 1.4L) 8.84 0.18200 1.61 
25 Petrol, Small (up to 1.4L) 113.92 0.18200 20.73 
26 Petrol, Small (up to 1.4L) 18.68 0.18200 3.40 
27 Petrol, Small (up to 1.4L) 43.5 0.18200 7.92 
28 Petrol, Small (up to 1.4L) 12.98 0.18200 2.36 
29 Petrol, Small (up to 1.4L) 241.26 0.18200 43.91 
30 Petrol, Small (up to 1.4L) 9.84 0.18200 1.79 
 Total 1180.16  241.47 
 Mean 39.34  8.05 
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Although the majority (25) of the 30 patients reported a return travel distance of less than 50 km, there 
was considerable variation in the extremes of distance reported. Renal transplantation is undertaken in 
tertiary referral centres which often cover large geographical areas. Whilst the follow up of patients 
from the peripheries of these catchment areas is often ‘handed back’ to their local renal services, it is 
not uncommon for some patients to travel long distances to transplant clinics (for example, patients 14, 
16 and 25). Patient 29 had been under the care of the UHCW renal service for many years and 
therefore, after moving away from the area, had opted to continue to return to the service for follow up 
rather than register with a new service (a relatively rare but not exceptional scenario). 
 
Further reductions (and time savings) result from reduced physician travel to outlying clinics as an 
estimated annual total of 20 clinics across two sites (Stratford and Warwick) became redundant. 
Assuming the physician would have undertaken return journeys from the UHCW site by car, this 
further annual reduction in GHG emissions amounts to ([10 x 0.20487 x 2 x 20.4] + [10 x 0.20487 x 2 
x 36.2]) 232 kg CO2eq (where 20.4 and 36.2 are the return distances to the outlying clinics, in km, and 
0.20487 is the conversion factor for an average sized car [DEFRA, 2009]).  
 
Further potential, but probably less significant, carbon savings result from the reductions in building 
energy use (for example, the lighting and heating requirements of a hospital waiting room) and in 
associated staff commuting (for example, outpatient nurses and reception staff). The overall annual 
carbon saving is therefore estimated to be over 3 tonnes CO2eq. 
 
 
Setting Up a Telephone Consultation Service 
 
Potential disadvantages and barriers 
Telephone consultation is not appropriate when formal physical examination is a likely necessity. Its 
role is primarily in the management of established chronic disease, rather than where diagnostic 
evaluation is required. Even during follow up, one clear drawback of telephone consulting remains the 
loss of visual clues to a patient’s well-being [McKinstry et al., 2009]. A thorough history is therefore 
important and familiarity with the patient must not be considered to be a substitute for this.  
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Cultural barriers, as well as logistical and administrative challenges, may present potential barriers to 
effective implementation of telephone services. For example, the clinician might ideally wish to control 
the process by which patients organise their subsequent appointment, a duty which previously would 
have been undertaken by the outpatient receptionist, in order to include the information in the clinic 
letter (the patient copy of which also acts as the appointment letter). Similarly, patients might find 
automatically generated reminder letters asking them to ‘attend’ clinics confusing; such letters should 
be tailored to the telephone service. 
 
Patient Selection 
The UHCW service does not currently adhere to firm criteria regarding patient selection. However, the 
spectrum of patients to whom the service is offered has broadened as a result of positive responses 
from those already entered into it and the increasing experience and confidence of the physicians. 
When the service is offered to patients, its optional nature – and the opportunity to return to face-to-
face clinics at any stage – is emphasised. The service is only offered to patients with stable graft 
function (a twelve month period appears to be sufficient). Those with complex co-morbidities, or in 
whom regular physical examination is a likely necessity, are less likely to be suitable.  
 
Telephone consultations are less appropriate for patients with hearing, speech or cognitive impairment, 
or where a language barrier exists. Patients should ideally be well known to the department and the 
clinician providing telephone follow up; both clinicians and patients place greater confidence in 
telephone consultations when a face-to-face relationship already exists [McKinstry et al., 2009]. It 
would seem that telephone consultations are not well suited to managing patients with poor attendance 
records in face-to-face clinics, as they are also likely to be poorly compliant with telephone clinics 
(seven such patients have been discharged back to face-to-face follow up from the UHCW service).  
 
Funding 
Acute trusts are presently rewarded for their services through the Payment by Results (PbR, see 
Appendix 1) system. Guidance on the application of PbR to non-face-to-face outpatient activity is 
provided in clauses 344-346 of the PbR Guidance for 2011/12 [Department of Health, 2011]. A face-
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to-face consultation in renal medicine commands a tariff of £128, whilst the tariff for all non-face-to-
face activity is £23. This is derived from the average of the reference costs reported annually across all 
specialties. As such, it is quite possible that this figure does not reflect the true financial cost of any 
given non-face-to-face consultation, particularly as such activity may range from a short phone call 
from a single junior staff member to a video-conference with an experienced multidisciplinary team. It 
is therefore important to note that the tariff for non-face-to-face activity is designated as non-mandatory 
and can be negotiated with Primary Care Trust commissioning bodies. 
 
Although beyond the scope of this report, a full economic analysis is therefore required, and should 
consider the changes to the staff workloads; for example, that of the outpatient department nursing staff 
is reduced, whilst that of the administration team will remain unchanged or may even increase. It might 
also include the implications for patients (who save on travel costs and from not taking time off work) 
and for Trusts (for example, the Trust may incur costs for blood tests undertaken elsewhere, whilst 
suffering a loss in car park revenue).  
 
Potential National GHG Reductions  
On the 31st December, 2007, there were 22,300 adults with functioning renal transplants in the United 
Kingdom [Byrne, Steenkamp et al., 2010). Accepting the inaccuracies resulting from geographically 
and demographically related differences in the distances and modalities of outpatient travel, and 
assuming that patients would otherwise be seen quarterly, we estimate that if the care of 30% (6690) of 
these patients were to be provided by telephone clinic model, an annual carbon saving of (6690 x 3 x 
8.05) over 160 tonnes CO2eq might be realised.  
 
Wider Implications 
The UHCW service currently provides follow up to seven patients with stable chronic kidney disease 
(CKD), a condition which is also well suited to follow up by telephone consultation. The age 
standardised prevalence of stage 3-5 CKD within the United Kingdom has been estimated at 8.5%, but 
the condition remains largely under-recognised (only 2.1% of patients with stage 3-5 CKD had a coded 
diagnosis of renal disease) [Stevens et al., 2007]. The proportion of patients diagnosed with CKD is 
anticipated to rise, due in part to the provision of national guidance [National Collaborating Centre for 
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Chronic Conditions, 2008]. Telephone consulting may become an important component of the service 
reconfiguration that would be required for current renal services to meet this increased demand.   
 
Furthermore, as telephone consulting is well suited to the follow up of patients with stable chronic 
conditions, its widespread adoption across different specialties (for example, to provide follow up to 
patients with diabetes or heart failure) offers considerable benefits to patients and the environment.  
 
Overall, this case study suggests that, implemented appropriately, the use of telephone consulting to 
follow up renal transplant recipients is safe, empowers patients, improves access to healthcare and 
confers environmental benefits. Further research is required to better understand the attitudes of 
patients to these clinic models and to validate their safety. 
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The Fourth Case Study: Sustainable Waste Management Strategies. 
 
The disposal of waste contributes to the environmental impact of healthcare. Renal healthcare, and 
dialysis in particular, produces large amounts of plastic and packaging waste. Chapters 4 and 5 have 
reported the contribution of waste management to the GHG emissions of a renal service and 
haemodialysis treatments respectively. This case study describes how the fundamental principles of 
waste reduction, ‘reduce - reuse - recycle’, can be applied within a dialysis unit to realise both financial 
and environmental savings.  
 
 
The scale of waste in the NHS 
 
The NHS generates over 400,000 tonnes of waste per year, of which almost one third is clinical waste 
[Hutchins & White, 2009]. This equates to 5.5 kg of waste per patient per day. Although waste 
management is reported to contribute only 3% of the GHG emissions of NHS England [Sustainable 
Development Commission, 2008], waste minimisation strategies have the potential to achieve much 
greater savings, by reducing the need for manufacture of medical equipment and thereby the 
“embedded” carbon which is attributed to procurement. Waste management is also a considerable 
economic burden, with an annual cost to the NHS of around £73 million. The proven opportunities for 
financial savings [Tudor et al., 2008] might be used as a driver for change towards more sustainable 
waste management strategies within renal units. 
 
The longer term goal must be to match or exceed the achievements of other countries. In France and 
Germany, where a greater commitment to sustainable resource use is embedded within the nations’ 
culture and legislation, and where the strategies used to manage infection risks perhaps exhibit a greater 
sympathy to the health threat presented by GHG emissions and climate change, the production of 
healthcare waste is markedly lower (at 1.9 kg and 0.4 kg per patient per day respectively) [Tudor et al., 
2008]. 
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As has previously been described, the increasing availability of dialysis has been dependent upon 
single-use, pre-packaged products. Chapters 4 and 5 have outlined the extent to which the disposal of 
the resultant waste contributes to the GHG emissions attributable to a haemodialysis treatment and a 
renal service respectively.  However, it is clear from the results of the survey reported in Chapter 3 that 
waste management strategies are rarely optimal and significant opportunity for improvement exists.  
 
 
What happens to waste produced by the provision of renal healthcare? 
 
Environmental legislation mandates a ‘cradle-to-grave’ approach, such that waste producers must 
ensure that all waste is handled, treated and disposed of safely and with minimal harm to humans and 
the environment. The waste management hierarchy (Figure 12) reflects the sustainability of the 
differing waste management options. Waste should be disposed of as high up the hierarchy as possible. 
As the disposal of waste by any method will have some environmental impact, the reduction of waste is 
at the top of the hierarchy. Reuse is followed by recovery techniques (such as recycling), whilst 
incineration and landfill have poor environmental profiles.  
 
Figure 12. The waste management hierarchy. 
 
 
Renal healthcare produces two main forms of waste; non-clinical (domestic) and clinical waste. 
Clinical waste contains human or animal tissue, blood or bodily fluids, excretions, pharmaceuticals, 
swabs or dressings, syringes, or other sharp instruments [Department of Environment, 1990]. Clinical 
waste is commonly disposed of in yellow bags and is commonly incinerated [Department of 
 204 
Environment, 1994]. Increasingly, hospitals are providing orange bags for hazardous clinical waste that 
must be incinerated, and ‘tiger bags’ for offensive (low or no infection risk) clinical waste that may be 
adequately treated with alternative heat treatments. Waste that has not come into contact with a patient 
or medicine is domestic waste, although it may be produced during clinical work (eg packaging waste 
from medical equipment). Most Trusts presently recycle approximately one quarter of their domestic 
waste. The remainder is predominantly disposed of in landfill. As was discussed in Chapter 2, further 
research is required to better understand the respective environmental impacts of the different disposal 
strategies for healthcare waste. 
 
 
Reduce, Reuse, Recycle in Renal Services 
 
The recent appreciation of the importance of the topic of sustainable waste management is reflected by 
its increasing coverage in health estate management journals, and the development of recycling within 
healthcare [Park & Jeong, 2001]. However, the results of the survey reported in Chapter 3 reveal that 
facilities to collect plastic and packaging waste for recycling are not present in the clinical areas of over 
70% of renal services. The principles most commonly used to deliver waste reduction strategies – 
reduce, reuse, recycle – are applicable to renal healthcare and, more specifically, to dialysis.  
 
 
Reduce 
 
Whilst disease prevention and patient empowerment will contribute to reductions in the waste 
generated by renal healthcare in the longer term, it is the application of the third principle of clinical 
transformation – leaner system development [Connor, Mortimer et al., 2010; Mortimer, 2010] - that is 
likely to offer more immediate results. At its simplest, the application of lean methodology involves 
analysing a process to ensure that the right things are in the right place at the right time. Waste can be 
reduced by very simple measures, including using small aperture sharps bins (so that only the sharps 
waste is placed inside) and unpacking equipment as it is required (so that it is only used when 
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necessary). Similarly, to facilitate the recycling of waste arising from haemodialysis, recycling bins 
must be easily accessible to the staff member as they put a patient onto dialysis.  
 
Leaner Haemodiafiltration   
Opportunities to reduce waste were identified at the Queen Margaret Hospital dialysis unit in 
Dunfermline, which provides around 10,764 haemodiafiltration treatments per year using Fresenius 
5008 machines. Previous practice was to connect a 1 litre bag of normal saline and giving set at the 
start of each treatment (in case the patient became hypotensive – a relatively uncommon scenario for 
the majority of patients receiving maintenance dialysis), despite the fact that substitution fluid may be 
prepared online. Around 200mls of this saline was also used to re-infuse the patient’s blood at the end 
of the treatment. The remaining 800mls, the plastic bag containing it, and the plastic giving set – along 
with the extracorporeal circuit and bicarbonate bag – were all disposed of as clinical waste. Variations 
upon this scenario are common to many dialysis units. 
 
First Reduction 
The use of saline and giving sets was reduced by stopping the unnecessary practice of hanging a bag 
for emergencies in favour of using the online facilities for emergencies and re-infusion. This saved not 
only the GHG emissions resulting from the manufacture of these items, but also the emissions 
associated with their disposal. A bag of normal saline was costing the dialysis unit £0.52, whilst a 
single giving set was costing £0.35. During the course of the 10,764 treatments provided per year, the 
use of online substitution fluid saves £9,364 (minus the very small, but less quantifiable, cost of 
producing the exact fluid volumes online). 
 
Second Reduction  
The amount of clinical waste produced was further reduced by improving segregation at source. The 
first measure had already removed a partially filled bag of normal saline (an average of 0.9 kg) and 
giving set (0.1 kg) from the waste stream, but the bicarbonate bag (1 kg) could also be diverted away 
from the clinical waste stream to domestic waste, giving an overall reduction in clinical waste of 2 kg 
per treatment, or 21.5 tonnes per year, and a financial saving of £6,458 (given a cost of £300 per tonne 
of clinical waste). This saving was offset by the increased cost of the domestic waste (£85 per tonne) 
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attributable to the addition of the bicarbonate bag to this waste stream. As the provision of 10,764 
treatments produces 10,764 bicarbonate bags, with a total weight of 10.764 tonnes, this cost was 
£914.90, resulting in an overall annual saving of £5,543.10.  
 
The financial savings arising from these changes in practice have been reported. However, the 
associated reductions in GHG emissions have not been quantified. Although DEFRA has produced 
emissions factors for the procurement of medical equipment and pharmaceuticals (DEFRA, 2009], the 
limitations of their application to a narrow inventory of specific items have previously been discussed 
(Chapter 5, under the heading Calculating Medical Equipment Procurement Emissions from Economic 
Activity Data), and it is therefore anticipated that their use in the context of these initiatives (and those 
that follow in this chapter) may yield inaccurate results. However, the alternative strategy, in which the 
emissions attributable to the procurement and disposal of these items are determined from an analysis 
of their constituent materials, is beyond the scope of this chapter.   
 
 
Reuse 
 
The contraction of prion disease through medical procedures is extremely uncommon, and the risk of 
death from iatrogenic Creutzfeldt-Jakob disease has been estimated to be less than 1 in 10,000,000 per 
year [Hotchkiss, 2009]. Yet this minute risk has provoked the adoption of precautionary principles and 
disposable medical equipment has become ubiquitous. The financial implications are outweighed only 
by the environmental concerns. The discrepancy between the aim of maintaining health by negating the 
already miniscule risk of infection, and the acceptance of the degree to which this approach contributes 
to the arguably greater threat to health presented by climate change, has been highlighted within other 
specialties [Somner et al., 2010], perhaps most eloquently through the description of the Nipper 
Mountain [Hotchkiss, 2009]. It is also evident across renal healthcare, where it is likely that single-use 
equipment will become increasingly prevalent until infection control risk management strategies 
become more sympathetic to the health threats posed by climate change.   
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Concerns around infection resulting from equipment reuse are lower when the patient remains 
unchanged - the example of dialyser re-use has been discussed in detail in Chapters 2 and 5. The reuse 
of many items in renal units becomes possible with only a little re-organisation. For example, plastic 
sharps carriers for bedside venous cannulation can be washed and re-used and should be chosen in 
preference to paper trays [McGain et al., 2010], whilst plastic sharps containers can be reused if they 
can be safely emptied into a central collection point. Many suppliers will collect and re-use the pallets 
and cardboard boxes in which dialysis supplies are delivered. Patients might be encouraged to use the 
internet resource, Freecycle (www.uk.freecycle.org), to pass on the cardboard boxes containing medical 
supplies delivered to their home.    
 
 
Recycle 
 
The key to successful recycling, the segregation of waste at source, is infrequently achieved in the 
healthcare setting. One case study within the NHS showed that approximately 50% of the waste treated 
as clinical waste should have been considered to be domestic waste, and 35% of this was recyclable 
[Olko & Winch, 2002]. The survey reported in Chapter 3 revealed that less than one third of renal 
services recycle any plastic and packaging waste from single-use dialysis equipment. Among those 
services which do recycle, more than half estimated that they recycle less than 40% of the waste, 
perhaps as a result of the previously mentioned absence of recycling bins for plastic and packaging 
waste in clinical areas. However, the case studies described below illustrate that recycling can lead to 
financial, as well as environmental, savings. 
 
Recycling Cardboard and Plastic Waste 
An assessment by the waste management team at the Runcorn Road satellite dialysis unit in 
Birmingham identified two separate, but not uncommon, problems. The first problem was the disposal 
of the plastic acid containers, which were needlessly entering the clinical waste stream. The second 
problem was the disposal of the large amounts of cardboard packaging associated with the clinical 
supplies purchased by the unit. This was entering the domestic waste stream but was not being 
recycled. Moreover, collections were infrequent and the cardboard was frequently accumulating in 
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piles. As well as taking up valuable space, these piles were identified as a fire risk, prompting the 
facility’s leaseholder to cover the resulting increases in insurance costs with higher rental fees. The 
solution to all of these problems was the purchase of a baling machine to compact the waste. 
 
Figure 13. The baling process during the disposal of cardboard and plastic acid containers. 
 
 
The machine (Figure 13, picture 1) is housed in the storage room adjacent to the dialysis unit and 
measures approximately 1.8 metres by 0.9 metres by 0.9 metres. Used acid containers are emptied, 
rinsed with tap water and collected in bags holding eight containers (picture 2). These bags are then 
baled together, along with bags containing other plastic waste collected within the unit (picture 3). Ten 
bags are baled together, with cardboard layers at the top and bottom, to produce packages that weigh 
approximately 19 kg and are held together with binding tape (picture 4). Excess cardboard is baled 
together in separate packages weighing around 10 kg. The machine is operated by a single staff 
member for 20-30 minutes each day. The plastic and cardboard packages are collected on a weekly 
basis, free of charge, by a local company which recycles them. Were they not baled on-site, this would 
not prove economically viable for the company and collection would not be possible.  
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Investment Appraisal 
The Runcorn Road unit generates 270 empty acid containers per week, resulting in 4.2 tonnes of plastic 
waste per year and a disposal cost of £3,150 per year. The unit also produces approximately 1 tonne of 
cardboard per year. The saving resulting from the free collection of this cardboard, in place of the costs 
associated with the domestic waste stream, has been estimated at around £1,000 per year. So the annual 
saving to the dialysis unit (equivalent to the overall cost of the original waste disposal methods) is 
approximately £4,000. The cost of a baler (£3,500) and its annual running costs (£195 maintenance, 
£342 binding tape, £50 plastic bags) means the total cost incurred during the year of implementation is 
£4,087, with an annual cost of £587 thereafter. The Runcorn Road unit therefore recouped the outlay 
cost at one year, and has been saving around £4,000 thereafter. These savings do not include the other 
plastics that are baled, and would be even greater in units using plastic bicarbonate containers.  
 
 
Conclusion  
 
The preceding chapters have focused upon an exploration of the different ways in which the provision 
of renal healthcare impacts upon the environment (Chapters 2 and 3) and studies to quantify the extent 
of some of these impacts (Chapters 4 and 5). In contrast, this chapter seeks to illustrate how the 
environmental impact of renal healthcare might be reduced through widely achievable measures. 
Furthermore, in recognition of the fact that, in many cases, the sustainability agenda may not be a 
priority for those with the responsibility for determining how renal healthcare is provided, care has 
been taken to describe any additional benefits offered by the initiatives that have been reported (such as 
reductions in financial cost and improvements in  patient experience). 
 
Opportunities to reduce the use of resources exist at all levels of the provision of renal healthcare. 
Strategies to lessen resource use at the level of individual patient care (for example, the opportunities to 
reduce and recycle the medical equipment and packaging used during a haemodialysis treatment) are 
likely to be most evident to those healthcare professionals with direct patient contact. Although the 
environmental benefits of such interventions may be relatively modest, the early experiences of the 
Green Nephrology Programme suggests that the associated benefit of engaging those healthcare 
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professionals that are providing clinical care in environmental issues may make an important 
contribution to the development of the movement towards more sustainable healthcare.  
 
Meanwhile, the case studies describing the use of heat exchangers and the conservation of reject water 
in dialysis services illustrate how simple changes to existing technologies can reduce the environmental 
impact at the level of standardised treatments. Whilst those staff routinely using and, particularly, 
servicing and maintaining equipment (for example, renal technicians) might be well placed to identify 
opportunities of this nature, manufacturers must also be encouraged to incorporate sustainability 
considerations into their products, and those within the healthcare services responsible for procuring 
medical equipment and facilities should seek to incentivise this.  
 
However, the greatest environmental savings within renal healthcare will almost certainly result from 
the inclusion of sustainability as an important consideration during service reconfigurations. The nature 
of the providers of healthcare, the resources available to these providers, their understanding of what 
constitutes optimal healthcare in the light of ongoing medical research, and the needs and 
demographics of the patients that they serve, are all constantly evolving and changes in the way that 
healthcare is provided are therefore common. The case study describing the delivery of outpatient 
services by telephone consultation illustrates how service reconfigurations can support the 
transformation to more sustainable renal healthcare. Whilst the environmental benefits reported in this 
case are comparatively modest, it should be noted that the strategy was considered to be applicable to 
only a small cohort of patients (those with stable renal transplants) who were accessing the services on 
a relatively infrequent (quarterly) basis. Instead, service reconfigurations of the care of those patients 
using services frequently (for example, recent recipients of renal transplants or patients undertaking 
maintenance haemodialysis) or in high numbers (for example, all inpatients or all outpatients) might be 
expected to offer greater environmental benefits.  
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Chapter 7.  
 
Conclusions. 
 
 
This thesis has explored the direct environmental impact of providing renal healthcare. Particular 
consideration has been given to the contribution being made to GHG emissions in recognition of the 
relatively recent appreciation of the impact of anthropogenic climate change upon global health. This 
concluding chapter reviews the key findings of the thesis. The influence of these findings upon the 
ongoing efforts to reduce the environmental impact of renal services in the United Kingdom is 
discussed. Further recommendations for the translation of these findings into service provision are 
made, and suggestions for the direction of future research are outlined. 
 
In Chapter 2 it was established that there has been very little research published on the environmental 
impact of renal medicine. Despite this, several examples of improvements in the sustainability of renal 
medicine were identified. In each case, the impetus for change had been a perceived benefit to one or 
more of the quality domains in healthcare, as defined by the Institute of Medicine [Institute of 
Medicine, 2001], rather than a primary intention to reduce an environmental impact. This chapter 
therefore demonstrated an important principle – that the transformation to the delivery of more 
sustainable renal healthcare may be realised alongside, rather than instead of, improvements in the 
quality of healthcare.  
 
The opportunities to reduce the environmental impact of healthcare may not always be readily 
apparent. The application of the principles of clinical transformation, outlined in Chapter 2, as a 
framework to identify opportunities is therefore to be encouraged, particularly during service 
reconfigurations. The use of these principles within renal medicine has been illustrated in Chapter 2.  
 
The results of the survey reported in Chapter 3 provided the first assessment of the extent to which 
sustainable practices are presently incorporated into the delivery of renal healthcare. A set of 
opportunities for sustainable practice were identified from a number of sources, including the results of 
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the literature search (reported in Chapter 2), staff working within the renal services (including 
clinicians and members of the Estates and Procurement departments), and members of the renal 
industry. The practices of the majority of the renal services across England, Scotland and Wales were 
surveyed to establish a baseline of practice. Feedback was provided to participating units by way of 
individualised annotated slide sets. These slide sets included the aggregated national results and, to 
facilitate comparison, the data submitted by the individual unit. 
 
Perhaps the most important finding of this survey was the confirmation that the opportunities to 
improve the sustainability of renal services are not only numerous but also varied in nature. The survey 
results also help to identify those aspects of the delivery of renal healthcare in which these 
opportunities arise. It is clear, for example, that many of the opportunities to improve sustainability will 
not be realised through strategies that focus primarily upon the direct energy consumption of a renal 
service, but might best be achieved through reconsideration of the way in which clinical services are 
delivered. This requirement for a clinical transformation has been a central theme within the thesis. 
 
However, whilst it is evident that there is considerable scope to improve the sustainability of renal 
healthcare, the survey did not attempt to quantify, or indeed compare, the magnitude of each potential 
opportunity to enhance sustainability. It follows that an improved understanding of not only the 
magnitude of the overall environmental impact of renal healthcare, but also of the contributions made 
by the different components of this impact, is required to ensure the prioritisation of the most effective 
strategies.  
 
Such quantitative information might also allow future versions of the survey to attribute appropriate 
weighting to the different opportunities for improvements in sustainability. In this way, the survey may 
then act as a tool with which individual renal services might more accurately determine the areas in 
which to focus strategies to reduce their environmental impact. Such a survey may also, in time, allow 
the sustainability of different renal services to be comparisons. This public benchmarking of the 
variation in practice between different renal services could be developed in line with the Renal 
Registry, which currently provides a clinical equivalent, and might be anticipated to drive 
improvements in performance. 
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The contribution of renal healthcare to GHG emissions represents an aspect of the overall 
environmental impact for which quantitative data can readily be determined. Furthermore, guidance on 
the magnitude of the reductions required in these emissions already exists [NHS Sustainable 
Development Unit, 2009]. Realising the targets set by the NHS Carbon Reduction Strategy within renal 
healthcare will require an improved understanding of the GHG emissions associated with the delivery 
of healthcare. The studies detailed in Chapters 4 and 5 have shown that the determination of the carbon 
footprints, including direct and indirect emissions, of both medical services (such as the Dorset Renal 
Service) and treatments (such as haemodialysis) is possible through adherence to the principles and 
definitions described within an existing methodology which is already in use across other sectors. In 
some places it was considered pragmatic to tailor the methodology of PAS2050 in order that it might 
more accurately reflect the carbon footprint of what the service or treatment under consideration was 
widely understood to include. Any such alterations, for example the inclusion of the emissions 
attributable to patient and staff travel, have been carefully outlined in this thesis. To date, there has 
been no proposed standard to which carbon footprinting methodologies within healthcare should 
adhere. This thesis therefore offers an innovative template for future studies of this nature across 
different specialties.  
 
Improvements in the efficiency with which resources are used will not, in themselves, realise sufficient 
reductions in the GHG emissions associated with healthcare and, instead, a transformation of the 
current systems and practices used to deliver healthcare will be required. Carbon footprinting studies 
must play an important role in the evaluation of the environmental benefits of such service 
reconfigurations. Where appropriate, carbon footprinting studies should be aligned with the more 
traditional forms of healthcare research, for example, those designed to assess parameters such as the 
clinical efficacy and financial cost of treatments and services. This will allow their value to be judged 
against their carbon burden. Further research might consider how best to aggregate clinical, economic 
and environmental data. However, improvements in the sensitivity and accuracy of the carbon 
footprinting studies incorporated into these analyses will be necessary in order to provide meaningful 
comparisons and to show change over time. A pressing requirement is therefore the development of 
more specific emissions factors. This is of particular importance within the subsectors of 
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pharmaceuticals and medical equipment given their significant contributions to the carbon footprints 
reported in this thesis.  
 
The undertaking of future carbon footprinting studies within healthcare would be greatly facilitated by 
the more ready availability of activity data. Hospital trusts must be encouraged to implement the simple 
measures, such as sub-metering of electricity consumption in renal units, regular auditing of waste 
disposal, and the use of more refined procurement data recording systems to support this need. The 
Green Nephrology Programme is now piloting the integration of the reporting of this data within 
existing data collection processes through the Scottish Renal Registry (personal communication with 
Dr Jamie Traynor, Consultant Nephrologist, Monklands Hospital, Airdrie, April 27th 2011; also see 
http://www.srr.scot.nhs.uk/About/Guide.htm). Similarly, the development of an open access database 
has been proposed, into which the providers of renal healthcare products will be encouraged to enter 
information pertaining to their products, such as the carbon footprint of the product, the materials used 
and the opportunities for recycling the product and its packaging. 
 
The determination of the GHG emissions arising from the provision of renal medicine across England 
represents the first estimate of an individual specialty’s contribution to the carbon footprint of NHS 
England and provides the context in which many of the findings of this thesis must be considered. 
Renal medicine produces approximately 200,000 tonnes of CO2eq per annum, which equates to around 
1% of the carbon footprint of NHS England [Sustainable Development Commission, 2008] and over 
2% of the emissions attributable to secondary care [Eastern Region Public Health Observatory, 2010]. 
Given the relatively small numbers of patients treated directly by the specialty, and therefore included 
in these footprints, renal medicine appears to have a disproportionately high carbon footprint. These 
findings support the assumption that renal medicine is an appropriate specialty in which to introduce 
the process of clinical transformation, as the Green Nephrology Programme has sought to do.  
 
Procurement contributes 60% of the GHG emissions attributable to NHS England [Sustainable 
Development Commission, 2008]. Reducing these emissions represents a major challenge and will 
require collaboration between clinicians, commissioners and the industry. To date, this challenge has 
not been effectively met. A few of the many potential and realised barriers within renal medicine have 
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been outlined in Chapter 3, and many of these will also be application to other clinical specialties. The 
results of the study reported in Chapter 4 suggest that the contribution of the procurement sector is even 
greater within renal medicine. This is potentially the most important finding of the thesis, as it 
emphasises the importance of addressing these emissions and has resulted in the formation of the Renal 
Sustainable Procurement Working Group within the Green Nephrology Programme. This group 
provides a forum in which the relevant parties can collaborate. The author developed a set of 
sustainable procurement criteria appropriate to the renal industry, and their use (in a slightly revised 
form) is now being piloted in a number of contracts being tendered by English renal services.  
 
In addition to driving forward the inclusion of sustainability criteria within the contracts that renal 
services put out to tender, the publication of the results of the studies reported in Chapters 4 and 5 
[Connor, Lillywhite et al, 2010; Connor, Lillywhite et al, 2011] is also encouraging the renal industry 
to accurately calculate the carbon footprints of the products which it develops in anticipation of the 
need fulfil these orders (correspondence with Derek Wiebenson, Senior Manager, Renal Global 
Marketing, Baxter Healthcare Corporation, by email, 21st April 2011; correspondence with Patrick 
Ward, Business Development Manager, Quanta, by email, 4th March 2011).  
 
Although there are apparent advantages in the use of sustainability criteria as a factor contributing to 
the award of a contract, this approach may prove problematic. Difficulties arise in ensuring that the 
sustainability criteria are afforded adequate weighting amongst the other criteria such as financial cost 
and product quality. The use of sustainability criteria in this manner is also complicated by the 
European Laws on Fair Trade. Early experience from the work of the Renal Sustainable Procurement 
Working Group suggests that the inclusion of the criteria as part of a “supplier development 
programme” may be a more effective alternative. In this way, the successful suppliers are committed to 
reducing the environmental impact of their products and services over the duration of the contract. 
Because this approach will also reward providers for future improvements as well as for present 
performance, it may also allow the more meaningful inclusion of product-specific criteria by helping to 
negate the benefits of ‘creative accounting’ of emissions attributable to a particular product to other 
aspects of an organisation’s resource use. 
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The delivery of different aspects of patient care within the NHS is subject to constant change, for which 
there are many drivers. This is well illustrated by the provision of haemodialysis. In the 1960s, access 
to haemodialysis was limited to small numbers of patients at few, geographically disperse, centres. 
Technological constraints meant that dialysis treatments were typically 8 hours long. Treatments were 
undertaken in hospital and the dialysis membranes were reused. In the late 1970s, technological 
developments allowed a reduction in typical treatment times to 4 hours and the treatments were 
increasingly undertaken at home, such that this became the norm. The subsequent development of 
single-use, disposable, items of medical equipment has underpinned a dramatic rise in the availability 
of haemodialysis. This has, in turn, contributed to the development of an increasingly elderly and frail 
population of haemodialysis patients, who once again dialyse predominantly in-centre. Dialysis 
membranes (now known as dialysers) are no longer reused in the United Kingdom whilst, for clinical 
reasons, there is a revived interest in more frequent and longer sessions of dialysis.  
 
As was the case with the developments in clinical practice reported in Chapter 2 as examples of more 
sustainable healthcare, none of these changes in the provision of haemodialysis services have been 
driven by the sustainability agenda. Furthermore, although the importance of sustainability within 
healthcare is increasingly appreciated, it is not strongly incentivised at present and consequently is 
likely to remain a low priority for the majority of individual renal services in the immediate future. 
Vigilance is therefore required to identify the opportunities to implement more sustainable models of 
care that arise from the need for service reconfiguration driven by other influences, of which financial 
pressure is perhaps currently the most significant.  
 
The case studies reported in Chapter 6 have illustrated how the sustainability, care quality and cost-
saving agendas may be aligned. However, in order that such opportunities may be taken, tools must be 
developed to allow the timely and uncomplicated evaluation of the environmental impacts of potential 
models of care. The ideal of detailed carbon footprinting studies, such as those reported in this thesis, is 
unlikely to be practical in every case. Indeed it may not be necessary because the use of indicative 
carbon burdens for standard episodes of patient care, such as those determined for inpatient admissions 
and outpatient appointments (Tables 12 and 13), offers a more feasible approach. Further research 
might be directed towards the development of an open access library of indicative carbon burdens 
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covering the more common episodes of patient care. These could then be used as the building blocks 
with which to model the carbon footprints of different models of care. Considerable overlap exists 
between this approach and that of the aforementioned product database, with information derived from 
the latter contributing to the development of individual indicative carbon burdens.   
 
The provision of sustainable healthcare remains in its formative stages, the evidence base is small and 
there are many areas of uncertainty. A pragmatic approach is therefore required but assumptions should 
be tested wherever possible, as the benefits of a particular approach may not always be realised when it 
is applied generically. For example, moving healthcare ‘closer to home’ has been advocated as a key 
action to reduce GHG emissions [NHS Sustainable Development Unit, 2009] but this may not always 
hold true; the findings of the study reported in Chapter 5 suggest that the rising uptake of HHD, in its 
current form and using standard machines, is likely to increase, rather than decrease, the carbon 
footprint of haemodialysis programmes.  
 
Through the example of the potential reduction in GHG emissions achievable by dialyser reuse, the 
same study illustrates a further important point. Whilst patient safety must undoubtedly remain the 
priority, the balance between the current profligate pattern of resource use and the extent to which the 
immediate risk of harm to patients (for example, through infection) should be minimised must be re-
evaluated if the procurement emissions, which dominate the carbon footprints of renal services 
(Chapter 4), haemodialysis (Chapter 5) and the NHS as a whole [Sustainable Development 
Commission, 2008], are to be reduced effectively.  
 
However, only when the health impacts of climate change are more widely appreciated is it likely that 
such an approach might be considered acceptable. In the meantime, other drivers for change must be 
identified to encourage renal services to adopt more sustainable methods. The development of a 
funding model that promotes sustainable healthcare must be a priority. Acute trusts within the NHS are 
currently financially rewarded for the services they provide though the PbR system [Department of 
Health, 2011]. A fixed tariff payment system which reimburses hospitals for the type and number of 
patients treated, PbR is primarily designed to encourage activity and clinicians already recognise that 
the system may create perverse incentives. For example, it may be financially preferable for the 
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provider to manage patients as inpatients rather than outpatients [Patterson, 2010], although this will 
almost certainly generate higher GHG emissions. In this way, it might be argued that PbR does not 
actively support sustainable healthcare at the present time. Research is therefore required to develop 
new funding models within PbR.  
 
More direct financial penalties or rewards also represent an obvious and potentially powerful incentive 
for change. One such opportunity may lie within the CQUIN (Commissioning for Quality and 
Innovation) payment framework. This is intended to make the quality of care a core value for providers 
[Department of Health, 2010(b)]. Within the CQUIN framework, up to 1.5% of the provider’s income 
becomes conditional on quality and innovation measures. These goals are agreed at a local level 
between the provider (for example, a renal service) and the commissioning body, with at least one goal 
derived from each of four nationally-specified areas: safety, effectiveness, patient experience and 
innovation. The area of innovation offers an opportunity to incorporate sustainability measures into the 
provider’s CQUIN goals. Where the benefits include financial savings, it may be necessary to split 
these between the renal service and commissioning body.  
 
The transformation to more sustainable clinical services must be implemented by healthcare 
professionals. Although the Green Nephrology Programme successfully recruited Local 
Representatives in the majority of renal services across England, Scotland and Wales, many of these 
individuals reported difficulties in engaging influential colleagues within their departments in 
sustainability initiatives. Research to develop an improved understanding of the attitudes of renal 
physicians and healthcare professionals towards environmental issues, and climate change in particular, 
might improve the success of the future Green Nephrology Programme projects. However, the 
realisation of many of the possible opportunities for more sustainable renal healthcare requires the 
involvement of only a few committed individuals within a renal service, and it may be that educational 
resources should be focused upon those with an active interest in the subject, provided that they are 
also encouraged to develop leadership roles.  
 
In conclusion, this thesis has, for the first time, systematically explored the environmental impact of 
providing renal healthcare. Examples of good practice in the delivery of more sustainable renal 
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medicine have been identified and, in a few cases, fully evaluated as case studies. The extent to which 
these, and other, sustainable practices are included in the provision of renal services across England, 
Scotland and Wales at the present time has been reported. The carbon footprints of both an individual 
renal service and, by extrapolation, the provision of renal healthcare across England, have been 
determined. Similarly, the carbon footprint of a common form of treatment for renal disease, 
haemodialysis, has been reported. The results of these studies are already shaping the carbon reduction 
strategies employed within renal medicine throughout the United Kingdom. Moreover, the work can 
also serve as a template for studies in other specialties.  
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Appendix 1. 
 
A Description of Renal Services for Non-Clinicians. 
 
The primary functions of the kidneys are the removal of the waste products of metabolism from the 
body and the regulation of fluid balance through the production of urine. An individual’s kidney 
function is commonly reported as the glomerular filtration rate (GFR), which may be estimated from 
their serum creatinine level (determined by a blood test), age, gender and ethnicity, but can also be 
measured directly. The kidneys also contribute to the control of blood pressure, the production of red 
blood cells, and the maintenance of bone health. These functions also frequently deteriorate as a 
patient’s GFR decreases. Patients with reduced kidney function may therefore develop a wide range of 
symptoms. These include the symptoms of fluid accumulation (eg breathlessness and oedema), the 
build up of waste products of metabolism (eg nausea, fatigue, weakness, itching), anaemia (eg fatigue, 
headaches, breathlessness) and metabolic bone disease (eg bone pain). Patients might also report 
symptoms indicative of the underlying cause of the renal disease.  
 
The terms ‘chronic renal failure’ and ‘chronic kidney disease’ are used to encompass the many 
conditions that result in a relatively slow, and typically unrecoverable, reduction in the GFR. The more 
abrupt deteriorations, which may or may not be reversible, are described as ‘acute renal failure’ or 
‘acute kidney injury’. The term ‘end-stage renal disease’ (ESRD§) describes the total or near-total 
failure of the kidneys to undertake their primary functions, and may result from either acute kidney 
injury, chronic kidney disease, or a combination of the two. 
 
For patients with ESRD, treatments exist that can partially replace the primary functions of the kidneys 
(the maintenance of fluid balance and the removal of metabolic waste products). The treatments are 
termed ‘renal replacement therapies’ (RRT) and include transplantation and the different forms of 
dialysis.  
 
                                                 
§
 End-stage renal disease (ESRD) is defined as either the requirement for renal replacement therapy (in the form of dialysis or 
transplantation) or a fall in the GFR to below 15 mls/min/1.73m2. 
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Kidney transplantation is the treatment of choice for many patients. However, not all patients are 
suitable for transplantation. This, in conjunction with other factors such as the constraints on donor 
organ availability, results in around half of all patients receiving RRT in the United Kingdom 
undertaking dialysis.  
 
The most commonly undertaken form of dialysis is haemodialysis (44% of prevalent RRT patients), 
with smaller numbers undertaking peritoneal dialysis (9% of prevalent RRT patients) [Byrne, 
Steenkamp, et al., 2010]. Although small numbers of patients undertake haemodialysis at home, the 
majority of patients receive thrice weekly treatments of around four hours duration in specialised 
dialysis units (either in hospitals or purpose-built ‘satellite’ dialysis units). During a haemodialysis 
treatment, a patient’s blood is circulated through a machine which removes metabolic waste products 
and, if necessary, also free water. Patients undertaking peritoneal dialysis typically do so in their own 
home. In this modality, the patient’s peritoneal cavity (a virtual space within their abdomen) is 
intermittently filled with fluid. Waste products within the patient’s blood diffuse down their 
concentration gradient, across the peritoneal membrane and into this fluid, which is then drained away. 
The regular fluid exchanges are either undertaken manually during the day or by a machine overnight.  
 
For an individual patient with ESRD, the modality of RRT may change over time. For example, they 
might begin by undertaking peritoneal dialysis, before later receiving a renal transplant. Should this 
transplant later fail, they might then revert to peritoneal dialysis or perhaps switch to haemodialysis. 
Although both forms of dialysis can also be used to treat severe episodes of acute kidney injury, 
haemodialysis is most commonly used for this purpose. 
 
Renal services undertake the detection, diagnosis and management of renal diseases arising within the 
population that they serve, and typically require both inpatient and outpatient facilities. The provision 
of RRT programmes constitutes much of their workload, and requires considerable specialist personnel 
and infrastructure. Although haemodialysis is provided on an outpatient basis, the need for dedicated 
units is dictated by the specialist nature of the treatments, their duration and intensive frequency, and 
the number of patients requiring these services. The majority of patients receiving any of the forms of 
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RRT will, at one time or another also require inpatient services, and renal services therefore also 
provide ward-based inpatient care.  
 
Inpatient services are also essential to other aspects of the workload of a renal service. For example, the 
provision of emergency renal care is predominantly inpatient-based and includes the management of 
patients with acute kidney injury. The early management of patients receiving renal transplants requires 
ward-based care. Patients with renal disease are also commonly admitted to inpatient beds to undergo 
medical investigations and procedures. The care of patients with renal disease can be complex and, for 
this reason, many patients with renal diseases are admitted under the care of the renal services when 
undergoing investigations into not only their renal conditions but also other unrelated conditions.  
 
Patients are also often followed up through outpatient clinics – a further dimension to most renal 
services. Delivering these differing forms of care across differing forums requires renal services to 
employ a wide range of staff, including doctors, nurses, dieticians, physiotherapists, occupational 
therapists, social workers, administrators and managers.  
 
The care of patients with mild renal disease is usually delivered in the primary care setting under the 
supervision of General Practitioners. Patients with more severe disease are likely to require referral to 
see a nephrologist (a doctor specialising in renal medicine) at the local renal service. Most renal 
services will provide the majority of the aspects of care described earlier, with the exception of acute 
transplantation surgery which is provided at tertiary referral centres.  
 
At the time of writing, the Primary Care Trusts (PCTs) hold the financial resources and overall 
accountability for healthcare commissioning. Taking guidance where necessary from both the local 
Strategic Health Authority and from the Department of Health, PCTs negotiate contracts with local 
renal services to ensure that the hospital Trusts are appropriately reimbursed for the renal healthcare 
services that they provide. However, it is likely that responsibility for commissioning services will be 
passed to General Practitioners in the near future. 
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Until relatively recently, these negotiations resulted in ‘block contracts’ for particular services, with a 
resource allocation based upon historical activity and expenditure. In this way, a PCT would pay an 
agreed sum to a hospital Trust to provide particular services to their population of patients for a given 
period of time – irrespective of the number of healthcare episodes that subsequently arose. However, in 
England at least, the commissioning process is instead increasingly supported by the Payment by 
Results (PbR) system. PbR assigns national tariffs (fixed prices) to discrete episodes of healthcare (for 
example, one outpatient appointment, a single haemodialysis treatment). The tariff for a particular 
episode is derived from ‘reference costs’ reported by organisations across the NHS, and adjustments 
are made for market forces. Not all healthcare drugs, devices and procedures are presently included in 
PbR: for example, particularly costly drugs for which the demand is anticipated to be low but may be 
variable are commonly excluded.  
 
 
A Fictional Patient’s Journey.  
 
No two patients with kidney disease are the same. Their experiences, and the care provided to them by 
renal services, vary considerably. The following vignette of a fictional patient’s experiences of living 
with kidney disease is intended to illustrate some of the services provided and how they might be 
accessed, in order to provide a broader context to some of the areas covered in this thesis. The reader 
may find it helpful to refer to Figures 6 and 7 in Chapter 5. 
 
Mr Smith first reported occasionally passing blood in his urine to his family doctor, Dr Jones, at the age 
of 24. Dr Jones identified that Mr Smith had high blood pressure, and undertook urine tests (which 
showed that Mr Smith was passing both blood and protein in his urine) and blood tests (from which it 
was ascertained that Mr Smith’s kidney function was less than might be expected for a man of his age, 
with an estimated GFR of 52 mls/min/1.73m2). Dr Jones referred Mr Smith to his local hospital to see a 
nephrologist, Dr Taylor, in the outpatient clinic, where a full history of his illness was taken and he was 
examined. Further blood tests were sent and Mr Smith was asked to attend the radiology department to 
have an ultrasound scan of his kidneys. At a follow up clinic appointment he was commenced on 
medications for his blood pressure and advised that he should have a kidney biopsy. Two weeks later 
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he was admitted overnight to the renal ward for the procedure. At his third clinic appointment, he was 
told that the biopsy had confirmed that he had IgA nephropathy, a condition affecting the filters in his 
kidneys, and advised to remain on his blood pressure tablets.  
 
Mr Smith’s kidney function declined slowly but steadily over the next decade, despite the nephrologists 
adding further tablets for his blood pressure. During this time he continued to attend Dr Roberts’ 
nephrology clinic, although he was often seen by other doctors from Dr Roberts’ team, and, as his 
kidney function lessened, the appointments became more frequent. Before each appointment he would 
have a blood test at his family practice and the results would be reviewed at the hospital clinic. By the 
time his estimated GFR had fallen to about 30 mls/min/1.73m2, Mr Smith was beginning to notice that 
he was more tired than normal. Dr Taylor told him that the levels of iron in his blood were low and he 
attended the renal day-case unit to have these topped up with infusions. A little later on he was started 
on fortnightly injections of ‘epo’, a medicine to boost the blood count. Initially he visited his family 
practice to have these injections, but he soon learnt to administer them himself. Around this time, Dr 
Taylor also asked Mr Smith to see the renal dietician at the clinic. She provided him with advice about 
eating healthily and safely with kidney disease. Mr Smith began taking chalky tablets with his meals to 
reduce the amount of phosphate he absorbed, as his kidneys could no longer remove it from his blood 
effectively.  
 
Encouraged by his nephrologists (Dr Taylor had retired by now, and the team had expanded), Mr Smith 
began to use a computer system called Renal PatientView to access his own blood results online. When 
his estimated GFR reached about 20 mls/min/1.73m2, the doctors began to talk about the different 
forms of RRT that might be needed in the future. He attended patient seminars at the renal unit to learn 
more, and began to log on to patient forums on the internet. By this time, he had begun to notice some 
swelling around his ankles and he was more breathless than he used to be. He had lost his appetite, was 
losing weight and was tired all the time.  
 
It was clear that the best form of treatment for Mr Smith would be a kidney transplant. His brother 
came forward as a potential kidney donor and underwent blood tests at the renal department, but 
unfortunately he proved not to be a suitable match. Mr Smith was asked to go for more tests, including 
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a heart scan, and was then activated onto the national transplant waiting list. However, over the next 
year, both his renal function and his symptoms deteriorated more rapidly and he and his nephrologists 
agreed that he should start dialysis. 
 
Mr Smith had previously decided that, were dialysis to become necessary, he would prefer peritoneal 
dialysis. This decision was based upon the information he had gained from the outpatient consultations, 
patient seminars, educational videos he had been given, and also from what he had read online and 
gleaned from other patients. Just before his fortieth birthday, he was admitted to the renal ward at the 
hospital for a few days and underwent an operation to insert a peritoneal dialysis catheter into his 
abdomen. Two weeks later he started peritoneal dialysis, initially frequently coming up to the 
‘Peritoneal Dialysis Department’ at the renal unit to see the ‘Specialist Nurses’ for training. Once he 
was established on this treatment he began to feel better in himself (although his blood tests did not 
look much different on Renal PatientView). Each day he would perform four ‘exchanges’, during 
which he drained fluid out of his abdomen and replaced it with new fluid from special 2.5 litre bags 
which were delivered to his house by a pharmaceutical company. He learnt to live with the restrictions 
this treatment put on his lifestyle but suffered an episode of ‘peritonitis’ – the result of bacteria 
contaminating the fluid he exchanged – that gave him severe abdominal pain and required a brief 
inpatient admission to the renal ward. 
 
He remained on peritoneal dialysis for 11 months until, one day, he was called up for a kidney 
transplant. The operation was performed at the larger renal unit in the neighbouring city and he 
remained an inpatient there for ten days. Even after his discharge, he returned to attend the clinics in 
this other hospital twice a week for the first month. Then his care was handed back to his local renal 
service and nephrologists again. His medications had been altered completely. He no longer needed any 
tablets for his blood pressure or phosphate levels, but was now taking medications to stop his body 
rejecting the transplanted kidney. Gradually he was asked to come to outpatient clinics less and less 
frequently. A number of other tablets, to prevent opportunistic infections, were phased out. 
 
 226 
Over the next few years, Mr Smith’s care was provided exclusively through the outpatient department, 
with the exception of one admission to have his gallbladder removed (during which, once again, he was 
admitted to the renal ward).  
 
Some seven years later, Mr Smith’s blood tests began to show a steady deterioration in the function of 
his transplant. Initially this was managed through changes in his medications. Eventually he was again 
admitted to the renal ward and, after another ultrasound scan, he underwent a biopsy of the transplanted 
kidney. This showed that the disease that had originally affected his native kidneys was now beginning 
to affect the transplanted kidney. As time passed, Mr Smith once again began to develop the symptoms 
of chronic kidney disease, until twelve years after transplantation, it was agreed that he should go back 
on dialysis.  
 
On this occasion, however, Mr Smith and his nephrologists agreed that he should have haemodialysis 
rather than peritoneal dialysis (partly for lifestyle reasons and partly due to his previous abdominal 
surgeries). He was booked into the renal day-case unit and underwent surgery to create a fistula in his 
arm. This took six weeks to mature, after which he began to attend the satellite haemodialysis unit near 
to his home. This large, open-plan building housed sixteen dialysis machines, individually supplied 
with purified water from a central water purification unit. The unit was open six days a week, and 
patients came in three sittings each day. Like most patients, Mr Smith dialysed three times a week for 
four hours at a time. At each treatment Mr Smith was weighed, and the amount of fluid to be removed 
from his body was calculated. Needles were inserted into his fistula and he was then connected to the 
dialysis machine by tubes. His blood was cycled through the machine and the metabolic waste products 
were washed out. He no longer passed much urine and his doctors encouraged him to restrict himself to 
one litre of fluid a day. Once again, the dieticians advised him on his eating habits, restricting his intake 
of certain foods.  
 
Mr Smith found his dialysis days very tiring as a result of the travelling and the rigorous nature of the 
treatment. His nephrologist suggested he consider ‘home haemodialysis’ and the nursing staff at the 
dialysis unit began to teach him how to set up the dialysis machine, ‘needle’ his fistula  and connect 
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himself to the machine. Once he could perform his dialysis independently, his home environment was 
converted to accommodate a dialysis machine.  
 
Mr Smith found that doing ‘home haemodialysis’ left him free to control the frequency and duration of 
his own dialysis treatments. Encouraged by the doctors and nurses at the renal unit, he began to dialyse 
more frequently. Instead of the thrice-weekly, four-hour treatments, Mr Smith undertook daily 
treatments of 3 hours, usually taking Sunday off. He noticed he needed fewer blood pressure tablets 
and felt less tired on this regime. After online forum discussions with patients in Australia, Mr Smith 
began to discuss the possibility of dialysing overnight, for eights hours every night, with his 
nephrology team. By this time, he was also back on the transplant waiting list again. 
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Appendix 2. 
 
A full account of the methodology for the determination of the emissions data for 
waste. 
 
The components of the Dorset Renal Service each produce waste. This waste is categorised as being 
either clinical or domestic waste. The disposal of this waste contributes to the carbon footprint of the 
Dorset Renal Service, although the model used in this study assigns the carbon embedded in products 
to the manufacturing process, and it is therefore included within the carbon footprint attributable to 
their procurement rather than their disposal (the ‘end of life’ carbon footprint has been calculated as 
opposed to the sum of the ‘end of life’ and ‘production’ carbon footprints). 
 
The disposal of the waste produced by the Dorset Renal Service is assumed to be undertaken by the 
following three methods only; incineration, recycling, and landfill.   
 
1. Waste that is incinerated 
 
1.a. Clinical Waste 
 
Estimation of the weight of clinical waste produced by the Haemodialysis and Peritoneal Dialysis 
Services  
The weight of clinical waste produced per year by the haemodialysis and peritoneal dialysis 
departments has been estimated from the weight of clinical waste produced per patient per treatment 
[Hoenich et al., 2005] and the number of patients receiving these treatments in each department. It has 
been assumed that all haemodialysis patients dialyse thrice weekly and that all peritoneal dialysis 
patients undertake four exchanges per day. The nature and proportions of the constituents of the clinical 
waste arising from haemodialysis and peritoneal dialysis have been estimated from previous published 
studies [Hoenich et al., 2005] and from personal communication with the author of these studies (Dr 
Nicholas Hoenich, by email, 12th May 2010). DEFRA emissions factors for the incineration of waste 
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have been applied to each of these constituents to determine their associated emissions [DEFRA, 
2009].  
 
Estimation of the weight of clinical waste produced by the acute inpatient ward 
The weight of clinical waste produced per year by the acute inpatient ward has been estimated from the 
annual number of bed days and previous studies of the weight of clinical waste produced per inpatient 
per day [Audit Commission, 1997]. It has been assumed that the renal ward will generate similar 
amounts of clinical waste to other wards. In addition, the clinical waste attributable to the provision of 
four haemodialysis treatments per day has been included (as these include acute patients whose dialysis 
would not be accounted for in calculations for the other services). As acute patients are less commonly 
commenced on peritoneal dialysis, no contribution to the inpatient clinical waste has been assigned to 
this. The nature and proportions of the constituents of the clinical waste arising from acute inpatient 
ward has been estimated from previous studies [Hoenich et al., 2005] and personal communication with 
the author (Dr Nicholas Hoenich, by email, 9th March 2010). DEFRA emissions factors for incineration 
of waste have been applied to each of these constituents to determine their associated emissions 
[DEFRA, 2009].  
 
Estimation of the weight of clinical waste produced by the Transplantation Services 
The care of patients with renal transplants is encompassed by the acute inpatient service and the 
outpatient services. All waste produced in their care is therefore accounted for within these services. 
 
Estimation of the weight of clinical waste produced by the administration departments 
It has been assumed that the administration departments generate no clinical waste. 
 
1.b. Domestic waste that is incinerated. 
 
It has been assumed that segregation at source is imperfect, and that domestic waste enters the clinical 
waste stream and is incinerated. The amount of domestic waste entering the clinical waste stream has 
been estimated at 25% of the original volume of clinical waste produced by each component of the 
Dorset Renal Service. The nature and proportions of the constituents of the domestic waste entering the 
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clinical waste streams of each of component of the Dorset Renal Service has been estimated from 
previous studies [Tudor et al., 2008]. DEFRA emissions factors for incineration of waste have been 
applied to each of these constituents to determine their associated emissions [DEFRA, 2009]. 
 
2. Waste that is not incinerated (disposal by recycling or landfill) 
 
The weight of domestic waste produced by the different components of the Dorset Renal Service has 
been estimated from the respective weights of clinical waste and the assumption that 40% of all waste 
produced by the Dorset Renal Service is clinical waste and that the remainder is domestic waste (based 
on a previous study suggesting that 30% of all hospital waste is clinical waste [Askarian et al., 2004], 
and the assumption that renal medicine produces a higher proportion of clinical waste than the 
average), with the exception of the Outpatient Services, where is has been assumed that only 20% of all 
waste produced is clinical waste. 
 
2.a. Domestic waste that is recycled. 
 
For the purposes of this study it has been assumed that only half of the recyclable waste produced by 
the Dorset Renal Service enters the recycling waste stream. Published studies suggest 60% of all 
domestic healthcare waste is recyclable [Tudor et al., 2008]. Therefore, 30% of all domestic waste 
produced by each of the components of the Dorset Renal Service is considered to be recycled. The 
nature and proportions of the constituents of the clinical waste arising from the components of the 
Dorset Renal Service have been estimated from previous studies [Tudor et al., 2008]. DEFRA 
emissions factors for the recycling of waste have been applied to each of these constituents to 
determine their associated emissions [DEFRA, 2009]. 
 
2.a. Domestic waste that is sent to landfill 
 
It therefore follows that, within each component of the Dorset Renal Service, 70% of all domestic 
waste is not recycled. This waste is sent to landfill. 
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It has been assumed that 40% of this waste is not organic [Tudor et al., 2008]. The nature and 
proportions of the constituents of this waste arising from the components of the Dorset Renal Service 
have been estimated from the findings of previous studies [Tudor et al., 2008]. Emissions associated 
with the disposal of this waste have been determined by the application of DEFRA emissions factors to 
these constituents. 
 
The remaining 60% of the domestic waste that is not recycled is therefore assumed to be organic. In the 
acute inpatient ward (and, by assumption, also in the administration services), 25% of this domestic, 
non-recycled, organic waste is food waste [Tudor et al., 2008] and 75% is non-food waste. In the 
Outpatient Services, and by assumption also the Haemodialysis and Peritoneal Dialysis Services, the 
proportion of food waste falls to 8%. Emissions associated with the disposal of food and non-food 
organic domestic waste from each component of the Dorset Renal Service have been determined by the 
application of DEFRA emissions factors [DEFRA, 2009]. 
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Appendix 3. 
 
An assessment of the Carbon Footprint of the Dorset Renal Service using 
alternative emissions factors for pharmaceuticals and medical equipment. 
 
The three sets of emissions factors applied to the activity data collected for pharmaceuticals and 
medical equipment in this study are outlined in Table 25 below. 
 
Table 25. Emissions Factors applicable to pharmaceuticals and medical equipment. 
 Pharmaceuticals Medical Equipment 
Source of Emissions 
Factor 
Emissions 
Intensity (kg/£ 
spent) for C02 
 
Emissions 
Intensity (kg/£ 
spent) for C02eq 
Emissions 
Intensity (kg/£ 
spent) for C02 
 
Emissions 
Intensity (kg/£ 
spent) for C02eq 
DEFRA [DEFRA, 2009] 0.62 0.81 0.45 0.57 
National Statistics of 
Environmental 
Accounts [Sustainable 
Development Commission, 2008]
 
0.24 0.27 0.20 0.23 
Averaged Emissions 
Factors 
0.430 0.540 0.325 0.400 
 
The results of the carbon footprint of the Dorset Renal Service, determined using the DEFRA 
emissions factors, are presented and discussed in the main text of Chapter 3. In this Appendix, the 
results of the carbon footprint derived using the two alternative sets of emissions factors for 
pharmaceuticals and medical equipment are presented.  
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1. An assessment using emissions factors from the National Statistics of Environmental 
Accounts.  
 
Primary Sector Results 
The calculated emissions for the primary sectors resulting from the application of emissions factors 
from the National Statistics of Environmental Accounts to the activity data for medical equipment 
and pharmaceuticals, are given below in Table 26.  
 
Table 26. The emissions attributable to the primary sectors, determined through the application of the 
emissions factors from the National Statistics of Environmental Accounts to the activity data for 
medical equipment and pharmaceuticals. 
Sector 
GHG Emissions 
(kg CO2eq) 
%age of GHG 
Emissions a 
Building Energy Use 381,331 20% 
Travel  461,886 25% 
Procurement 1,028,698 55% 
Total Dorset Renal Service Emissions (Kg) 1,871,916 100% 
Total Dorset Renal Service Emissions (tonnes) 1,872 100% 
a
 Values rounded to nearest 1% 
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Sub-sector Results 
The calculated emissions for the sub-sectors resulting from the application of emissions factors from 
the National Statistics of Environmental Accounts to the activity data for medical equipment and 
pharmaceuticals, are given below in Table 27.  
 
Table 27. The emissions attributable to the sub-sectors, determined through the application of the 
emissions factors from the National Statistics of Environmental Accounts to the activity data for 
medical equipment and pharmaceuticals. 
Sector Subsector 
GHG Emissions 
(kg CO2eq) 
%age of GHG 
Emissions 
Building Energy Use  381,331 20.43% 
 Total for Building Energy Use 381,331 20.43% 
      
Staff Commuting 143,774 7.70% 
Staff Business 17,774 0.95% 
Patient Travel 279,293 14.96% 
Visitor Travel 20,448 1.10% 
Travel 
Other Travel 598 0.03% 
 Total for Travel 461,886 24.74% 
     
Pharmaceuticals 351,780 18.85% 
Medical Equipment 304,738 16.32% 
Diagnostics (Radiology) 209 0.01% 
Diagnostics (Pathology) 4,720 0.25% 
Paper 8,383 0.45% 
Food 6,933 0.37% 
Laundry Services 14,070 0.75% 
Construction 28,262 1.51% 
IT  5,268 0.28% 
Water 6,169 0.33% 
Sanitation Products 1,743 0.09% 
Procurement 
Waste 291,125 15.60% 
 Total for Procurement 1,023,400 54.83% 
      
Kg 1,866,617 100% 
Overall Totals 
Tonnes 1,866 100% 
 235 
2. An assessment using emissions factors averaged from those produced by the National 
Statistics of Environmental Accounts and from DEFRA. 
 
Primary Sector Results 
The calculated emissions for the primary sectors resulting from the application of averaged emissions 
factors to the activity data for medical equipment and pharmaceuticals are given below in Table 28.  
 
Table 28. The emissions attributable to the primary sectors, determined through the application of the 
averaged emissions factors to the activity data for medical equipment and pharmaceuticals. 
Sector 
GHG Emissions 
(kg CO2eq) 
%age of GHG 
Emissions a 
Building Energy Use 381,331 16% 
Travel  461,886 19% 
Procurement 1,593,401 65% 
Total Dorset Renal Service Emissions (Kg) 2,436,619 100% 
Total Dorset Renal Service Emissions (tonnes) 2,437 100% 
a
 Values rounded to the nearest 1% 
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Sub-sector Results 
The calculated emissions for the sub-sectors resulting from the application of averaged emissions 
factors to the activity data for medical equipment and pharmaceuticals are given below in Table 29.  
 
Table 29. The emissions attributable to the sub-sectors, determined through the application of the 
averaged emissions factors to the activity data for medical equipment and pharmaceuticals. 
Sector Subsector 
GHG Emissions 
(kg CO2eq) 
%age of GHG 
Emissions 
Building Energy Use  381,331 15.65% 
 Total for Building Energy Use 381,331 15.65% 
      
Staff Commuting 143,774 5.90% 
Staff Business  17,774 0.73% 
Patient Travel 279,293 11.46% 
Visitor Travel 20,448 0.84% 
Travel 
Other Travel 598 0.02% 
 Total for Travel 461,886 18.96% 
     
Pharmaceuticals 697,720 28.63% 
Medical Equipment 528,800 21.70% 
Diagnostics (Radiology) 209 0.01% 
Diagnostics (Pathology) 4,720 0.19% 
Paper 8,383 0.34% 
Food 6,933 0.28% 
Laundry Services 14,070 0.58% 
Construction 28,262 1.16% 
IT  5,268 0.22% 
Water 6,169 0.25% 
Sanitation Products 1,743 0.07% 
Procurement 
Waste 291,125 11.95% 
 Total for Procurement 1,593,401 65.39% 
      
Kg 2,436,619 100% 
Overall Totals 
Tonnes 2,437 100% 
 
Considerable variation exists between the emissions factors quoted by different sources for the medical 
equipment and pharmaceutical supply chains. The impact of this variation, which is emphasised by the 
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extent to which these subsectors contribute to the carbon footprint, is illustrated in Figure 5 within the 
main text of Chapter 4.  
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Appendix 4. 
 
Inventory of the Consumables Used during the Provision of Haemodialysis 
(ICHD or HHD) using a Standard Machine. 
 
The consumable items of medical equipment used during the provision of haemodialysis using a 
standard haemodialysis machine are listed in table 30.  
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Table 30. The consumable items of medical equipment used during the provision of 
haemodialysis using a standard haemodialysis machine.  
Item Constituent Materials 
Optimal Waste 
Stream for 
each item 
Constituent Materials of 
Associated Packaging 
Optimal Waste 
Stream for Each 
Piece of Packaging 
Paper Recycling 
Blood Lines PVC Incineration 
Low density Polyethylene Recycling 
Polycarbonate shell 
Synthetic fibres: polyamide/nylon Dialyser 
Polyurethane 'glue' 
Incineration Low density Polyethylene Recycling 
Polypropylene 
Polyethylene 
Polyamide 
Saline 1L 
Saline solution 
Landfill High density polyethylene Recycling 
PVC Paper 
Giving Set 
Polycarbonate 
Incineration 
Low density Polyethylene 
Recycling 
Acid Solution Acid 
Cartridge General Plastic 
Landfill Low density Polyethylene Recycling 
Bicarbonate solution (BiBag 650g) 
Bicarbonate 
Polypropylene 
Landfill Low density Polyethylene Recycling 
Stainless steel Paper Recycling 
PVC 
Fistula 
needles 
Polycarbonate 
Incineration 
Low density Polyethylene Recycling 
Paper Recycling 2x 10 
millilitres 
syringe 
Polypropylene Incineration 
Low density Polyethylene Recycling 
2 pairs of 
disposable 
gloves 
Rubber Incineration Paper Recycling 
Apron Low density Polyethylene Incineration Nil N/A 
Kidney 
Dish 
Paper Incineration Nil N/A 
2 x Gauze 
packs 
Polypropylene film Incineration Paper Recycling 
2 x plasters Polyurethane Landfill Paper Recycling 
2 x dressing 
towels 
Paper Recycling Low density Polyethylene Recycling 
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Appendix 5. 
 
Inventory of the Consumables Used during the Provision of HHD using a Mobile 
NxStage Machine. 
 
The consumable items of medical equipment used during the provision of haemodialysis using a 
Mobile NxStage haemodialysis machine are listed in Table 31.  
 
Table 31. The consumable items of medical equipment used during the provision of 
haemodialysis using a Mobile NxStage haemodialysis machine.  
Item Constituent Parts Constituent Materials 
Optimal waste 
stream for each 
item 
Constituent Materials 
of Associated 
Packaging 
Optimal Waste 
Stream for 
Each Piece of 
Packaging 
Blood Lines PVC 
Polycarbonate shell 
Synthetic fibres: polyamide/nylon Dialyser 
Polyurethane 'glue' 
Cassette Tray Polystyrene 
Cartridge 
Plastic Wallet General Plastic 
Incineration 
(although individual 
constituent parts may 
be recyclable, they 
cannot easily be 
detached from those 
parts requiring 
incineration).  
One polythene packet Recycling 
Low density Polyethylene 
PVC Bag 
Nylon 
Locks etc Polycarbonate 
SAK (a disposable 
container in which 
the dialysate is 
stored and 
produced). 
[One SAK used for 
every 2 treatments 
undertaken at home.] 
Tubing PVC 
Landfill (the 
constituent parts 
cannot currently be 
recycled and are not 
easily segregated). 
One polythene packet Recycling 
Bags PVC 
Dialysate solution Dialysis Solution 
5 Pre-packaged 
fluid bags of 
dialysate 
[5 bags required for 
every treatment away 
from home] 
Tubing PVC 
Landfill (the 
constituent parts 
cannot currently be 
recycled and are not 
easily segregated).  
5 high density polythene 
packets 
Recycling 
 Table continued overleaf. 
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Table 31 continued… 
Item Constituent Parts Constituent Materials 
Optimal waste 
stream for each 
item 
Constituent Materials 
of Associated 
Packaging 
Optimal Waste 
Stream for 
Each Piece of 
Packaging 
Stainless steel Paper Recycling 
PVC Fistula needles 
Polycarbonate 
Incineration Low density polythene 
Recycling 
2 x 10 millilitres 
syringe 
Polypropylene Incineration Paper  Recycling 
   Low density polythene Recycling 
     
2 pairs of disposable 
gloves 
Rubber Incineration Paper Recycling 
Apron Low density Polyethylene Incineration Nil N/A 
Kidney Dish Paper Incineration Nil N/A 
2 x Gauze packs Polypropylene film Incineration Paper Recycling 
2 x plasters Polyurethane Landfill Paper Recycling 
2 x dressing towels 
 
Paper Recycling Low density polythene Recycling 
Polycarbonate shell 
Synthetic fibres: polyamide/nylon  Paper 
Polyurethane 'glue' 
Plastic Conductivity cell 
& locks etc Metal 
Canisters ABS plastic 
cannister media Activated carbon 
ion exchange resin Polystyrene 
Tubing PVC 
Plastic 
Electrical wiring 
Copper 
Polystyrene 
PAK (Disposable 
Filter) 
 
[Assumed to be 
changed every 10 
weeks.] 
Outer casing 
Plastic 
Landfill (although 
individual constituent 
parts may be 
recyclable, they 
cannot easily be 
detached from those 
parts that are not). 
One cardboard box Recycling 
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Appendix 6. 
 
Electricity Consumed by Water Treatment Systems in ICHD Facilities. 
 
Electricity use by the pump 
In the Dorset County Hospital dialysis facility water treatment system, a water pressurising pump, 
powered by a 1.5 kWh motor, runs for 20 hours a day at an estimated 90% of its capacity, and idles for 
the remaining four hours (during which time it is assumed that the pump draws a negligible amount of 
electricity). The pump therefore draws (20 x 1.35) 27 kWh of electricity per day, six days a week. The 
pump therefore draws (27 * 6) 162 kWh of electricity each week, during which 165 ICHD treatments 
are provided. Therefore the energy use of the pressurising pump is 0.98 kWh per ICHD treatment. It 
follows, therefore, that the provision of 156 ICHD treatments to an individual patient over the course of 
one year will draw (156 * 0.98) 152.88 kWh.  
 
Electricity use by the reverse osmosis plant 
The Dorset County Hospital dialysis facility water treatment system uses two Gambro 104s reverse 
osmosis systems running in tandem. Each reverse osmosis system has a pump, valves and membranes. 
The power consumption is stated as 2.2 kWh for each pump and 2.5 kWh for each reverse osmosis 
system in total. Therefore, the Dorset County Hospital reverse osmosis plant draws a total 5 kWh of 
electricity per hour. The reverse osmosis plant runs from 0545 hrs to 0100 hrs on Mondays, Tuesdays 
and Fridays (a total of 17.25 hrs), and from 0545 hrs to 2000 hrs on Tuesdays, Thursdays and 
Saturdays (a total of 14.25 hrs). The weekly running time is therefore 94.5 hours, during which it draws 
a total of 472.5 kWh, whilst supporting the provision of 165 ICHD treatments. The electricity drawn by 
the reverse osmosis plant and attributable to the provision of one ICHD treatment is therefore 2.86 
kWh. The provision of 156 ICHD treatments to an individual patient over the course of one year will 
therefore draw (156 * 2.86) 446.16 kWh.    
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Electricity used to maintain the temperature of the stored pure water above 60 °C  
In the Dorset County Hospital dialysis facility, the purified water is stored in a 330 litre tank. In order 
to maintain the water temperature above 60 °C, the water is heated to 63 °C eight times each day (and 
allowed to cool spontaneously) on six days of the week, and six times on the day of the ‘loop 
disinfection’ cycle. Making the assumption that the process is 100% efficient, the energy required for 
this process has been calculated using the formula Energy Used = C x M x ∆ T, where: C = specific 
heat capacity of water (4.19 J g-1 K-1); M= the mass of water being heated, in g (330 litres of water 
equates to 330 kg or 330,000 g); and ∆T = the change in temperature required, in °K or °C (3 °C).  
 
Energy used = 4.19 J g-1 K-1 x 330,000 g x 3 °C = 4,148,100 watt seconds or joules. 
 
Therefore, the energy used to heat the 330 litres of stored water from 60 °C to 63 °C is (4,148,100 / 
3,600,000) 1.152 kWh. Therefore, the energy used to maintain the stored water at or above 60 °C for 
one week is [(1.152 x 8 x 6) + (1.152 x 6 x 1)] 62.208 kWh. In one week, this water will support the 
provision of 165 ICHD treatments. Therefore the energy required to store the heated water for one 
treatment is (62.208 / 165) 0.3770 kWh. Finally, therefore, the energy attributable to storing heated 
water to provide one patient with one year of ICHD treatment (156 sessions)  is (156 * 0.377) 58.815 
kWh. 
 
Electricity used during loop disinfections 
During the periodic ‘loop disinfections’, the stored water is heated from 60°C to 90 °C and pumped 
through the pipe-work supplying the haemodialysis machines. It has been assumed that loop 
disinfection is undertaken on a weekly basis and that the process described is 100% efficient. The 
energy required to heat the water has once again been calculated using the formula Energy Used = C x 
M x ∆ T, where ∆T is now equal to 30 °C. 
 
Energy used = 4.19 J g-1 K-1 x 330,000 g x 30 °C = 41,481,000 watt seconds or joules 
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Therefore, the energy used to heat the 330 litres of stored water from 60 °C to 90 °C on a weekly basis 
is (41,481,000 / 3,600,000) 11.52 kWh. Once heated to 90°C, the water is pumped around the loop. It 
has been assumed that a 1kW pump is used and that the process takes approximately 1 hour. Therefore 
a further 1 kWh of energy is used. A single loop disinfection therefore requires 12.52 kWh (11.52 + 
1.0) and serves the facility for one week, during which time 165 treatments are provided. The energy 
consumed by loop disinfections and attributable to a single ICHD treatment is therefore (12.52/165) 
0.0758 kWh. As such, the energy use attributable to the loop disinfections entailed in the provision of 
ICHD to one patient for one year is (156 * 0.0758) 11.8 kWh. 
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Appendix 7. 
 
A comparison of the constituent materials method and the economic activity data 
method to determine the medical equipment emissions arising from a single 
haemodialysis treatment using a standard haemodialysis machine. 
 
For the reasons outlined previously, the emissions attributable to the consumable items of medical 
equipment have been determined through the application of emissions factors from the ICE database to 
the weights of the constituent materials of these items. However, an alternative approach, using 
economic activity data and DEFRA supply chain emissions factors [DEFRA, 2009], is possible. 
Although the two approaches might be anticipated to produce differing results, any significant 
discrepancy would require further examination. For this reason, a comparison of the use of the two 
approaches to determine the medical equipment emissions for a single haemodialysis treatment using a 
standard haemodialysis machine has been undertaken.  
 
The data sources and assumptions supporting the constituent materials method have been outlined 
previously. To determine emissions using economic activity data, the unit prices of the items of 
medical equipment were obtained from a combination of the British National Formulary [British 
National Formulary, 2010], the on-line services of dialysis and hospital equipment suppliers, and 
costings reported by the Procurement Department of a United Kingdom renal service (the Dorset Renal 
Service). The results are shown in Table 32 below. The DEFRA supply chain emissions factors include 
the emissions attributable to processes such as transportation and manufacturing [DEFRA, 2009], and 
the 10% uplift factor used in constituent materials method is therefore not required. 
 
The two approaches produce very similar results when used to determine the emissions attributable to 
the medical equipment required to provide a single treatment using a standard haemodialysis machine. 
These results therefore support the use of the constituent materials method to determine the emissions 
attributable to the medical equipment used in Mobile HHD technologies (for which economic activity 
data were anticipated to reflect emissions less consistently).  
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Table 32. The medical equipment emissions arising from a single haemodialysis treatment using a 
standard haemodialysis machine. 
  Economic Activity Data Method Constituent Materials Method 
 Constituent Materials 
Financial 
Cost 
Deflated to 
2004 prices 
(£) 
DEFRA 
Emissions 
Factor  
(kg CO2 
per £) 
CO2 
Emissions 
(kg CO2) 
Weight (kg) 
ICE Supply 
Chain Emissions 
Factor (kg CO2 
per kg weight) 
CO2 Emissions  
(kg CO2) 
Blood 
Lines 
PVC 
4.46 
 
 
0.45 2.01 0.336 2.41 0.80976 
Polycarbonate shell 0.192 6 1.152 
Synthetic fibres: 
polyamide/nylon 
0.118 6 0.708 Dialyser 
Polyurethane 'glue' 
6.24 0.45 2.81 
0.005 3 0.015 
Polypropylene 33% 0.008 2.7 0.0216 
Polyethylene 33% 0.008 1.94 0.01552 
Polyamide 33% 0.008 2.53 0.02024 
Saline 1L 
Saline solution 
0.44 0.45 0.20 
0.494 a 0.62 b 0.30628 
PVC 0.016 2.41 0.03856 
Giving Set 
Polycarbonate 
0.89 0.45 0.40 
0.012 6 0.072 
Acid Solution 2.65 a 0.62 b 1.643 Acid 
Cartridge Plastic (unclear) 
2.36 0.45 1.06 
0.294 2.53 0.74382 
Bicarbonate solution 
(BiBag 650g) 
1.8 a 0.62 b 1.116 
Bicarbonate 
Polypropylene 
1.60 0.45 0.72 
0.084 3.9 0.3276 
Stainless steel 0.002 6.15 0.0123 
PVC 0.008 2.41 0.01928 
Fistula 
needles 
Polycarbonate 
0.27 0.45 0.12 
0.006 6 0.036 
2x 10 ml 
syringes 
Polypropylene 0.07 0.45 0.03 0.016 2.7 0.0432 
Disposable 
gloves 
Rubber 0.07 0.45 0.03 0.016 3.18 0.05088 
Apron Low density Polyethylene 0.03 0.45 0.01 0.005 1.7 0.0085 
Kidney 
Dish 
Paper 0.06 0.45 0.03 0.016 1.5 0.024 
Disposable 
gloves 
Rubber 0.07 0.45 0.03 0.016 3.18 0.05088 
2 x gauze 
packs 
Polypropylene film 0.22 0.45 0.10 0.006 2.7 0.0162 
2 x 
plasters 
Polyurethane 0.09 0.45 0.04 0.002 3 0.006 
2 x 
dressing 
towels 
Paper 0.27 0.45 0.12 0.004 1.5 0.006 
Total   7.715     7.26262 
10% (for manufacturing 
energies, distribution etc) 
  
Not 
appropriate 
    0.726262 
  
  
  
Overall Total    7.715     7.988882 
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a,b
 for the constituent materials method, the emissions attributable to the procurement of the 
pharmaceutical grade fluids (saline, acid and alkali) have been determined from economic activity data 
a
 (in £) and DEFRA pharmaceuticals emissions factors [DEFRA, 2009] b. 
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